cancer_group,confounder,hugo_symbol,cancer,variable,y,n,mean,median,q1,q2,ras,codon_range,codon_label
single,Age,KRAS,appendiceal cancer,<40,0,28,0.004,0.002,0,0.016,KRAS_12A,12A,NA
single,Age,KRAS,appendiceal cancer,40-50,0,62,0.003,0.002,0,0.013,KRAS_12A,12A,NA
single,Age,KRAS,appendiceal cancer,50-65,1,161,0.004,0.003,0,0.015,KRAS_12A,12A,NA
single,Age,KRAS,appendiceal cancer,>65,0,90,0.003,0.002,0,0.012,KRAS_12A,12A,NA
single,Age,KRAS,colorectal cancer,<40,7,565,0.019,0.02,0.01,0.026,KRAS_12A,12A,NA
single,Age,KRAS,colorectal cancer,40-50,28,1280,0.021,0.021,0.016,0.028,KRAS_12A,12A,NA
single,Age,KRAS,colorectal cancer,50-65,70,2815,0.023,0.023,0.019,0.029,KRAS_12A,12A,NA
single,Age,KRAS,colorectal cancer,>65,40,2055,0.02,0.02,0.016,0.025,KRAS_12A,12A,NA
single,Age,KRAS,cancer of unknown primary,<40,0,167,0.006,0.006,0.001,0.012,KRAS_12A,12A,NA
single,Age,KRAS,cancer of unknown primary,40-50,1,211,0.007,0.007,0.002,0.013,KRAS_12A,12A,NA
single,Age,KRAS,cancer of unknown primary,50-65,5,810,0.007,0.007,0.003,0.012,KRAS_12A,12A,NA
single,Age,KRAS,cancer of unknown primary,>65,8,797,0.008,0.008,0.004,0.014,KRAS_12A,12A,NA
single,Age,KRAS,non-small cell lung cancer,<40,0,161,0.006,0.004,0,0.019,KRAS_12A,12A,NA
single,Age,KRAS,non-small cell lung cancer,40-50,3,585,0.007,0.006,0.002,0.015,KRAS_12A,12A,NA
single,Age,KRAS,non-small cell lung cancer,50-65,67,3677,0.018,0.018,0.014,0.023,KRAS_12A,12A,NA
single,Age,KRAS,non-small cell lung cancer,>65,156,5698,0.027,0.027,0.023,0.032,KRAS_12A,12A,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0.015,0.009,0,0.064,KRAS_12A,12A,NA
single,Age,KRAS,breast cancer,<40,0,841,0.001,0,0,0.002,KRAS_12A,12A,NA
single,Age,KRAS,breast cancer,40-50,0,1910,0,0,0,0.001,KRAS_12A,12A,NA
single,Age,KRAS,breast cancer,50-65,2,3989,0.001,0.001,0,0.001,KRAS_12A,12A,NA
single,Age,KRAS,breast cancer,>65,4,2583,0.001,0.001,0,0.003,KRAS_12A,12A,NA
single,Age,KRAS,breast cancer,NA,0,10,0.001,0.001,0,0.006,KRAS_12A,12A,NA
single,Age,KRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,pancreatic cancer,<40,0,87,0.005,0.004,0,0.011,KRAS_12A,12A,NA
single,Age,KRAS,pancreatic cancer,40-50,0,200,0.004,0.004,0,0.009,KRAS_12A,12A,NA
single,Age,KRAS,pancreatic cancer,50-65,4,1000,0.005,0.005,0.002,0.008,KRAS_12A,12A,NA
single,Age,KRAS,pancreatic cancer,>65,9,1205,0.006,0.006,0.003,0.011,KRAS_12A,12A,NA
single,Age,KRAS,leukemia,<40,1,204,0.004,0.003,0.001,0.009,KRAS_12A,12A,NA
single,Age,KRAS,leukemia,40-50,0,128,0.003,0.003,0,0.008,KRAS_12A,12A,NA
single,Age,KRAS,leukemia,50-65,1,515,0.003,0.003,0.001,0.007,KRAS_12A,12A,NA
single,Age,KRAS,leukemia,>65,3,720,0.003,0.003,0.001,0.008,KRAS_12A,12A,NA
single,Age,KRAS,melanoma,<40,0,289,0,0,0,0.002,KRAS_12A,12A,NA
single,Age,KRAS,melanoma,40-50,0,282,0,0,0,0.002,KRAS_12A,12A,NA
single,Age,KRAS,melanoma,50-65,0,1016,0,0,0,0.001,KRAS_12A,12A,NA
single,Age,KRAS,melanoma,>65,1,1259,0.001,0,0,0.002,KRAS_12A,12A,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0.001,0,0,0.004,KRAS_12A,12A,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0.001,0,0,0.003,KRAS_12A,12A,NA
single,Age,KRAS,head and neck cancer,50-65,0,799,0.001,0,0,0.002,KRAS_12A,12A,NA
single,Age,KRAS,head and neck cancer,>65,1,582,0.001,0.001,0,0.004,KRAS_12A,12A,NA
single,Age,KRAS,uterine cancer,<40,0,57,0.013,0.013,0.002,0.022,KRAS_12A,12A,NA
single,Age,KRAS,uterine cancer,40-50,1,162,0.013,0.013,0.003,0.021,KRAS_12A,12A,NA
single,Age,KRAS,uterine cancer,50-65,17,1046,0.015,0.014,0.009,0.021,KRAS_12A,12A,NA
single,Age,KRAS,uterine cancer,>65,13,988,0.013,0.013,0.008,0.02,KRAS_12A,12A,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,1,87,0.007,0.003,0,0.032,KRAS_12A,12A,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.001,0,0,0.007,KRAS_12A,12A,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0.001,0,0,0.003,KRAS_12A,12A,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0.003,KRAS_12A,12A,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,KRAS_12A,12A,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.005,KRAS_12A,12A,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.005,KRAS_12A,12A,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.005,KRAS_12A,12A,NA
single,Age,KRAS,ovarian cancer,<40,3,141,0.009,0.007,0.003,0.027,KRAS_12A,12A,NA
single,Age,KRAS,ovarian cancer,40-50,1,253,0.006,0.006,0.002,0.012,KRAS_12A,12A,NA
single,Age,KRAS,ovarian cancer,50-65,6,1092,0.006,0.006,0.003,0.01,KRAS_12A,12A,NA
single,Age,KRAS,ovarian cancer,>65,4,849,0.006,0.006,0.003,0.01,KRAS_12A,12A,NA
single,Age,KRAS,esophagogastric cancer,<40,0,122,0.002,0.002,0,0.009,KRAS_12A,12A,NA
single,Age,KRAS,esophagogastric cancer,40-50,1,200,0.004,0.003,0,0.014,KRAS_12A,12A,NA
single,Age,KRAS,esophagogastric cancer,50-65,0,752,0.002,0.001,0,0.005,KRAS_12A,12A,NA
single,Age,KRAS,esophagogastric cancer,>65,5,725,0.006,0.005,0.002,0.012,KRAS_12A,12A,NA
single,Age,KRAS,thyroid cancer,<40,0,150,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,thyroid cancer,50-65,0,374,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,thyroid cancer,>65,0,370,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,cervical cancer,<40,0,85,0.003,0.002,0,0.012,KRAS_12A,12A,NA
single,Age,KRAS,cervical cancer,40-50,0,99,0.003,0.002,0,0.012,KRAS_12A,12A,NA
single,Age,KRAS,cervical cancer,50-65,1,144,0.004,0.003,0,0.016,KRAS_12A,12A,NA
single,Age,KRAS,cervical cancer,>65,0,36,0.003,0.002,0,0.015,KRAS_12A,12A,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0.004,0.004,0,0.011,KRAS_12A,12A,NA
single,Age,KRAS,hepatobiliary cancer,40-50,1,110,0.006,0.005,0.001,0.02,KRAS_12A,12A,NA
single,Age,KRAS,hepatobiliary cancer,50-65,5,525,0.007,0.006,0.002,0.015,KRAS_12A,12A,NA
single,Age,KRAS,hepatobiliary cancer,>65,1,601,0.004,0.004,0,0.009,KRAS_12A,12A,NA
single,Age,KRAS,kidney cancer,<40,0,191,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,kidney cancer,50-65,0,628,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,kidney cancer,>65,0,440,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,KRAS_12A,12A,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,KRAS_12A,12A,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,KRAS_12A,12A,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,KRAS_12A,12A,NA
single,Age,KRAS,cns cancer,<40,5,1602,0.002,0.002,0.001,0.005,KRAS_12A,12A,NA
single,Age,KRAS,cns cancer,40-50,0,687,0.001,0.001,0,0.003,KRAS_12A,12A,NA
single,Age,KRAS,cns cancer,50-65,1,1439,0.001,0.001,0,0.003,KRAS_12A,12A,NA
single,Age,KRAS,cns cancer,>65,0,836,0.001,0.001,0,0.002,KRAS_12A,12A,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,prostate cancer,50-65,0,960,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,prostate cancer,>65,0,1402,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.009,0.005,0,0.04,KRAS_12A,12A,NA
single,Age,KRAS,anal cancer,50-65,1,88,0.009,0.007,0,0.033,KRAS_12A,12A,NA
single,Age,KRAS,anal cancer,>65,0,45,0.007,0.004,0,0.029,KRAS_12A,12A,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0.003,0.001,0,0.02,KRAS_12A,12A,NA
single,Age,KRAS,neuroendocrine tumors,40-50,1,55,0.01,0.005,0,0.051,KRAS_12A,12A,NA
single,Age,KRAS,neuroendocrine tumors,50-65,0,161,0.002,0.001,0,0.01,KRAS_12A,12A,NA
single,Age,KRAS,neuroendocrine tumors,>65,0,121,0.002,0.001,0,0.011,KRAS_12A,12A,NA
single,Age,KRAS,bladder cancer,<40,1,25,0.013,0.003,0,0.085,KRAS_12A,12A,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0.002,0.002,0,0.011,KRAS_12A,12A,NA
single,Age,KRAS,bladder cancer,50-65,0,511,0.001,0.001,0,0.005,KRAS_12A,12A,NA
single,Age,KRAS,bladder cancer,>65,2,962,0.002,0.002,0,0.005,KRAS_12A,12A,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,1,142,0.005,0.004,0,0.019,KRAS_12A,12A,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.005,0.003,0,0.023,KRAS_12A,12A,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0.004,0.003,0,0.019,KRAS_12A,12A,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.005,0.003,0,0.019,KRAS_12A,12A,NA
single,Age,KRAS,small bowel cancer,40-50,0,29,0.018,0.015,0,0.049,KRAS_12A,12A,NA
single,Age,KRAS,small bowel cancer,50-65,3,96,0.024,0.021,0.006,0.057,KRAS_12A,12A,NA
single,Age,KRAS,small bowel cancer,>65,1,78,0.018,0.016,0.002,0.046,KRAS_12A,12A,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.007,KRAS_12A,12A,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.009,KRAS_12A,12A,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0.001,0,0,0.007,KRAS_12A,12A,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.007,KRAS_12A,12A,NA
single,Age,KRAS,bone cancer,<40,0,342,0.002,0.002,0,0.009,KRAS_12A,12A,NA
single,Age,KRAS,bone cancer,40-50,1,61,0.009,0.005,0.001,0.042,KRAS_12A,12A,NA
single,Age,KRAS,bone cancer,50-65,0,96,0.003,0.002,0,0.013,KRAS_12A,12A,NA
single,Age,KRAS,bone cancer,>65,1,67,0.009,0.005,0.001,0.037,KRAS_12A,12A,NA
single,Age,KRAS,vaginal cancer,50-65,0,34,0.013,0.007,0,0.057,KRAS_12A,12A,NA
single,Age,KRAS,vaginal cancer,>65,1,30,0.025,0.017,0.001,0.094,KRAS_12A,12A,NA
single,Age,KRAS,thymic tumor,<40,0,14,0.001,0,0,0.005,KRAS_12A,12A,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0,0,0,0.004,KRAS_12A,12A,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.004,KRAS_12A,12A,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.004,KRAS_12A,12A,NA
single,Age,KRAS,ampullary cancer,40-50,1,12,0.047,0.022,0.001,0.22,KRAS_12A,12A,NA
single,Age,KRAS,ampullary cancer,50-65,0,40,0.007,0.003,0,0.037,KRAS_12A,12A,NA
single,Age,KRAS,ampullary cancer,>65,0,50,0.007,0.003,0,0.035,KRAS_12A,12A,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0.004,0.002,0,0.018,KRAS_12A,12A,NA
single,Age,KRAS,small cell lung cancer,50-65,0,144,0.002,0.001,0,0.01,KRAS_12A,12A,NA
single,Age,KRAS,small cell lung cancer,>65,1,224,0.004,0.003,0,0.013,KRAS_12A,12A,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0.001,KRAS_12A,12A,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0.001,KRAS_12A,12A,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0,KRAS_12A,12A,NA
single,Age,KRAS,germ cell tumor,<40,4,650,0.008,0.007,0.003,0.015,KRAS_12A,12A,NA
single,Age,KRAS,germ cell tumor,40-50,2,131,0.01,0.009,0.003,0.025,KRAS_12A,12A,NA
single,Age,KRAS,germ cell tumor,50-65,1,92,0.009,0.008,0.003,0.023,KRAS_12A,12A,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0.009,0.008,0.001,0.027,KRAS_12A,12A,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0.005,0.003,0,0.024,KRAS_12A,12A,NA
single,Age,KRAS,nerve sheath tumor,40-50,1,27,0.018,0.009,0,0.087,KRAS_12A,12A,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0.006,0.003,0,0.028,KRAS_12A,12A,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0.008,0.004,0,0.041,KRAS_12A,12A,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.003,0,0,0.032,KRAS_12A,12A,NA
single,Age,KRAS,penile cancer,>65,0,11,0.003,0,0,0.033,KRAS_12A,12A,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.003,0,0,0.035,KRAS_12A,12A,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0.002,0.002,0,0.008,KRAS_12A,12A,NA
single,Age,KRAS,b cell lymphoma,40-50,0,105,0.002,0.002,0,0.008,KRAS_12A,12A,NA
single,Age,KRAS,b cell lymphoma,50-65,1,357,0.002,0.002,0,0.007,KRAS_12A,12A,NA
single,Age,KRAS,b cell lymphoma,>65,1,413,0.002,0.002,0,0.007,KRAS_12A,12A,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.042,KRAS_12A,12A,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.001,0,0,0.01,KRAS_12A,12A,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.007,KRAS_12A,12A,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.027,KRAS_12A,12A,NA
single,Age,KRAS,lung cancer,>65,0,18,0.003,0,0,0.038,KRAS_12A,12A,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.054,KRAS_12A,12A,NA
single,Age,KRAS,appendiceal cancer,<40,1,28,0.029,0.026,0.007,0.072,KRAS_12C,12C,NA
single,Age,KRAS,appendiceal cancer,40-50,1,62,0.025,0.024,0.006,0.053,KRAS_12C,12C,NA
single,Age,KRAS,appendiceal cancer,50-65,2,161,0.022,0.021,0.006,0.044,KRAS_12C,12C,NA
single,Age,KRAS,appendiceal cancer,>65,5,90,0.035,0.032,0.013,0.08,KRAS_12C,12C,NA
single,Age,KRAS,colorectal cancer,<40,16,565,0.03,0.03,0.022,0.039,KRAS_12C,12C,NA
single,Age,KRAS,colorectal cancer,40-50,34,1280,0.029,0.029,0.022,0.036,KRAS_12C,12C,NA
single,Age,KRAS,colorectal cancer,50-65,102,2815,0.034,0.033,0.028,0.041,KRAS_12C,12C,NA
single,Age,KRAS,colorectal cancer,>65,58,2055,0.03,0.03,0.024,0.036,KRAS_12C,12C,NA
single,Age,KRAS,cancer of unknown primary,<40,0,167,0.011,0.008,0,0.034,KRAS_12C,12C,NA
single,Age,KRAS,cancer of unknown primary,40-50,3,211,0.018,0.017,0.005,0.037,KRAS_12C,12C,NA
single,Age,KRAS,cancer of unknown primary,50-65,28,810,0.033,0.033,0.023,0.047,KRAS_12C,12C,NA
single,Age,KRAS,cancer of unknown primary,>65,30,797,0.036,0.035,0.025,0.05,KRAS_12C,12C,NA
single,Age,KRAS,non-small cell lung cancer,<40,1,161,0.017,0.014,0.002,0.045,KRAS_12C,12C,NA
single,Age,KRAS,non-small cell lung cancer,40-50,41,585,0.07,0.07,0.051,0.092,KRAS_12C,12C,NA
single,Age,KRAS,non-small cell lung cancer,50-65,439,3677,0.119,0.119,0.109,0.13,KRAS_12C,12C,NA
single,Age,KRAS,non-small cell lung cancer,>65,731,5698,0.128,0.128,0.12,0.137,KRAS_12C,12C,NA
single,Age,KRAS,non-small cell lung cancer,NA,1,10,0.094,0.078,0.012,0.273,KRAS_12C,12C,NA
single,Age,KRAS,breast cancer,<40,0,841,0.001,0.001,0,0.002,KRAS_12C,12C,NA
single,Age,KRAS,breast cancer,40-50,0,1910,0.001,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,breast cancer,50-65,3,3989,0.001,0.001,0,0.002,KRAS_12C,12C,NA
single,Age,KRAS,breast cancer,>65,5,2583,0.001,0.001,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,breast cancer,NA,0,10,0.002,0.001,0,0.009,KRAS_12C,12C,NA
single,Age,KRAS,soft tissue sarcoma,<40,2,672,0.002,0.002,0.001,0.005,KRAS_12C,12C,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0.002,0.002,0,0.004,KRAS_12C,12C,NA
single,Age,KRAS,soft tissue sarcoma,50-65,1,951,0.002,0.002,0,0.004,KRAS_12C,12C,NA
single,Age,KRAS,soft tissue sarcoma,>65,2,777,0.002,0.002,0.001,0.005,KRAS_12C,12C,NA
single,Age,KRAS,pancreatic cancer,<40,0,87,0.008,0.008,0,0.016,KRAS_12C,12C,NA
single,Age,KRAS,pancreatic cancer,40-50,1,200,0.008,0.008,0.001,0.015,KRAS_12C,12C,NA
single,Age,KRAS,pancreatic cancer,50-65,6,1000,0.007,0.007,0.003,0.012,KRAS_12C,12C,NA
single,Age,KRAS,pancreatic cancer,>65,15,1205,0.01,0.01,0.006,0.017,KRAS_12C,12C,NA
single,Age,KRAS,leukemia,<40,0,204,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,leukemia,40-50,0,128,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,leukemia,50-65,0,515,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,leukemia,>65,0,720,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,melanoma,<40,0,289,0.001,0,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,melanoma,40-50,0,282,0.001,0,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,melanoma,50-65,0,1016,0.001,0,0,0.002,KRAS_12C,12C,NA
single,Age,KRAS,melanoma,>65,2,1259,0.001,0.001,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0.001,0.001,0,0.005,KRAS_12C,12C,NA
single,Age,KRAS,head and neck cancer,40-50,1,216,0.002,0.001,0,0.009,KRAS_12C,12C,NA
single,Age,KRAS,head and neck cancer,50-65,1,799,0.001,0.001,0,0.004,KRAS_12C,12C,NA
single,Age,KRAS,head and neck cancer,>65,0,582,0.001,0.001,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,uterine cancer,<40,0,57,0.01,0.01,0,0.02,KRAS_12C,12C,NA
single,Age,KRAS,uterine cancer,40-50,0,162,0.009,0.009,0,0.017,KRAS_12C,12C,NA
single,Age,KRAS,uterine cancer,50-65,13,1046,0.012,0.012,0.007,0.018,KRAS_12C,12C,NA
single,Age,KRAS,uterine cancer,>65,13,988,0.012,0.012,0.007,0.019,KRAS_12C,12C,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,KRAS_12C,12C,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,ovarian cancer,<40,4,141,0.019,0.017,0.003,0.052,KRAS_12C,12C,NA
single,Age,KRAS,ovarian cancer,40-50,0,253,0.003,0.002,0,0.009,KRAS_12C,12C,NA
single,Age,KRAS,ovarian cancer,50-65,3,1092,0.003,0.003,0.001,0.007,KRAS_12C,12C,NA
single,Age,KRAS,ovarian cancer,>65,3,849,0.004,0.004,0.001,0.008,KRAS_12C,12C,NA
single,Age,KRAS,esophagogastric cancer,<40,1,122,0.004,0.003,0.001,0.012,KRAS_12C,12C,NA
single,Age,KRAS,esophagogastric cancer,40-50,0,200,0.003,0.002,0,0.007,KRAS_12C,12C,NA
single,Age,KRAS,esophagogastric cancer,50-65,2,752,0.003,0.003,0.001,0.006,KRAS_12C,12C,NA
single,Age,KRAS,esophagogastric cancer,>65,2,725,0.003,0.003,0.001,0.006,KRAS_12C,12C,NA
single,Age,KRAS,thyroid cancer,<40,0,150,0.002,0.002,0,0.007,KRAS_12C,12C,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0.002,0.002,0,0.007,KRAS_12C,12C,NA
single,Age,KRAS,thyroid cancer,50-65,1,374,0.002,0.002,0,0.007,KRAS_12C,12C,NA
single,Age,KRAS,thyroid cancer,>65,1,370,0.002,0.002,0,0.007,KRAS_12C,12C,NA
single,Age,KRAS,cervical cancer,<40,0,85,0.002,0.001,0,0.012,KRAS_12C,12C,NA
single,Age,KRAS,cervical cancer,40-50,0,99,0.002,0.001,0,0.011,KRAS_12C,12C,NA
single,Age,KRAS,cervical cancer,50-65,1,144,0.005,0.003,0,0.019,KRAS_12C,12C,NA
single,Age,KRAS,cervical cancer,>65,0,36,0.003,0.001,0,0.014,KRAS_12C,12C,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0.006,0.006,0,0.014,KRAS_12C,12C,NA
single,Age,KRAS,hepatobiliary cancer,40-50,0,110,0.006,0.006,0,0.014,KRAS_12C,12C,NA
single,Age,KRAS,hepatobiliary cancer,50-65,5,525,0.008,0.007,0.003,0.015,KRAS_12C,12C,NA
single,Age,KRAS,hepatobiliary cancer,>65,5,601,0.008,0.007,0.003,0.014,KRAS_12C,12C,NA
single,Age,KRAS,kidney cancer,<40,0,191,0.001,0,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0.001,0,0,0.004,KRAS_12C,12C,NA
single,Age,KRAS,kidney cancer,50-65,0,628,0,0,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,kidney cancer,>65,1,440,0.002,0.001,0,0.007,KRAS_12C,12C,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,cns cancer,<40,0,1602,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,cns cancer,40-50,0,687,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,cns cancer,50-65,0,1439,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,cns cancer,>65,0,836,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,prostate cancer,50-65,0,960,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,prostate cancer,>65,0,1402,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,anal cancer,40-50,0,12,0,0,0,0.002,KRAS_12C,12C,NA
single,Age,KRAS,anal cancer,50-65,0,88,0,0,0,0.002,KRAS_12C,12C,NA
single,Age,KRAS,anal cancer,>65,0,45,0,0,0,0.002,KRAS_12C,12C,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0.007,0.005,0,0.025,KRAS_12C,12C,NA
single,Age,KRAS,neuroendocrine tumors,40-50,1,55,0.009,0.006,0.001,0.037,KRAS_12C,12C,NA
single,Age,KRAS,neuroendocrine tumors,50-65,1,161,0.006,0.005,0.001,0.019,KRAS_12C,12C,NA
single,Age,KRAS,neuroendocrine tumors,>65,0,121,0.005,0.004,0,0.017,KRAS_12C,12C,NA
single,Age,KRAS,bladder cancer,<40,0,25,0.006,0.005,0,0.015,KRAS_12C,12C,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0.005,0.005,0,0.012,KRAS_12C,12C,NA
single,Age,KRAS,bladder cancer,50-65,3,511,0.005,0.005,0.002,0.011,KRAS_12C,12C,NA
single,Age,KRAS,bladder cancer,>65,5,962,0.005,0.005,0.002,0.01,KRAS_12C,12C,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,small bowel cancer,40-50,0,29,0.021,0.016,0,0.071,KRAS_12C,12C,NA
single,Age,KRAS,small bowel cancer,50-65,7,96,0.06,0.057,0.022,0.12,KRAS_12C,12C,NA
single,Age,KRAS,small bowel cancer,>65,1,78,0.023,0.019,0.001,0.061,KRAS_12C,12C,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.005,KRAS_12C,12C,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.005,KRAS_12C,12C,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0,0,0,0.004,KRAS_12C,12C,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.005,KRAS_12C,12C,NA
single,Age,KRAS,bone cancer,<40,0,342,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,bone cancer,40-50,0,61,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,bone cancer,50-65,0,96,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,bone cancer,>65,0,67,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,vaginal cancer,50-65,1,34,0.024,0.017,0.001,0.084,KRAS_12C,12C,NA
single,Age,KRAS,vaginal cancer,>65,0,30,0.013,0.008,0,0.059,KRAS_12C,12C,NA
single,Age,KRAS,thymic tumor,<40,0,14,0,0,0,0.002,KRAS_12C,12C,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0,0,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.002,KRAS_12C,12C,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.003,KRAS_12C,12C,NA
single,Age,KRAS,ampullary cancer,40-50,0,12,0.035,0.03,0,0.101,KRAS_12C,12C,NA
single,Age,KRAS,ampullary cancer,50-65,3,40,0.052,0.045,0.013,0.132,KRAS_12C,12C,NA
single,Age,KRAS,ampullary cancer,>65,1,50,0.034,0.03,0.004,0.083,KRAS_12C,12C,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0.009,0.007,0,0.028,KRAS_12C,12C,NA
single,Age,KRAS,small cell lung cancer,50-65,1,144,0.008,0.007,0.001,0.021,KRAS_12C,12C,NA
single,Age,KRAS,small cell lung cancer,>65,2,224,0.008,0.007,0.002,0.021,KRAS_12C,12C,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0.001,KRAS_12C,12C,NA
single,Age,KRAS,germ cell tumor,<40,0,650,0.001,0.001,0,0.006,KRAS_12C,12C,NA
single,Age,KRAS,germ cell tumor,40-50,3,131,0.019,0.016,0.003,0.049,KRAS_12C,12C,NA
single,Age,KRAS,germ cell tumor,50-65,1,92,0.009,0.007,0,0.035,KRAS_12C,12C,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0.009,0.003,0,0.061,KRAS_12C,12C,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.005,KRAS_12C,12C,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.005,KRAS_12C,12C,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.005,KRAS_12C,12C,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.006,KRAS_12C,12C,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.002,0,0,0.028,KRAS_12C,12C,NA
single,Age,KRAS,penile cancer,>65,0,11,0.002,0,0,0.027,KRAS_12C,12C,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.003,0,0,0.042,KRAS_12C,12C,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,b cell lymphoma,40-50,0,105,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,b cell lymphoma,50-65,0,357,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,b cell lymphoma,>65,0,413,0,0,0,0,KRAS_12C,12C,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.044,KRAS_12C,12C,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.019,KRAS_12C,12C,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.013,KRAS_12C,12C,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.023,KRAS_12C,12C,NA
single,Age,KRAS,lung cancer,>65,2,18,0.117,0.103,0.018,0.293,KRAS_12C,12C,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.005,0,0,0.056,KRAS_12C,12C,NA
single,Age,KRAS,appendiceal cancer,<40,12,28,0.307,0.292,0.222,0.474,KRAS_12D,12D,NA
single,Age,KRAS,appendiceal cancer,40-50,18,62,0.279,0.276,0.21,0.364,KRAS_12D,12D,NA
single,Age,KRAS,appendiceal cancer,50-65,40,161,0.263,0.263,0.206,0.321,KRAS_12D,12D,NA
single,Age,KRAS,appendiceal cancer,>65,22,90,0.264,0.265,0.196,0.331,KRAS_12D,12D,NA
single,Age,KRAS,colorectal cancer,<40,86,565,0.14,0.138,0.122,0.165,KRAS_12D,12D,NA
single,Age,KRAS,colorectal cancer,40-50,180,1280,0.137,0.136,0.123,0.154,KRAS_12D,12D,NA
single,Age,KRAS,colorectal cancer,50-65,365,2815,0.131,0.131,0.12,0.142,KRAS_12D,12D,NA
single,Age,KRAS,colorectal cancer,>65,253,2055,0.127,0.128,0.114,0.14,KRAS_12D,12D,NA
single,Age,KRAS,cancer of unknown primary,<40,5,167,0.047,0.048,0.022,0.066,KRAS_12D,12D,NA
single,Age,KRAS,cancer of unknown primary,40-50,8,211,0.049,0.049,0.027,0.066,KRAS_12D,12D,NA
single,Age,KRAS,cancer of unknown primary,50-65,43,810,0.053,0.053,0.041,0.066,KRAS_12D,12D,NA
single,Age,KRAS,cancer of unknown primary,>65,51,797,0.058,0.057,0.045,0.075,KRAS_12D,12D,NA
single,Age,KRAS,non-small cell lung cancer,<40,6,161,0.041,0.042,0.028,0.054,KRAS_12D,12D,NA
single,Age,KRAS,non-small cell lung cancer,40-50,19,585,0.04,0.04,0.028,0.048,KRAS_12D,12D,NA
single,Age,KRAS,non-small cell lung cancer,50-65,154,3677,0.042,0.042,0.037,0.048,KRAS_12D,12D,NA
single,Age,KRAS,non-small cell lung cancer,>65,253,5698,0.043,0.043,0.039,0.049,KRAS_12D,12D,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0.041,0.042,0.024,0.056,KRAS_12D,12D,NA
single,Age,KRAS,breast cancer,<40,0,841,0.001,0.001,0,0.002,KRAS_12D,12D,NA
single,Age,KRAS,breast cancer,40-50,1,1910,0.001,0.001,0,0.002,KRAS_12D,12D,NA
single,Age,KRAS,breast cancer,50-65,4,3989,0.001,0.001,0,0.002,KRAS_12D,12D,NA
single,Age,KRAS,breast cancer,>65,5,2583,0.002,0.001,0.001,0.003,KRAS_12D,12D,NA
single,Age,KRAS,breast cancer,NA,1,10,0.015,0.002,0.001,0.143,KRAS_12D,12D,NA
single,Age,KRAS,soft tissue sarcoma,<40,3,672,0.004,0.004,0.002,0.008,KRAS_12D,12D,NA
single,Age,KRAS,soft tissue sarcoma,40-50,1,367,0.004,0.004,0.001,0.007,KRAS_12D,12D,NA
single,Age,KRAS,soft tissue sarcoma,50-65,3,951,0.004,0.004,0.002,0.007,KRAS_12D,12D,NA
single,Age,KRAS,soft tissue sarcoma,>65,4,777,0.004,0.004,0.002,0.008,KRAS_12D,12D,NA
single,Age,KRAS,pancreatic cancer,<40,16,87,0.256,0.262,0.153,0.327,KRAS_12D,12D,NA
single,Age,KRAS,pancreatic cancer,40-50,56,200,0.291,0.293,0.234,0.339,KRAS_12D,12D,NA
single,Age,KRAS,pancreatic cancer,50-65,327,1000,0.322,0.321,0.295,0.351,KRAS_12D,12D,NA
single,Age,KRAS,pancreatic cancer,>65,383,1205,0.315,0.315,0.291,0.341,KRAS_12D,12D,NA
single,Age,KRAS,leukemia,<40,3,204,0.014,0.013,0.006,0.024,KRAS_12D,12D,NA
single,Age,KRAS,leukemia,40-50,0,128,0.012,0.012,0.002,0.021,KRAS_12D,12D,NA
single,Age,KRAS,leukemia,50-65,7,515,0.013,0.013,0.007,0.021,KRAS_12D,12D,NA
single,Age,KRAS,leukemia,>65,11,720,0.014,0.014,0.008,0.022,KRAS_12D,12D,NA
single,Age,KRAS,melanoma,<40,0,289,0.004,0.004,0,0.008,KRAS_12D,12D,NA
single,Age,KRAS,melanoma,40-50,0,282,0.004,0.004,0,0.008,KRAS_12D,12D,NA
single,Age,KRAS,melanoma,50-65,5,1016,0.005,0.005,0.002,0.009,KRAS_12D,12D,NA
single,Age,KRAS,melanoma,>65,9,1259,0.006,0.006,0.003,0.011,KRAS_12D,12D,NA
single,Age,KRAS,head and neck cancer,<40,1,140,0.004,0.003,0,0.014,KRAS_12D,12D,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0.002,0.002,0,0.006,KRAS_12D,12D,NA
single,Age,KRAS,head and neck cancer,50-65,3,799,0.003,0.003,0.001,0.007,KRAS_12D,12D,NA
single,Age,KRAS,head and neck cancer,>65,0,582,0.002,0.001,0,0.005,KRAS_12D,12D,NA
single,Age,KRAS,uterine cancer,<40,1,57,0.041,0.042,0.011,0.07,KRAS_12D,12D,NA
single,Age,KRAS,uterine cancer,40-50,14,162,0.062,0.058,0.038,0.11,KRAS_12D,12D,NA
single,Age,KRAS,uterine cancer,50-65,50,1046,0.047,0.047,0.036,0.06,KRAS_12D,12D,NA
single,Age,KRAS,uterine cancer,>65,37,988,0.041,0.041,0.029,0.053,KRAS_12D,12D,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0.003,0.001,0,0.016,KRAS_12D,12D,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0.003,0.001,0,0.017,KRAS_12D,12D,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,1,149,0.004,0.002,0,0.017,KRAS_12D,12D,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0.002,0.001,0,0.007,KRAS_12D,12D,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.003,0.003,0,0.01,KRAS_12D,12D,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.003,0.003,0,0.01,KRAS_12D,12D,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,2,373,0.004,0.003,0.001,0.01,KRAS_12D,12D,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,2,664,0.003,0.003,0.001,0.008,KRAS_12D,12D,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,KRAS_12D,12D,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,KRAS_12D,12D,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.003,KRAS_12D,12D,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,KRAS_12D,12D,NA
single,Age,KRAS,ovarian cancer,<40,12,141,0.063,0.06,0.031,0.114,KRAS_12D,12D,NA
single,Age,KRAS,ovarian cancer,40-50,10,253,0.039,0.038,0.022,0.062,KRAS_12D,12D,NA
single,Age,KRAS,ovarian cancer,50-65,40,1092,0.037,0.036,0.027,0.048,KRAS_12D,12D,NA
single,Age,KRAS,ovarian cancer,>65,20,849,0.027,0.027,0.017,0.039,KRAS_12D,12D,NA
single,Age,KRAS,esophagogastric cancer,<40,2,122,0.018,0.018,0.01,0.03,KRAS_12D,12D,NA
single,Age,KRAS,esophagogastric cancer,40-50,4,200,0.019,0.018,0.011,0.03,KRAS_12D,12D,NA
single,Age,KRAS,esophagogastric cancer,50-65,12,752,0.018,0.018,0.011,0.025,KRAS_12D,12D,NA
single,Age,KRAS,esophagogastric cancer,>65,15,725,0.019,0.019,0.012,0.028,KRAS_12D,12D,NA
single,Age,KRAS,thyroid cancer,<40,0,150,0.002,0.001,0,0.007,KRAS_12D,12D,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0.002,0.001,0,0.008,KRAS_12D,12D,NA
single,Age,KRAS,thyroid cancer,50-65,3,374,0.006,0.005,0.001,0.017,KRAS_12D,12D,NA
single,Age,KRAS,thyroid cancer,>65,0,370,0.001,0.001,0,0.006,KRAS_12D,12D,NA
single,Age,KRAS,cervical cancer,<40,1,85,0.025,0.024,0.006,0.049,KRAS_12D,12D,NA
single,Age,KRAS,cervical cancer,40-50,2,99,0.027,0.026,0.009,0.05,KRAS_12D,12D,NA
single,Age,KRAS,cervical cancer,50-65,5,144,0.03,0.028,0.013,0.055,KRAS_12D,12D,NA
single,Age,KRAS,cervical cancer,>65,2,36,0.032,0.029,0.012,0.078,KRAS_12D,12D,NA
single,Age,KRAS,hepatobiliary cancer,<40,6,138,0.041,0.04,0.025,0.062,KRAS_12D,12D,NA
single,Age,KRAS,hepatobiliary cancer,40-50,4,110,0.04,0.039,0.023,0.06,KRAS_12D,12D,NA
single,Age,KRAS,hepatobiliary cancer,50-65,16,525,0.037,0.037,0.024,0.05,KRAS_12D,12D,NA
single,Age,KRAS,hepatobiliary cancer,>65,29,601,0.043,0.042,0.031,0.059,KRAS_12D,12D,NA
single,Age,KRAS,kidney cancer,<40,0,191,0.003,0.003,0,0.008,KRAS_12D,12D,NA
single,Age,KRAS,kidney cancer,40-50,2,159,0.006,0.004,0.001,0.02,KRAS_12D,12D,NA
single,Age,KRAS,kidney cancer,50-65,1,628,0.003,0.003,0,0.007,KRAS_12D,12D,NA
single,Age,KRAS,kidney cancer,>65,2,440,0.004,0.004,0.001,0.009,KRAS_12D,12D,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,KRAS_12D,12D,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.002,KRAS_12D,12D,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,KRAS_12D,12D,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,KRAS_12D,12D,NA
single,Age,KRAS,cns cancer,<40,2,1602,0.002,0.001,0,0.003,KRAS_12D,12D,NA
single,Age,KRAS,cns cancer,40-50,4,687,0.004,0.003,0.001,0.01,KRAS_12D,12D,NA
single,Age,KRAS,cns cancer,50-65,0,1439,0.001,0.001,0,0.003,KRAS_12D,12D,NA
single,Age,KRAS,cns cancer,>65,2,836,0.002,0.002,0,0.005,KRAS_12D,12D,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0.001,0.001,0,0.007,KRAS_12D,12D,NA
single,Age,KRAS,prostate cancer,50-65,0,960,0.001,0,0,0.002,KRAS_12D,12D,NA
single,Age,KRAS,prostate cancer,>65,2,1402,0.001,0.001,0,0.003,KRAS_12D,12D,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.008,0.004,0,0.041,KRAS_12D,12D,NA
single,Age,KRAS,anal cancer,50-65,1,88,0.009,0.007,0,0.032,KRAS_12D,12D,NA
single,Age,KRAS,anal cancer,>65,0,45,0.007,0.004,0,0.029,KRAS_12D,12D,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0.032,0.031,0.001,0.077,KRAS_12D,12D,NA
single,Age,KRAS,neuroendocrine tumors,40-50,6,55,0.07,0.06,0.025,0.162,KRAS_12D,12D,NA
single,Age,KRAS,neuroendocrine tumors,50-65,5,161,0.035,0.034,0.014,0.063,KRAS_12D,12D,NA
single,Age,KRAS,neuroendocrine tumors,>65,3,121,0.033,0.032,0.009,0.062,KRAS_12D,12D,NA
single,Age,KRAS,bladder cancer,<40,0,25,0.018,0.018,0,0.035,KRAS_12D,12D,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0.016,0.017,0,0.03,KRAS_12D,12D,NA
single,Age,KRAS,bladder cancer,50-65,12,511,0.021,0.021,0.013,0.033,KRAS_12D,12D,NA
single,Age,KRAS,bladder cancer,>65,20,962,0.02,0.02,0.013,0.029,KRAS_12D,12D,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,5,142,0.033,0.032,0.014,0.061,KRAS_12D,12D,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.031,0.029,0.004,0.068,KRAS_12D,12D,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,1,48,0.031,0.03,0.008,0.063,KRAS_12D,12D,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,2,42,0.035,0.032,0.012,0.075,KRAS_12D,12D,NA
single,Age,KRAS,small bowel cancer,40-50,2,29,0.111,0.11,0.046,0.176,KRAS_12D,12D,NA
single,Age,KRAS,small bowel cancer,50-65,12,96,0.12,0.118,0.074,0.177,KRAS_12D,12D,NA
single,Age,KRAS,small bowel cancer,>65,10,78,0.121,0.118,0.073,0.181,KRAS_12D,12D,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.003,KRAS_12D,12D,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.003,KRAS_12D,12D,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0,0,0,0.003,KRAS_12D,12D,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.003,KRAS_12D,12D,NA
single,Age,KRAS,bone cancer,<40,1,342,0.004,0.003,0,0.011,KRAS_12D,12D,NA
single,Age,KRAS,bone cancer,40-50,0,61,0.004,0.003,0,0.013,KRAS_12D,12D,NA
single,Age,KRAS,bone cancer,50-65,0,96,0.004,0.003,0,0.012,KRAS_12D,12D,NA
single,Age,KRAS,bone cancer,>65,1,67,0.006,0.004,0.001,0.026,KRAS_12D,12D,NA
single,Age,KRAS,vaginal cancer,50-65,0,34,0.013,0.007,0,0.057,KRAS_12D,12D,NA
single,Age,KRAS,vaginal cancer,>65,1,30,0.025,0.017,0.001,0.094,KRAS_12D,12D,NA
single,Age,KRAS,thymic tumor,<40,0,14,0,0,0,0.004,KRAS_12D,12D,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0,0,0,0.004,KRAS_12D,12D,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.004,KRAS_12D,12D,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.004,KRAS_12D,12D,NA
single,Age,KRAS,ampullary cancer,40-50,0,12,0.116,0.083,0,0.332,KRAS_12D,12D,NA
single,Age,KRAS,ampullary cancer,50-65,11,40,0.27,0.266,0.155,0.403,KRAS_12D,12D,NA
single,Age,KRAS,ampullary cancer,>65,17,50,0.318,0.314,0.204,0.458,KRAS_12D,12D,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0.011,0.009,0,0.033,KRAS_12D,12D,NA
single,Age,KRAS,small cell lung cancer,50-65,1,144,0.01,0.009,0.002,0.024,KRAS_12D,12D,NA
single,Age,KRAS,small cell lung cancer,>65,3,224,0.011,0.01,0.003,0.026,KRAS_12D,12D,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0.001,KRAS_12D,12D,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0.001,KRAS_12D,12D,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0.001,KRAS_12D,12D,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0.001,KRAS_12D,12D,NA
single,Age,KRAS,germ cell tumor,<40,7,650,0.01,0.01,0.005,0.019,KRAS_12D,12D,NA
single,Age,KRAS,germ cell tumor,40-50,2,131,0.011,0.01,0.004,0.026,KRAS_12D,12D,NA
single,Age,KRAS,germ cell tumor,50-65,0,92,0.009,0.009,0,0.02,KRAS_12D,12D,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0.011,0.01,0.001,0.031,KRAS_12D,12D,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,KRAS_12D,12D,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.005,KRAS_12D,12D,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,KRAS_12D,12D,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.007,KRAS_12D,12D,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.002,0,0,0.019,KRAS_12D,12D,NA
single,Age,KRAS,penile cancer,>65,0,11,0.002,0,0,0.019,KRAS_12D,12D,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.004,0,0,0.046,KRAS_12D,12D,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0.003,0.003,0,0.01,KRAS_12D,12D,NA
single,Age,KRAS,b cell lymphoma,40-50,0,105,0.003,0.003,0,0.009,KRAS_12D,12D,NA
single,Age,KRAS,b cell lymphoma,50-65,2,357,0.004,0.003,0.001,0.01,KRAS_12D,12D,NA
single,Age,KRAS,b cell lymphoma,>65,1,413,0.003,0.003,0,0.008,KRAS_12D,12D,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.003,0,0,0.039,KRAS_12D,12D,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.019,KRAS_12D,12D,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.009,KRAS_12D,12D,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.021,KRAS_12D,12D,NA
single,Age,KRAS,lung cancer,>65,0,18,0,0,0,0,KRAS_12D,12D,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.005,0,0,0.062,KRAS_12D,12D,NA
single,Age,KRAS,appendiceal cancer,<40,0,28,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,colorectal cancer,<40,0,565,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,colorectal cancer,40-50,0,1280,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,colorectal cancer,50-65,1,2815,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,colorectal cancer,>65,0,2055,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,cancer of unknown primary,<40,0,167,0.002,0.001,0,0.005,KRAS_12F,12F,NA
single,Age,KRAS,cancer of unknown primary,40-50,0,211,0.002,0.001,0,0.004,KRAS_12F,12F,NA
single,Age,KRAS,cancer of unknown primary,50-65,1,810,0.002,0.001,0,0.004,KRAS_12F,12F,NA
single,Age,KRAS,cancer of unknown primary,>65,2,797,0.002,0.002,0,0.005,KRAS_12F,12F,NA
single,Age,KRAS,non-small cell lung cancer,<40,0,161,0.003,0.003,0,0.006,KRAS_12F,12F,NA
single,Age,KRAS,non-small cell lung cancer,40-50,0,585,0.002,0.002,0,0.005,KRAS_12F,12F,NA
single,Age,KRAS,non-small cell lung cancer,50-65,10,3677,0.003,0.003,0.001,0.004,KRAS_12F,12F,NA
single,Age,KRAS,non-small cell lung cancer,>65,22,5698,0.003,0.003,0.002,0.005,KRAS_12F,12F,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0.004,0.003,0,0.014,KRAS_12F,12F,NA
single,Age,KRAS,breast cancer,<40,0,841,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,breast cancer,40-50,0,1910,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,breast cancer,50-65,0,3989,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,breast cancer,>65,0,2583,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,breast cancer,NA,0,10,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,pancreatic cancer,<40,0,87,0.001,0,0,0.003,KRAS_12F,12F,NA
single,Age,KRAS,pancreatic cancer,40-50,0,200,0.001,0,0,0.002,KRAS_12F,12F,NA
single,Age,KRAS,pancreatic cancer,50-65,0,1000,0,0,0,0.002,KRAS_12F,12F,NA
single,Age,KRAS,pancreatic cancer,>65,1,1205,0.001,0,0,0.002,KRAS_12F,12F,NA
single,Age,KRAS,leukemia,<40,0,204,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,leukemia,40-50,0,128,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,leukemia,50-65,0,515,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,leukemia,>65,0,720,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,melanoma,<40,0,289,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,melanoma,40-50,0,282,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,melanoma,50-65,0,1016,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,melanoma,>65,0,1259,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,head and neck cancer,50-65,0,799,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,head and neck cancer,>65,0,582,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,uterine cancer,<40,0,57,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,uterine cancer,40-50,0,162,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,uterine cancer,50-65,0,1046,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,uterine cancer,>65,0,988,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,KRAS_12F,12F,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.005,KRAS_12F,12F,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,KRAS_12F,12F,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,KRAS_12F,12F,NA
single,Age,KRAS,ovarian cancer,<40,1,141,0.004,0.002,0,0.02,KRAS_12F,12F,NA
single,Age,KRAS,ovarian cancer,40-50,0,253,0,0,0,0.003,KRAS_12F,12F,NA
single,Age,KRAS,ovarian cancer,50-65,0,1092,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,ovarian cancer,>65,0,849,0,0,0,0.002,KRAS_12F,12F,NA
single,Age,KRAS,esophagogastric cancer,<40,0,122,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,esophagogastric cancer,>65,0,725,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,thyroid cancer,<40,0,150,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,thyroid cancer,50-65,0,374,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,thyroid cancer,>65,0,370,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,cervical cancer,<40,0,85,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,cervical cancer,40-50,0,99,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,cervical cancer,50-65,0,144,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,cervical cancer,>65,0,36,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,kidney cancer,<40,0,191,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,kidney cancer,50-65,0,628,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,kidney cancer,>65,0,440,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,KRAS_12F,12F,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,KRAS_12F,12F,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,KRAS_12F,12F,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,KRAS_12F,12F,NA
single,Age,KRAS,cns cancer,<40,0,1602,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,cns cancer,40-50,0,687,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,cns cancer,50-65,0,1439,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,cns cancer,>65,0,836,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,prostate cancer,50-65,0,960,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,prostate cancer,>65,0,1402,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.001,0,0,0.005,KRAS_12F,12F,NA
single,Age,KRAS,anal cancer,50-65,0,88,0,0,0,0.004,KRAS_12F,12F,NA
single,Age,KRAS,anal cancer,>65,0,45,0,0,0,0.004,KRAS_12F,12F,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,bladder cancer,<40,0,25,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,bladder cancer,50-65,0,511,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,bladder cancer,>65,0,962,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,KRAS_12F,12F,NA
single,Age,KRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,KRAS_12F,12F,NA
single,Age,KRAS,small bowel cancer,>65,0,78,0,0,0,0.002,KRAS_12F,12F,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.006,KRAS_12F,12F,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.006,KRAS_12F,12F,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0,0,0,0.005,KRAS_12F,12F,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.005,KRAS_12F,12F,NA
single,Age,KRAS,bone cancer,<40,0,342,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,bone cancer,40-50,0,61,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,bone cancer,50-65,0,96,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,bone cancer,>65,0,67,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,KRAS_12F,12F,NA
single,Age,KRAS,vaginal cancer,>65,0,30,0.001,0,0,0.008,KRAS_12F,12F,NA
single,Age,KRAS,thymic tumor,<40,0,14,0.001,0,0,0.006,KRAS_12F,12F,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0.001,0,0,0.005,KRAS_12F,12F,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.004,KRAS_12F,12F,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.005,KRAS_12F,12F,NA
single,Age,KRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.008,KRAS_12F,12F,NA
single,Age,KRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.007,KRAS_12F,12F,NA
single,Age,KRAS,ampullary cancer,>65,0,50,0.001,0,0,0.007,KRAS_12F,12F,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,germ cell tumor,<40,0,650,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,germ cell tumor,40-50,0,131,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,germ cell tumor,50-65,0,92,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0,0,0,0.001,KRAS_12F,12F,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,KRAS_12F,12F,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,KRAS_12F,12F,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,KRAS_12F,12F,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,KRAS_12F,12F,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.003,0,0,0.032,KRAS_12F,12F,NA
single,Age,KRAS,penile cancer,>65,0,11,0.003,0,0,0.031,KRAS_12F,12F,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.003,0,0,0.035,KRAS_12F,12F,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,b cell lymphoma,40-50,0,105,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,b cell lymphoma,50-65,0,357,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,b cell lymphoma,>65,0,413,0,0,0,0,KRAS_12F,12F,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.047,KRAS_12F,12F,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.018,KRAS_12F,12F,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,KRAS_12F,12F,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.025,KRAS_12F,12F,NA
single,Age,KRAS,lung cancer,>65,0,18,0.003,0,0,0.031,KRAS_12F,12F,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,KRAS_12F,12F,NA
single,Age,KRAS,appendiceal cancer,<40,0,28,0.008,0.007,0,0.028,KRAS_12R,12R,NA
single,Age,KRAS,appendiceal cancer,40-50,1,62,0.011,0.009,0.001,0.035,KRAS_12R,12R,NA
single,Age,KRAS,appendiceal cancer,50-65,2,161,0.01,0.009,0.002,0.026,KRAS_12R,12R,NA
single,Age,KRAS,appendiceal cancer,>65,0,90,0.007,0.006,0,0.022,KRAS_12R,12R,NA
single,Age,KRAS,colorectal cancer,<40,0,565,0.004,0.004,0,0.007,KRAS_12R,12R,NA
single,Age,KRAS,colorectal cancer,40-50,7,1280,0.005,0.005,0.003,0.008,KRAS_12R,12R,NA
single,Age,KRAS,colorectal cancer,50-65,13,2815,0.005,0.005,0.003,0.007,KRAS_12R,12R,NA
single,Age,KRAS,colorectal cancer,>65,14,2055,0.006,0.005,0.004,0.009,KRAS_12R,12R,NA
single,Age,KRAS,cancer of unknown primary,<40,0,167,0.008,0.008,0.001,0.014,KRAS_12R,12R,NA
single,Age,KRAS,cancer of unknown primary,40-50,2,211,0.009,0.008,0.003,0.017,KRAS_12R,12R,NA
single,Age,KRAS,cancer of unknown primary,50-65,9,810,0.009,0.009,0.005,0.016,KRAS_12R,12R,NA
single,Age,KRAS,cancer of unknown primary,>65,6,797,0.008,0.008,0.004,0.014,KRAS_12R,12R,NA
single,Age,KRAS,non-small cell lung cancer,<40,0,161,0.003,0.003,0.001,0.006,KRAS_12R,12R,NA
single,Age,KRAS,non-small cell lung cancer,40-50,3,585,0.004,0.004,0.002,0.007,KRAS_12R,12R,NA
single,Age,KRAS,non-small cell lung cancer,50-65,11,3677,0.003,0.003,0.002,0.005,KRAS_12R,12R,NA
single,Age,KRAS,non-small cell lung cancer,>65,22,5698,0.004,0.004,0.002,0.005,KRAS_12R,12R,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0.004,0.004,0.001,0.008,KRAS_12R,12R,NA
single,Age,KRAS,breast cancer,<40,1,841,0.001,0,0,0.002,KRAS_12R,12R,NA
single,Age,KRAS,breast cancer,40-50,0,1910,0,0,0,0.001,KRAS_12R,12R,NA
single,Age,KRAS,breast cancer,50-65,2,3989,0,0,0,0.001,KRAS_12R,12R,NA
single,Age,KRAS,breast cancer,>65,1,2583,0,0,0,0.001,KRAS_12R,12R,NA
single,Age,KRAS,breast cancer,NA,0,10,0.001,0,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,soft tissue sarcoma,<40,1,672,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,soft tissue sarcoma,50-65,1,951,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,soft tissue sarcoma,>65,1,777,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,pancreatic cancer,<40,4,87,0.082,0.084,0.032,0.122,KRAS_12R,12R,NA
single,Age,KRAS,pancreatic cancer,40-50,16,200,0.091,0.092,0.056,0.123,KRAS_12R,12R,NA
single,Age,KRAS,pancreatic cancer,50-65,102,1000,0.103,0.102,0.085,0.121,KRAS_12R,12R,NA
single,Age,KRAS,pancreatic cancer,>65,154,1205,0.123,0.123,0.105,0.143,KRAS_12R,12R,NA
single,Age,KRAS,leukemia,<40,0,204,0.001,0.001,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,leukemia,40-50,0,128,0.001,0.001,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,leukemia,50-65,1,515,0.002,0.001,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,leukemia,>65,1,720,0.001,0.001,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,melanoma,<40,0,289,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,melanoma,40-50,0,282,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,melanoma,50-65,1,1016,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,melanoma,>65,2,1259,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,head and neck cancer,50-65,0,799,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,head and neck cancer,>65,0,582,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,uterine cancer,<40,0,57,0.001,0.001,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,uterine cancer,40-50,0,162,0.001,0.001,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,uterine cancer,50-65,1,1046,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,uterine cancer,>65,1,988,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.002,0.001,0,0.007,KRAS_12R,12R,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.002,0.001,0,0.007,KRAS_12R,12R,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0.001,0.001,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,2,664,0.002,0.002,0,0.007,KRAS_12R,12R,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,ovarian cancer,<40,1,141,0.005,0.004,0.002,0.014,KRAS_12R,12R,NA
single,Age,KRAS,ovarian cancer,40-50,3,253,0.006,0.005,0.002,0.017,KRAS_12R,12R,NA
single,Age,KRAS,ovarian cancer,50-65,3,1092,0.004,0.004,0.001,0.007,KRAS_12R,12R,NA
single,Age,KRAS,ovarian cancer,>65,3,849,0.004,0.004,0.002,0.008,KRAS_12R,12R,NA
single,Age,KRAS,esophagogastric cancer,<40,0,122,0.001,0.001,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,esophagogastric cancer,40-50,1,200,0.002,0.001,0,0.009,KRAS_12R,12R,NA
single,Age,KRAS,esophagogastric cancer,50-65,1,752,0.001,0.001,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,esophagogastric cancer,>65,0,725,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,thyroid cancer,<40,0,150,0.001,0.001,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0.001,0.001,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,thyroid cancer,50-65,1,374,0.002,0.001,0,0.006,KRAS_12R,12R,NA
single,Age,KRAS,thyroid cancer,>65,0,370,0.001,0.001,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,cervical cancer,<40,0,85,0.002,0.001,0,0.012,KRAS_12R,12R,NA
single,Age,KRAS,cervical cancer,40-50,0,99,0.002,0.001,0,0.011,KRAS_12R,12R,NA
single,Age,KRAS,cervical cancer,50-65,0,144,0.002,0.001,0,0.01,KRAS_12R,12R,NA
single,Age,KRAS,cervical cancer,>65,1,36,0.013,0.005,0,0.07,KRAS_12R,12R,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0.002,0.002,0,0.007,KRAS_12R,12R,NA
single,Age,KRAS,hepatobiliary cancer,40-50,0,110,0.002,0.002,0,0.007,KRAS_12R,12R,NA
single,Age,KRAS,hepatobiliary cancer,50-65,1,525,0.002,0.002,0,0.006,KRAS_12R,12R,NA
single,Age,KRAS,hepatobiliary cancer,>65,2,601,0.003,0.002,0.001,0.007,KRAS_12R,12R,NA
single,Age,KRAS,kidney cancer,<40,0,191,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,kidney cancer,50-65,0,628,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,kidney cancer,>65,0,440,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,KRAS_12R,12R,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,KRAS_12R,12R,NA
single,Age,KRAS,cns cancer,<40,1,1602,0.001,0,0,0.002,KRAS_12R,12R,NA
single,Age,KRAS,cns cancer,40-50,0,687,0,0,0,0.001,KRAS_12R,12R,NA
single,Age,KRAS,cns cancer,50-65,1,1439,0.001,0,0,0.002,KRAS_12R,12R,NA
single,Age,KRAS,cns cancer,>65,0,836,0,0,0,0.001,KRAS_12R,12R,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0.002,0.001,0,0.006,KRAS_12R,12R,NA
single,Age,KRAS,prostate cancer,50-65,2,960,0.002,0.001,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,prostate cancer,>65,1,1402,0.001,0.001,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.001,0,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,anal cancer,50-65,0,88,0,0,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,anal cancer,>65,0,45,0,0,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0.006,0.004,0,0.024,KRAS_12R,12R,NA
single,Age,KRAS,neuroendocrine tumors,40-50,0,55,0.005,0.004,0,0.019,KRAS_12R,12R,NA
single,Age,KRAS,neuroendocrine tumors,50-65,2,161,0.008,0.007,0.001,0.025,KRAS_12R,12R,NA
single,Age,KRAS,neuroendocrine tumors,>65,0,121,0.004,0.003,0,0.015,KRAS_12R,12R,NA
single,Age,KRAS,bladder cancer,<40,0,25,0.003,0.002,0,0.011,KRAS_12R,12R,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0.002,0.002,0,0.008,KRAS_12R,12R,NA
single,Age,KRAS,bladder cancer,50-65,2,511,0.003,0.002,0,0.007,KRAS_12R,12R,NA
single,Age,KRAS,bladder cancer,>65,1,962,0.002,0.002,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,small bowel cancer,40-50,0,29,0.014,0.012,0,0.042,KRAS_12R,12R,NA
single,Age,KRAS,small bowel cancer,50-65,1,96,0.014,0.012,0.002,0.038,KRAS_12R,12R,NA
single,Age,KRAS,small bowel cancer,>65,2,78,0.019,0.016,0.003,0.051,KRAS_12R,12R,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.006,KRAS_12R,12R,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.006,KRAS_12R,12R,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0,0,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,bone cancer,<40,0,342,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,bone cancer,40-50,0,61,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,bone cancer,50-65,0,96,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,bone cancer,>65,0,67,0,0,0,0,KRAS_12R,12R,NA
single,Age,KRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,KRAS_12R,12R,NA
single,Age,KRAS,vaginal cancer,>65,0,30,0.001,0,0,0.008,KRAS_12R,12R,NA
single,Age,KRAS,thymic tumor,<40,0,14,0.001,0,0,0.006,KRAS_12R,12R,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0.001,0,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,ampullary cancer,40-50,0,12,0.021,0.014,0,0.084,KRAS_12R,12R,NA
single,Age,KRAS,ampullary cancer,50-65,0,40,0.016,0.011,0,0.062,KRAS_12R,12R,NA
single,Age,KRAS,ampullary cancer,>65,3,50,0.046,0.04,0.009,0.119,KRAS_12R,12R,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,KRAS_12R,12R,NA
single,Age,KRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,KRAS_12R,12R,NA
single,Age,KRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,KRAS_12R,12R,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0.001,KRAS_12R,12R,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0.001,KRAS_12R,12R,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0.001,KRAS_12R,12R,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0.001,KRAS_12R,12R,NA
single,Age,KRAS,germ cell tumor,<40,3,650,0.007,0.007,0.002,0.015,KRAS_12R,12R,NA
single,Age,KRAS,germ cell tumor,40-50,3,131,0.016,0.013,0.005,0.043,KRAS_12R,12R,NA
single,Age,KRAS,germ cell tumor,50-65,1,92,0.012,0.01,0.002,0.032,KRAS_12R,12R,NA
single,Age,KRAS,germ cell tumor,>65,1,12,0.026,0.013,0.004,0.131,KRAS_12R,12R,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,KRAS_12R,12R,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,KRAS_12R,12R,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,KRAS_12R,12R,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.003,0,0,0.032,KRAS_12R,12R,NA
single,Age,KRAS,penile cancer,>65,0,11,0.003,0,0,0.031,KRAS_12R,12R,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.003,0,0,0.035,KRAS_12R,12R,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0.002,0.002,0,0.008,KRAS_12R,12R,NA
single,Age,KRAS,b cell lymphoma,40-50,0,105,0.002,0.002,0,0.007,KRAS_12R,12R,NA
single,Age,KRAS,b cell lymphoma,50-65,1,357,0.002,0.002,0,0.007,KRAS_12R,12R,NA
single,Age,KRAS,b cell lymphoma,>65,1,413,0.002,0.002,0,0.007,KRAS_12R,12R,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.047,KRAS_12R,12R,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.018,KRAS_12R,12R,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,KRAS_12R,12R,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.025,KRAS_12R,12R,NA
single,Age,KRAS,lung cancer,>65,0,18,0.003,0,0,0.031,KRAS_12R,12R,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,KRAS_12R,12R,NA
single,Age,KRAS,appendiceal cancer,<40,0,28,0.004,0.002,0,0.018,KRAS_12S,12S,NA
single,Age,KRAS,appendiceal cancer,40-50,0,62,0.003,0.002,0,0.013,KRAS_12S,12S,NA
single,Age,KRAS,appendiceal cancer,50-65,0,161,0.002,0.001,0,0.011,KRAS_12S,12S,NA
single,Age,KRAS,appendiceal cancer,>65,1,90,0.006,0.004,0,0.028,KRAS_12S,12S,NA
single,Age,KRAS,colorectal cancer,<40,15,565,0.02,0.02,0.015,0.03,KRAS_12S,12S,NA
single,Age,KRAS,colorectal cancer,40-50,23,1280,0.019,0.019,0.014,0.024,KRAS_12S,12S,NA
single,Age,KRAS,colorectal cancer,50-65,51,2815,0.019,0.019,0.015,0.023,KRAS_12S,12S,NA
single,Age,KRAS,colorectal cancer,>65,37,2055,0.019,0.019,0.015,0.023,KRAS_12S,12S,NA
single,Age,KRAS,cancer of unknown primary,<40,0,167,0.002,0.002,0,0.006,KRAS_12S,12S,NA
single,Age,KRAS,cancer of unknown primary,40-50,0,211,0.002,0.002,0,0.006,KRAS_12S,12S,NA
single,Age,KRAS,cancer of unknown primary,50-65,1,810,0.002,0.002,0,0.005,KRAS_12S,12S,NA
single,Age,KRAS,cancer of unknown primary,>65,4,797,0.004,0.003,0.001,0.009,KRAS_12S,12S,NA
single,Age,KRAS,non-small cell lung cancer,<40,0,161,0.005,0.005,0.001,0.008,KRAS_12S,12S,NA
single,Age,KRAS,non-small cell lung cancer,40-50,1,585,0.005,0.005,0.001,0.007,KRAS_12S,12S,NA
single,Age,KRAS,non-small cell lung cancer,50-65,21,3677,0.005,0.005,0.004,0.007,KRAS_12S,12S,NA
single,Age,KRAS,non-small cell lung cancer,>65,30,5698,0.005,0.005,0.004,0.007,KRAS_12S,12S,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0.005,0.005,0.001,0.01,KRAS_12S,12S,NA
single,Age,KRAS,breast cancer,<40,0,841,0.001,0.001,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,breast cancer,40-50,1,1910,0.001,0.001,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,breast cancer,50-65,4,3989,0.001,0.001,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,breast cancer,>65,1,2583,0.001,0.001,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,breast cancer,NA,0,10,0.001,0.001,0,0.003,KRAS_12S,12S,NA
single,Age,KRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,pancreatic cancer,<40,0,87,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,pancreatic cancer,40-50,0,200,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,pancreatic cancer,50-65,0,1000,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,pancreatic cancer,>65,0,1205,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,leukemia,<40,0,204,0.001,0,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,leukemia,40-50,0,128,0.001,0,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,leukemia,50-65,1,515,0.001,0.001,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,leukemia,>65,0,720,0.001,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,melanoma,<40,0,289,0,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,melanoma,40-50,0,282,0,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,melanoma,50-65,0,1016,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,melanoma,>65,1,1259,0.001,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,head and neck cancer,50-65,0,799,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,head and neck cancer,>65,0,582,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,uterine cancer,<40,0,57,0.003,0.002,0,0.008,KRAS_12S,12S,NA
single,Age,KRAS,uterine cancer,40-50,0,162,0.003,0.002,0,0.007,KRAS_12S,12S,NA
single,Age,KRAS,uterine cancer,50-65,2,1046,0.002,0.002,0.001,0.005,KRAS_12S,12S,NA
single,Age,KRAS,uterine cancer,>65,4,988,0.003,0.003,0.001,0.007,KRAS_12S,12S,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.002,0.001,0,0.007,KRAS_12S,12S,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.002,0.001,0,0.006,KRAS_12S,12S,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,1,373,0.002,0.002,0,0.006,KRAS_12S,12S,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,1,664,0.002,0.001,0,0.005,KRAS_12S,12S,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,KRAS_12S,12S,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,KRAS_12S,12S,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.003,KRAS_12S,12S,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,KRAS_12S,12S,NA
single,Age,KRAS,ovarian cancer,<40,1,141,0.004,0.001,0,0.019,KRAS_12S,12S,NA
single,Age,KRAS,ovarian cancer,40-50,0,253,0,0,0,0.003,KRAS_12S,12S,NA
single,Age,KRAS,ovarian cancer,50-65,0,1092,0,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,ovarian cancer,>65,0,849,0,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,esophagogastric cancer,<40,0,122,0.002,0.002,0,0.007,KRAS_12S,12S,NA
single,Age,KRAS,esophagogastric cancer,40-50,1,200,0.003,0.002,0,0.012,KRAS_12S,12S,NA
single,Age,KRAS,esophagogastric cancer,50-65,0,752,0.001,0.001,0,0.005,KRAS_12S,12S,NA
single,Age,KRAS,esophagogastric cancer,>65,3,725,0.003,0.003,0.001,0.008,KRAS_12S,12S,NA
single,Age,KRAS,thyroid cancer,<40,0,150,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,thyroid cancer,50-65,0,374,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,thyroid cancer,>65,0,370,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,cervical cancer,<40,0,85,0.007,0.006,0,0.021,KRAS_12S,12S,NA
single,Age,KRAS,cervical cancer,40-50,1,99,0.009,0.008,0.001,0.024,KRAS_12S,12S,NA
single,Age,KRAS,cervical cancer,50-65,2,144,0.01,0.009,0.002,0.027,KRAS_12S,12S,NA
single,Age,KRAS,cervical cancer,>65,0,36,0.008,0.007,0,0.025,KRAS_12S,12S,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0.001,0.001,0,0.005,KRAS_12S,12S,NA
single,Age,KRAS,hepatobiliary cancer,40-50,0,110,0.001,0.001,0,0.006,KRAS_12S,12S,NA
single,Age,KRAS,hepatobiliary cancer,50-65,0,525,0.001,0.001,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,hepatobiliary cancer,>65,2,601,0.002,0.002,0,0.007,KRAS_12S,12S,NA
single,Age,KRAS,kidney cancer,<40,0,191,0.001,0,0,0.003,KRAS_12S,12S,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0.001,0,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,kidney cancer,50-65,1,628,0.001,0.001,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,kidney cancer,>65,0,440,0.001,0,0,0.003,KRAS_12S,12S,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,cns cancer,<40,0,1602,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,cns cancer,40-50,0,687,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,cns cancer,50-65,0,1439,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,cns cancer,>65,0,836,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,prostate cancer,50-65,0,960,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,prostate cancer,>65,0,1402,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.001,0,0,0.005,KRAS_12S,12S,NA
single,Age,KRAS,anal cancer,50-65,0,88,0,0,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,anal cancer,>65,0,45,0,0,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,bladder cancer,<40,0,25,0.002,0.001,0,0.007,KRAS_12S,12S,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0.002,0.001,0,0.006,KRAS_12S,12S,NA
single,Age,KRAS,bladder cancer,50-65,1,511,0.002,0.001,0,0.005,KRAS_12S,12S,NA
single,Age,KRAS,bladder cancer,>65,1,962,0.001,0.001,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,small bowel cancer,40-50,0,29,0.009,0.004,0,0.039,KRAS_12S,12S,NA
single,Age,KRAS,small bowel cancer,50-65,3,96,0.025,0.022,0.005,0.065,KRAS_12S,12S,NA
single,Age,KRAS,small bowel cancer,>65,0,78,0.007,0.003,0,0.03,KRAS_12S,12S,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.003,KRAS_12S,12S,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.003,KRAS_12S,12S,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0,0,0,0.003,KRAS_12S,12S,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.003,KRAS_12S,12S,NA
single,Age,KRAS,bone cancer,<40,0,342,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,bone cancer,40-50,0,61,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,bone cancer,50-65,0,96,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,bone cancer,>65,0,67,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.009,KRAS_12S,12S,NA
single,Age,KRAS,vaginal cancer,>65,0,30,0.001,0,0,0.009,KRAS_12S,12S,NA
single,Age,KRAS,thymic tumor,<40,0,14,0,0,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0,0,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,ampullary cancer,40-50,0,12,0.011,0.006,0,0.052,KRAS_12S,12S,NA
single,Age,KRAS,ampullary cancer,50-65,1,40,0.017,0.011,0.001,0.066,KRAS_12S,12S,NA
single,Age,KRAS,ampullary cancer,>65,0,50,0.008,0.005,0,0.037,KRAS_12S,12S,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,KRAS_12S,12S,NA
single,Age,KRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0.001,KRAS_12S,12S,NA
single,Age,KRAS,germ cell tumor,<40,2,650,0.004,0.004,0.001,0.01,KRAS_12S,12S,NA
single,Age,KRAS,germ cell tumor,40-50,2,131,0.008,0.006,0.001,0.027,KRAS_12S,12S,NA
single,Age,KRAS,germ cell tumor,50-65,0,92,0.004,0.004,0,0.014,KRAS_12S,12S,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0.006,0.004,0,0.03,KRAS_12S,12S,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.005,KRAS_12S,12S,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,KRAS_12S,12S,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.007,KRAS_12S,12S,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.002,0,0,0.019,KRAS_12S,12S,NA
single,Age,KRAS,penile cancer,>65,0,11,0.002,0,0,0.019,KRAS_12S,12S,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.004,0,0,0.046,KRAS_12S,12S,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0.003,0.003,0,0.01,KRAS_12S,12S,NA
single,Age,KRAS,b cell lymphoma,40-50,0,105,0.003,0.003,0,0.009,KRAS_12S,12S,NA
single,Age,KRAS,b cell lymphoma,50-65,1,357,0.003,0.003,0,0.008,KRAS_12S,12S,NA
single,Age,KRAS,b cell lymphoma,>65,2,413,0.004,0.003,0.001,0.01,KRAS_12S,12S,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.003,0,0,0.039,KRAS_12S,12S,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,1,27,0.043,0.032,0.002,0.142,KRAS_12S,12S,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.009,KRAS_12S,12S,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.021,KRAS_12S,12S,NA
single,Age,KRAS,lung cancer,>65,0,18,0,0,0,0,KRAS_12S,12S,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.005,0,0,0.062,KRAS_12S,12S,NA
single,Age,KRAS,appendiceal cancer,<40,6,28,0.136,0.128,0.084,0.242,KRAS_12V,12V,NA
single,Age,KRAS,appendiceal cancer,40-50,5,62,0.113,0.113,0.06,0.163,KRAS_12V,12V,NA
single,Age,KRAS,appendiceal cancer,50-65,20,161,0.122,0.121,0.085,0.166,KRAS_12V,12V,NA
single,Age,KRAS,appendiceal cancer,>65,10,90,0.119,0.118,0.076,0.167,KRAS_12V,12V,NA
single,Age,KRAS,colorectal cancer,<40,32,565,0.071,0.071,0.048,0.094,KRAS_12V,12V,NA
single,Age,KRAS,colorectal cancer,40-50,118,1280,0.091,0.091,0.078,0.106,KRAS_12V,12V,NA
single,Age,KRAS,colorectal cancer,50-65,279,2815,0.097,0.097,0.087,0.108,KRAS_12V,12V,NA
single,Age,KRAS,colorectal cancer,>65,191,2055,0.092,0.092,0.081,0.104,KRAS_12V,12V,NA
single,Age,KRAS,cancer of unknown primary,<40,0,167,0.011,0.006,0,0.049,KRAS_12V,12V,NA
single,Age,KRAS,cancer of unknown primary,40-50,12,211,0.055,0.054,0.03,0.089,KRAS_12V,12V,NA
single,Age,KRAS,cancer of unknown primary,50-65,48,810,0.059,0.058,0.044,0.076,KRAS_12V,12V,NA
single,Age,KRAS,cancer of unknown primary,>65,47,797,0.058,0.058,0.043,0.075,KRAS_12V,12V,NA
single,Age,KRAS,non-small cell lung cancer,<40,3,161,0.038,0.038,0.012,0.059,KRAS_12V,12V,NA
single,Age,KRAS,non-small cell lung cancer,40-50,20,585,0.04,0.04,0.025,0.056,KRAS_12V,12V,NA
single,Age,KRAS,non-small cell lung cancer,50-65,202,3677,0.054,0.054,0.047,0.062,KRAS_12V,12V,NA
single,Age,KRAS,non-small cell lung cancer,>65,323,5698,0.056,0.056,0.05,0.062,KRAS_12V,12V,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0.045,0.046,0.009,0.086,KRAS_12V,12V,NA
single,Age,KRAS,breast cancer,<40,2,841,0.003,0.003,0.001,0.005,KRAS_12V,12V,NA
single,Age,KRAS,breast cancer,40-50,4,1910,0.003,0.003,0.001,0.005,KRAS_12V,12V,NA
single,Age,KRAS,breast cancer,50-65,15,3989,0.003,0.003,0.002,0.005,KRAS_12V,12V,NA
single,Age,KRAS,breast cancer,>65,9,2583,0.003,0.003,0.002,0.005,KRAS_12V,12V,NA
single,Age,KRAS,breast cancer,NA,0,10,0.004,0.003,0.001,0.006,KRAS_12V,12V,NA
single,Age,KRAS,soft tissue sarcoma,<40,2,672,0.002,0.002,0,0.005,KRAS_12V,12V,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0.001,0.001,0,0.004,KRAS_12V,12V,NA
single,Age,KRAS,soft tissue sarcoma,50-65,1,951,0.001,0.001,0,0.004,KRAS_12V,12V,NA
single,Age,KRAS,soft tissue sarcoma,>65,1,777,0.002,0.001,0,0.004,KRAS_12V,12V,NA
single,Age,KRAS,pancreatic cancer,<40,2,87,0.039,0.035,0.007,0.096,KRAS_12V,12V,NA
single,Age,KRAS,pancreatic cancer,40-50,31,200,0.155,0.153,0.109,0.207,KRAS_12V,12V,NA
single,Age,KRAS,pancreatic cancer,50-65,229,1000,0.228,0.228,0.203,0.254,KRAS_12V,12V,NA
single,Age,KRAS,pancreatic cancer,>65,320,1205,0.265,0.265,0.241,0.29,KRAS_12V,12V,NA
single,Age,KRAS,leukemia,<40,3,204,0.011,0.011,0.005,0.022,KRAS_12V,12V,NA
single,Age,KRAS,leukemia,40-50,0,128,0.009,0.009,0.001,0.017,KRAS_12V,12V,NA
single,Age,KRAS,leukemia,50-65,7,515,0.011,0.011,0.006,0.02,KRAS_12V,12V,NA
single,Age,KRAS,leukemia,>65,6,720,0.01,0.01,0.005,0.016,KRAS_12V,12V,NA
single,Age,KRAS,melanoma,<40,0,289,0.001,0,0,0.003,KRAS_12V,12V,NA
single,Age,KRAS,melanoma,40-50,0,282,0.001,0,0,0.003,KRAS_12V,12V,NA
single,Age,KRAS,melanoma,50-65,0,1016,0,0,0,0.002,KRAS_12V,12V,NA
single,Age,KRAS,melanoma,>65,2,1259,0.001,0.001,0,0.003,KRAS_12V,12V,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0.001,0,0,0.004,KRAS_12V,12V,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0.001,0,0,0.003,KRAS_12V,12V,NA
single,Age,KRAS,head and neck cancer,50-65,0,799,0.001,0,0,0.002,KRAS_12V,12V,NA
single,Age,KRAS,head and neck cancer,>65,1,582,0.001,0.001,0,0.004,KRAS_12V,12V,NA
single,Age,KRAS,uterine cancer,<40,0,57,0.035,0.038,0.001,0.065,KRAS_12V,12V,NA
single,Age,KRAS,uterine cancer,40-50,11,162,0.058,0.055,0.035,0.097,KRAS_12V,12V,NA
single,Age,KRAS,uterine cancer,50-65,63,1046,0.057,0.057,0.044,0.073,KRAS_12V,12V,NA
single,Age,KRAS,uterine cancer,>65,38,988,0.041,0.041,0.029,0.055,KRAS_12V,12V,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0.003,0.001,0,0.013,KRAS_12V,12V,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0.003,0.001,0,0.014,KRAS_12V,12V,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0.002,0.001,0,0.008,KRAS_12V,12V,NA
single,Age,KRAS,non-melanoma skin cancers,>65,1,317,0.003,0.002,0,0.009,KRAS_12V,12V,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.002,0.001,0,0.006,KRAS_12V,12V,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.002,0.001,0,0.006,KRAS_12V,12V,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,1,373,0.002,0.002,0,0.006,KRAS_12V,12V,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,1,664,0.002,0.001,0,0.005,KRAS_12V,12V,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,KRAS_12V,12V,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,KRAS_12V,12V,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.002,KRAS_12V,12V,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,KRAS_12V,12V,NA
single,Age,KRAS,ovarian cancer,<40,11,141,0.06,0.057,0.031,0.106,KRAS_12V,12V,NA
single,Age,KRAS,ovarian cancer,40-50,15,253,0.051,0.05,0.031,0.081,KRAS_12V,12V,NA
single,Age,KRAS,ovarian cancer,50-65,31,1092,0.031,0.031,0.021,0.041,KRAS_12V,12V,NA
single,Age,KRAS,ovarian cancer,>65,26,849,0.033,0.033,0.022,0.045,KRAS_12V,12V,NA
single,Age,KRAS,esophagogastric cancer,<40,1,122,0.008,0.008,0.002,0.017,KRAS_12V,12V,NA
single,Age,KRAS,esophagogastric cancer,40-50,0,200,0.007,0.007,0,0.014,KRAS_12V,12V,NA
single,Age,KRAS,esophagogastric cancer,50-65,8,752,0.009,0.009,0.005,0.015,KRAS_12V,12V,NA
single,Age,KRAS,esophagogastric cancer,>65,6,725,0.008,0.008,0.004,0.014,KRAS_12V,12V,NA
single,Age,KRAS,thyroid cancer,<40,1,150,0.006,0.006,0.002,0.014,KRAS_12V,12V,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0.006,0.005,0.001,0.013,KRAS_12V,12V,NA
single,Age,KRAS,thyroid cancer,50-65,3,374,0.006,0.006,0.002,0.014,KRAS_12V,12V,NA
single,Age,KRAS,thyroid cancer,>65,2,370,0.006,0.006,0.002,0.013,KRAS_12V,12V,NA
single,Age,KRAS,cervical cancer,<40,2,85,0.029,0.028,0.011,0.055,KRAS_12V,12V,NA
single,Age,KRAS,cervical cancer,40-50,2,99,0.028,0.027,0.01,0.052,KRAS_12V,12V,NA
single,Age,KRAS,cervical cancer,50-65,6,144,0.033,0.031,0.015,0.059,KRAS_12V,12V,NA
single,Age,KRAS,cervical cancer,>65,1,36,0.03,0.029,0.01,0.061,KRAS_12V,12V,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0.019,0.021,0.001,0.036,KRAS_12V,12V,NA
single,Age,KRAS,hepatobiliary cancer,40-50,5,110,0.033,0.03,0.017,0.069,KRAS_12V,12V,NA
single,Age,KRAS,hepatobiliary cancer,50-65,16,525,0.029,0.028,0.018,0.042,KRAS_12V,12V,NA
single,Age,KRAS,hepatobiliary cancer,>65,17,601,0.028,0.027,0.018,0.04,KRAS_12V,12V,NA
single,Age,KRAS,kidney cancer,<40,0,191,0.003,0.002,0,0.007,KRAS_12V,12V,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0.003,0.002,0,0.007,KRAS_12V,12V,NA
single,Age,KRAS,kidney cancer,50-65,2,628,0.003,0.003,0.001,0.007,KRAS_12V,12V,NA
single,Age,KRAS,kidney cancer,>65,2,440,0.003,0.003,0.001,0.008,KRAS_12V,12V,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0.005,0.002,0,0.026,KRAS_12V,12V,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,1,21,0.023,0.01,0,0.12,KRAS_12V,12V,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0.004,0.002,0,0.017,KRAS_12V,12V,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0.003,0.001,0,0.016,KRAS_12V,12V,NA
single,Age,KRAS,cns cancer,<40,2,1602,0.002,0.002,0,0.003,KRAS_12V,12V,NA
single,Age,KRAS,cns cancer,40-50,3,687,0.002,0.002,0.001,0.007,KRAS_12V,12V,NA
single,Age,KRAS,cns cancer,50-65,3,1439,0.002,0.002,0.001,0.004,KRAS_12V,12V,NA
single,Age,KRAS,cns cancer,>65,0,836,0.001,0.001,0,0.003,KRAS_12V,12V,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0.001,0.001,0,0.005,KRAS_12V,12V,NA
single,Age,KRAS,prostate cancer,50-65,1,960,0.001,0.001,0,0.003,KRAS_12V,12V,NA
single,Age,KRAS,prostate cancer,>65,1,1402,0.001,0.001,0,0.003,KRAS_12V,12V,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.001,0,0,0.006,KRAS_12V,12V,NA
single,Age,KRAS,anal cancer,50-65,0,88,0,0,0,0.004,KRAS_12V,12V,NA
single,Age,KRAS,anal cancer,>65,0,45,0,0,0,0.004,KRAS_12V,12V,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0.017,0.015,0.001,0.045,KRAS_12V,12V,NA
single,Age,KRAS,neuroendocrine tumors,40-50,3,55,0.027,0.021,0.007,0.082,KRAS_12V,12V,NA
single,Age,KRAS,neuroendocrine tumors,50-65,2,161,0.016,0.015,0.004,0.034,KRAS_12V,12V,NA
single,Age,KRAS,neuroendocrine tumors,>65,1,121,0.015,0.014,0.002,0.033,KRAS_12V,12V,NA
single,Age,KRAS,bladder cancer,<40,0,25,0.011,0.011,0,0.025,KRAS_12V,12V,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0.01,0.011,0,0.021,KRAS_12V,12V,NA
single,Age,KRAS,bladder cancer,50-65,7,511,0.013,0.012,0.007,0.021,KRAS_12V,12V,NA
single,Age,KRAS,bladder cancer,>65,12,962,0.012,0.012,0.007,0.019,KRAS_12V,12V,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,1,142,0.005,0.004,0,0.019,KRAS_12V,12V,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.005,0.003,0,0.022,KRAS_12V,12V,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0.004,0.003,0,0.018,KRAS_12V,12V,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.004,0.003,0,0.018,KRAS_12V,12V,NA
single,Age,KRAS,small bowel cancer,40-50,3,29,0.121,0.12,0.061,0.19,KRAS_12V,12V,NA
single,Age,KRAS,small bowel cancer,50-65,12,96,0.124,0.123,0.078,0.179,KRAS_12V,12V,NA
single,Age,KRAS,small bowel cancer,>65,10,78,0.125,0.123,0.078,0.184,KRAS_12V,12V,NA
single,Age,KRAS,sex cord stromal tumor,<40,1,29,0.023,0.018,0.002,0.072,KRAS_12V,12V,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0.019,0.015,0,0.062,KRAS_12V,12V,NA
single,Age,KRAS,sex cord stromal tumor,50-65,1,37,0.022,0.018,0.002,0.064,KRAS_12V,12V,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0.018,0.015,0,0.056,KRAS_12V,12V,NA
single,Age,KRAS,bone cancer,<40,0,342,0,0,0,0.001,KRAS_12V,12V,NA
single,Age,KRAS,bone cancer,40-50,0,61,0,0,0,0.001,KRAS_12V,12V,NA
single,Age,KRAS,bone cancer,50-65,0,96,0,0,0,0.001,KRAS_12V,12V,NA
single,Age,KRAS,bone cancer,>65,0,67,0,0,0,0.001,KRAS_12V,12V,NA
single,Age,KRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,KRAS_12V,12V,NA
single,Age,KRAS,vaginal cancer,>65,0,30,0.001,0,0,0.008,KRAS_12V,12V,NA
single,Age,KRAS,thymic tumor,<40,0,14,0.001,0,0,0.005,KRAS_12V,12V,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0,0,0,0.004,KRAS_12V,12V,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.004,KRAS_12V,12V,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.004,KRAS_12V,12V,NA
single,Age,KRAS,ampullary cancer,40-50,2,12,0.13,0.121,0.052,0.269,KRAS_12V,12V,NA
single,Age,KRAS,ampullary cancer,50-65,6,40,0.129,0.124,0.062,0.224,KRAS_12V,12V,NA
single,Age,KRAS,ampullary cancer,>65,4,50,0.109,0.106,0.046,0.185,KRAS_12V,12V,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0.009,0.007,0,0.029,KRAS_12V,12V,NA
single,Age,KRAS,small cell lung cancer,50-65,2,144,0.01,0.008,0.002,0.026,KRAS_12V,12V,NA
single,Age,KRAS,small cell lung cancer,>65,1,224,0.007,0.006,0.001,0.019,KRAS_12V,12V,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0.001,KRAS_12V,12V,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0.001,KRAS_12V,12V,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0,KRAS_12V,12V,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0,KRAS_12V,12V,NA
single,Age,KRAS,germ cell tumor,<40,10,650,0.018,0.018,0.01,0.029,KRAS_12V,12V,NA
single,Age,KRAS,germ cell tumor,40-50,6,131,0.03,0.026,0.013,0.066,KRAS_12V,12V,NA
single,Age,KRAS,germ cell tumor,50-65,2,92,0.022,0.021,0.008,0.047,KRAS_12V,12V,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0.023,0.02,0.002,0.06,KRAS_12V,12V,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,KRAS_12V,12V,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.005,KRAS_12V,12V,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,KRAS_12V,12V,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0,0,0,0.005,KRAS_12V,12V,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.003,0,0,0.034,KRAS_12V,12V,NA
single,Age,KRAS,penile cancer,>65,0,11,0.003,0,0,0.036,KRAS_12V,12V,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.004,0,0,0.051,KRAS_12V,12V,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0.004,0.004,0,0.011,KRAS_12V,12V,NA
single,Age,KRAS,b cell lymphoma,40-50,1,105,0.005,0.004,0.001,0.015,KRAS_12V,12V,NA
single,Age,KRAS,b cell lymphoma,50-65,1,357,0.004,0.004,0.001,0.01,KRAS_12V,12V,NA
single,Age,KRAS,b cell lymphoma,>65,2,413,0.005,0.004,0.001,0.011,KRAS_12V,12V,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.044,KRAS_12V,12V,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.022,KRAS_12V,12V,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.01,KRAS_12V,12V,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.023,KRAS_12V,12V,NA
single,Age,KRAS,lung cancer,>65,0,18,0.002,0,0,0.027,KRAS_12V,12V,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.006,0,0,0.067,KRAS_12V,12V,NA
single,Age,KRAS,appendiceal cancer,<40,0,28,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,colorectal cancer,<40,1,565,0.003,0.003,0.001,0.006,KRAS_13C,13C,NA
single,Age,KRAS,colorectal cancer,40-50,1,1280,0.002,0.002,0,0.005,KRAS_13C,13C,NA
single,Age,KRAS,colorectal cancer,50-65,15,2815,0.004,0.004,0.003,0.007,KRAS_13C,13C,NA
single,Age,KRAS,colorectal cancer,>65,7,2055,0.003,0.003,0.002,0.006,KRAS_13C,13C,NA
single,Age,KRAS,cancer of unknown primary,<40,0,167,0.004,0.003,0,0.008,KRAS_13C,13C,NA
single,Age,KRAS,cancer of unknown primary,40-50,0,211,0.004,0.003,0,0.008,KRAS_13C,13C,NA
single,Age,KRAS,cancer of unknown primary,50-65,4,810,0.004,0.004,0.002,0.009,KRAS_13C,13C,NA
single,Age,KRAS,cancer of unknown primary,>65,4,797,0.004,0.004,0.002,0.009,KRAS_13C,13C,NA
single,Age,KRAS,non-small cell lung cancer,<40,2,161,0.011,0.011,0.006,0.017,KRAS_13C,13C,NA
single,Age,KRAS,non-small cell lung cancer,40-50,3,585,0.01,0.01,0.005,0.014,KRAS_13C,13C,NA
single,Age,KRAS,non-small cell lung cancer,50-65,42,3677,0.011,0.011,0.008,0.014,KRAS_13C,13C,NA
single,Age,KRAS,non-small cell lung cancer,>65,62,5698,0.011,0.011,0.009,0.013,KRAS_13C,13C,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0.011,0.011,0.005,0.019,KRAS_13C,13C,NA
single,Age,KRAS,breast cancer,<40,0,841,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,breast cancer,40-50,0,1910,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,breast cancer,50-65,0,3989,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,breast cancer,>65,0,2583,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,breast cancer,NA,0,10,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,soft tissue sarcoma,<40,0,672,0,0,0,0.002,KRAS_13C,13C,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0.002,KRAS_13C,13C,NA
single,Age,KRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,soft tissue sarcoma,>65,1,777,0.001,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,pancreatic cancer,<40,0,87,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,pancreatic cancer,40-50,0,200,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,pancreatic cancer,50-65,0,1000,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,pancreatic cancer,>65,0,1205,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,leukemia,<40,0,204,0.001,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,leukemia,40-50,0,128,0.001,0,0,0.004,KRAS_13C,13C,NA
single,Age,KRAS,leukemia,50-65,1,515,0.001,0.001,0,0.005,KRAS_13C,13C,NA
single,Age,KRAS,leukemia,>65,0,720,0.001,0,0,0.002,KRAS_13C,13C,NA
single,Age,KRAS,melanoma,<40,0,289,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,melanoma,40-50,0,282,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,melanoma,50-65,0,1016,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,melanoma,>65,0,1259,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,head and neck cancer,50-65,0,799,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,head and neck cancer,>65,0,582,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,uterine cancer,<40,0,57,0.002,0.001,0,0.008,KRAS_13C,13C,NA
single,Age,KRAS,uterine cancer,40-50,0,162,0.002,0.001,0,0.006,KRAS_13C,13C,NA
single,Age,KRAS,uterine cancer,50-65,1,1046,0.002,0.001,0,0.004,KRAS_13C,13C,NA
single,Age,KRAS,uterine cancer,>65,4,988,0.003,0.003,0.001,0.007,KRAS_13C,13C,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,KRAS_13C,13C,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.006,KRAS_13C,13C,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.005,KRAS_13C,13C,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0.001,0,0,0.006,KRAS_13C,13C,NA
single,Age,KRAS,ovarian cancer,<40,0,141,0.001,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,ovarian cancer,40-50,0,253,0,0,0,0.002,KRAS_13C,13C,NA
single,Age,KRAS,ovarian cancer,50-65,0,1092,0,0,0,0.002,KRAS_13C,13C,NA
single,Age,KRAS,ovarian cancer,>65,1,849,0.001,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,esophagogastric cancer,<40,0,122,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,esophagogastric cancer,>65,0,725,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,thyroid cancer,<40,0,150,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,thyroid cancer,50-65,0,374,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,thyroid cancer,>65,0,370,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,cervical cancer,<40,0,85,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,cervical cancer,40-50,0,99,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,cervical cancer,50-65,0,144,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,cervical cancer,>65,0,36,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,kidney cancer,<40,0,191,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,kidney cancer,50-65,0,628,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,kidney cancer,>65,0,440,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,KRAS_13C,13C,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,KRAS_13C,13C,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,KRAS_13C,13C,NA
single,Age,KRAS,cns cancer,<40,0,1602,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,cns cancer,40-50,0,687,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,cns cancer,50-65,0,1439,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,cns cancer,>65,0,836,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,prostate cancer,50-65,0,960,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,prostate cancer,>65,0,1402,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.009,0.005,0,0.043,KRAS_13C,13C,NA
single,Age,KRAS,anal cancer,50-65,1,88,0.009,0.007,0,0.033,KRAS_13C,13C,NA
single,Age,KRAS,anal cancer,>65,0,45,0.007,0.005,0,0.03,KRAS_13C,13C,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,bladder cancer,<40,0,25,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,bladder cancer,50-65,0,511,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,bladder cancer,>65,0,962,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,KRAS_13C,13C,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.002,KRAS_13C,13C,NA
single,Age,KRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,KRAS_13C,13C,NA
single,Age,KRAS,small bowel cancer,>65,0,78,0,0,0,0.002,KRAS_13C,13C,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.009,KRAS_13C,13C,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.009,KRAS_13C,13C,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0.001,0,0,0.008,KRAS_13C,13C,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.009,KRAS_13C,13C,NA
single,Age,KRAS,bone cancer,<40,0,342,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,bone cancer,40-50,0,61,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,bone cancer,50-65,0,96,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,bone cancer,>65,0,67,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,vaginal cancer,50-65,1,34,0.023,0.017,0.001,0.084,KRAS_13C,13C,NA
single,Age,KRAS,vaginal cancer,>65,0,30,0.013,0.008,0,0.057,KRAS_13C,13C,NA
single,Age,KRAS,thymic tumor,<40,0,14,0,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.004,KRAS_13C,13C,NA
single,Age,KRAS,ampullary cancer,50-65,0,40,0,0,0,0.004,KRAS_13C,13C,NA
single,Age,KRAS,ampullary cancer,>65,0,50,0,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0,0,0,0.003,KRAS_13C,13C,NA
single,Age,KRAS,small cell lung cancer,50-65,0,144,0,0,0,0.002,KRAS_13C,13C,NA
single,Age,KRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,germ cell tumor,<40,0,650,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,germ cell tumor,40-50,0,131,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,germ cell tumor,50-65,0,92,0,0,0,0,KRAS_13C,13C,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0,0,0,0.001,KRAS_13C,13C,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.006,KRAS_13C,13C,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0.001,0,0,0.007,KRAS_13C,13C,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0.001,0,0,0.006,KRAS_13C,13C,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.008,KRAS_13C,13C,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.003,0,0,0.033,KRAS_13C,13C,NA
single,Age,KRAS,penile cancer,>65,0,11,0.003,0,0,0.03,KRAS_13C,13C,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.003,0,0,0.034,KRAS_13C,13C,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0.001,0.001,0,0.006,KRAS_13C,13C,NA
single,Age,KRAS,b cell lymphoma,40-50,0,105,0.001,0.001,0,0.005,KRAS_13C,13C,NA
single,Age,KRAS,b cell lymphoma,50-65,1,357,0.002,0.001,0,0.007,KRAS_13C,13C,NA
single,Age,KRAS,b cell lymphoma,>65,0,413,0.001,0.001,0,0.004,KRAS_13C,13C,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.051,KRAS_13C,13C,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.001,0,0,0.017,KRAS_13C,13C,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.01,KRAS_13C,13C,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.028,KRAS_13C,13C,NA
single,Age,KRAS,lung cancer,>65,0,18,0.003,0,0,0.038,KRAS_13C,13C,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.053,KRAS_13C,13C,NA
single,Age,KRAS,appendiceal cancer,<40,0,28,0.035,0.035,0.001,0.074,KRAS_13D,13D,NA
single,Age,KRAS,appendiceal cancer,40-50,4,62,0.049,0.045,0.021,0.1,KRAS_13D,13D,NA
single,Age,KRAS,appendiceal cancer,50-65,4,161,0.035,0.034,0.012,0.062,KRAS_13D,13D,NA
single,Age,KRAS,appendiceal cancer,>65,6,90,0.05,0.046,0.023,0.098,KRAS_13D,13D,NA
single,Age,KRAS,colorectal cancer,<40,46,565,0.076,0.076,0.065,0.092,KRAS_13D,13D,NA
single,Age,KRAS,colorectal cancer,40-50,93,1280,0.074,0.074,0.064,0.084,KRAS_13D,13D,NA
single,Age,KRAS,colorectal cancer,50-65,197,2815,0.072,0.072,0.064,0.08,KRAS_13D,13D,NA
single,Age,KRAS,colorectal cancer,>65,162,2055,0.076,0.076,0.068,0.087,KRAS_13D,13D,NA
single,Age,KRAS,cancer of unknown primary,<40,3,167,0.016,0.014,0.007,0.033,KRAS_13D,13D,NA
single,Age,KRAS,cancer of unknown primary,40-50,7,211,0.021,0.018,0.009,0.046,KRAS_13D,13D,NA
single,Age,KRAS,cancer of unknown primary,50-65,9,810,0.012,0.012,0.007,0.019,KRAS_13D,13D,NA
single,Age,KRAS,cancer of unknown primary,>65,7,797,0.011,0.011,0.005,0.018,KRAS_13D,13D,NA
single,Age,KRAS,non-small cell lung cancer,<40,0,161,0.008,0.008,0.002,0.012,KRAS_13D,13D,NA
single,Age,KRAS,non-small cell lung cancer,40-50,5,585,0.009,0.009,0.005,0.013,KRAS_13D,13D,NA
single,Age,KRAS,non-small cell lung cancer,50-65,37,3677,0.009,0.009,0.007,0.012,KRAS_13D,13D,NA
single,Age,KRAS,non-small cell lung cancer,>65,45,5698,0.008,0.008,0.006,0.01,KRAS_13D,13D,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0.009,0.008,0.003,0.015,KRAS_13D,13D,NA
single,Age,KRAS,breast cancer,<40,0,841,0,0,0,0.001,KRAS_13D,13D,NA
single,Age,KRAS,breast cancer,40-50,0,1910,0,0,0,0.001,KRAS_13D,13D,NA
single,Age,KRAS,breast cancer,50-65,5,3989,0.001,0.001,0,0.002,KRAS_13D,13D,NA
single,Age,KRAS,breast cancer,>65,0,2583,0,0,0,0.001,KRAS_13D,13D,NA
single,Age,KRAS,breast cancer,NA,0,10,0.002,0,0,0.016,KRAS_13D,13D,NA
single,Age,KRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,pancreatic cancer,<40,0,87,0.006,0.005,0.002,0.011,KRAS_13D,13D,NA
single,Age,KRAS,pancreatic cancer,40-50,1,200,0.006,0.005,0.002,0.011,KRAS_13D,13D,NA
single,Age,KRAS,pancreatic cancer,50-65,5,1000,0.006,0.005,0.003,0.009,KRAS_13D,13D,NA
single,Age,KRAS,pancreatic cancer,>65,8,1205,0.006,0.006,0.003,0.01,KRAS_13D,13D,NA
single,Age,KRAS,leukemia,<40,10,204,0.04,0.039,0.016,0.073,KRAS_13D,13D,NA
single,Age,KRAS,leukemia,40-50,3,128,0.022,0.02,0.007,0.049,KRAS_13D,13D,NA
single,Age,KRAS,leukemia,50-65,7,515,0.015,0.014,0.007,0.025,KRAS_13D,13D,NA
single,Age,KRAS,leukemia,>65,5,720,0.009,0.009,0.003,0.018,KRAS_13D,13D,NA
single,Age,KRAS,melanoma,<40,0,289,0.002,0.001,0,0.005,KRAS_13D,13D,NA
single,Age,KRAS,melanoma,40-50,0,282,0.002,0.001,0,0.005,KRAS_13D,13D,NA
single,Age,KRAS,melanoma,50-65,1,1016,0.002,0.002,0,0.004,KRAS_13D,13D,NA
single,Age,KRAS,melanoma,>65,6,1259,0.004,0.003,0.001,0.008,KRAS_13D,13D,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0.002,0.002,0,0.005,KRAS_13D,13D,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0.002,0.001,0,0.005,KRAS_13D,13D,NA
single,Age,KRAS,head and neck cancer,50-65,2,799,0.002,0.002,0,0.005,KRAS_13D,13D,NA
single,Age,KRAS,head and neck cancer,>65,1,582,0.002,0.002,0,0.005,KRAS_13D,13D,NA
single,Age,KRAS,uterine cancer,<40,1,57,0.021,0.02,0.011,0.033,KRAS_13D,13D,NA
single,Age,KRAS,uterine cancer,40-50,4,162,0.021,0.021,0.013,0.034,KRAS_13D,13D,NA
single,Age,KRAS,uterine cancer,50-65,20,1046,0.02,0.02,0.014,0.027,KRAS_13D,13D,NA
single,Age,KRAS,uterine cancer,>65,21,988,0.021,0.02,0.014,0.028,KRAS_13D,13D,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,KRAS_13D,13D,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,KRAS_13D,13D,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,KRAS_13D,13D,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,KRAS_13D,13D,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,2,87,0.009,0.007,0.002,0.033,KRAS_13D,13D,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.006,0.005,0,0.015,KRAS_13D,13D,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,1,373,0.005,0.005,0.001,0.011,KRAS_13D,13D,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,4,664,0.006,0.006,0.002,0.012,KRAS_13D,13D,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,KRAS_13D,13D,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.006,KRAS_13D,13D,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.005,KRAS_13D,13D,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0.001,0,0,0.006,KRAS_13D,13D,NA
single,Age,KRAS,ovarian cancer,<40,1,141,0.005,0.004,0.002,0.013,KRAS_13D,13D,NA
single,Age,KRAS,ovarian cancer,40-50,3,253,0.006,0.005,0.002,0.017,KRAS_13D,13D,NA
single,Age,KRAS,ovarian cancer,50-65,3,1092,0.004,0.004,0.001,0.007,KRAS_13D,13D,NA
single,Age,KRAS,ovarian cancer,>65,3,849,0.004,0.004,0.002,0.008,KRAS_13D,13D,NA
single,Age,KRAS,esophagogastric cancer,<40,1,122,0.012,0.012,0.005,0.021,KRAS_13D,13D,NA
single,Age,KRAS,esophagogastric cancer,40-50,2,200,0.012,0.012,0.005,0.021,KRAS_13D,13D,NA
single,Age,KRAS,esophagogastric cancer,50-65,7,752,0.011,0.011,0.006,0.018,KRAS_13D,13D,NA
single,Age,KRAS,esophagogastric cancer,>65,12,725,0.014,0.013,0.008,0.022,KRAS_13D,13D,NA
single,Age,KRAS,thyroid cancer,<40,0,150,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,thyroid cancer,50-65,0,374,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,thyroid cancer,>65,0,370,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,cervical cancer,<40,0,85,0.008,0.007,0,0.025,KRAS_13D,13D,NA
single,Age,KRAS,cervical cancer,40-50,3,99,0.018,0.015,0.004,0.053,KRAS_13D,13D,NA
single,Age,KRAS,cervical cancer,50-65,1,144,0.01,0.008,0.001,0.025,KRAS_13D,13D,NA
single,Age,KRAS,cervical cancer,>65,0,36,0.01,0.008,0,0.03,KRAS_13D,13D,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0.006,0.006,0.001,0.013,KRAS_13D,13D,NA
single,Age,KRAS,hepatobiliary cancer,40-50,2,110,0.009,0.007,0.003,0.024,KRAS_13D,13D,NA
single,Age,KRAS,hepatobiliary cancer,50-65,4,525,0.007,0.007,0.003,0.013,KRAS_13D,13D,NA
single,Age,KRAS,hepatobiliary cancer,>65,3,601,0.006,0.006,0.002,0.012,KRAS_13D,13D,NA
single,Age,KRAS,kidney cancer,<40,0,191,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,kidney cancer,50-65,0,628,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,kidney cancer,>65,0,440,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,KRAS_13D,13D,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,KRAS_13D,13D,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,KRAS_13D,13D,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,KRAS_13D,13D,NA
single,Age,KRAS,cns cancer,<40,0,1602,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,cns cancer,40-50,0,687,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,cns cancer,50-65,0,1439,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,cns cancer,>65,0,836,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0.001,0,0,0.005,KRAS_13D,13D,NA
single,Age,KRAS,prostate cancer,50-65,0,960,0,0,0,0.002,KRAS_13D,13D,NA
single,Age,KRAS,prostate cancer,>65,1,1402,0.001,0,0,0.002,KRAS_13D,13D,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.009,0.005,0,0.046,KRAS_13D,13D,NA
single,Age,KRAS,anal cancer,50-65,0,88,0.006,0.004,0,0.025,KRAS_13D,13D,NA
single,Age,KRAS,anal cancer,>65,1,45,0.013,0.009,0.001,0.056,KRAS_13D,13D,NA
single,Age,KRAS,neuroendocrine tumors,<40,2,22,0.032,0.021,0.007,0.13,KRAS_13D,13D,NA
single,Age,KRAS,neuroendocrine tumors,40-50,1,55,0.019,0.016,0.004,0.047,KRAS_13D,13D,NA
single,Age,KRAS,neuroendocrine tumors,50-65,2,161,0.016,0.015,0.004,0.034,KRAS_13D,13D,NA
single,Age,KRAS,neuroendocrine tumors,>65,1,121,0.015,0.014,0.003,0.034,KRAS_13D,13D,NA
single,Age,KRAS,bladder cancer,<40,0,25,0.003,0.002,0,0.015,KRAS_13D,13D,NA
single,Age,KRAS,bladder cancer,40-50,1,78,0.006,0.003,0.001,0.029,KRAS_13D,13D,NA
single,Age,KRAS,bladder cancer,50-65,0,511,0.002,0.002,0,0.006,KRAS_13D,13D,NA
single,Age,KRAS,bladder cancer,>65,3,962,0.003,0.003,0.001,0.007,KRAS_13D,13D,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,8,142,0.053,0.05,0.022,0.096,KRAS_13D,13D,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.009,0,0,0.056,KRAS_13D,13D,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0.006,0,0,0.039,KRAS_13D,13D,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.006,0,0,0.041,KRAS_13D,13D,NA
single,Age,KRAS,small bowel cancer,40-50,6,29,0.149,0.137,0.048,0.318,KRAS_13D,13D,NA
single,Age,KRAS,small bowel cancer,50-65,4,96,0.051,0.049,0.017,0.098,KRAS_13D,13D,NA
single,Age,KRAS,small bowel cancer,>65,3,78,0.05,0.048,0.014,0.1,KRAS_13D,13D,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.009,KRAS_13D,13D,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.009,KRAS_13D,13D,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0.001,0,0,0.008,KRAS_13D,13D,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.009,KRAS_13D,13D,NA
single,Age,KRAS,bone cancer,<40,0,342,0,0,0,0.001,KRAS_13D,13D,NA
single,Age,KRAS,bone cancer,40-50,0,61,0,0,0,0.001,KRAS_13D,13D,NA
single,Age,KRAS,bone cancer,50-65,0,96,0,0,0,0.001,KRAS_13D,13D,NA
single,Age,KRAS,bone cancer,>65,0,67,0,0,0,0.001,KRAS_13D,13D,NA
single,Age,KRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.011,KRAS_13D,13D,NA
single,Age,KRAS,vaginal cancer,>65,0,30,0.001,0,0,0.011,KRAS_13D,13D,NA
single,Age,KRAS,thymic tumor,<40,0,14,0,0,0,0.003,KRAS_13D,13D,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0,0,0,0.003,KRAS_13D,13D,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.003,KRAS_13D,13D,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.003,KRAS_13D,13D,NA
single,Age,KRAS,ampullary cancer,40-50,0,12,0.044,0.041,0.001,0.111,KRAS_13D,13D,NA
single,Age,KRAS,ampullary cancer,50-65,3,40,0.056,0.051,0.016,0.128,KRAS_13D,13D,NA
single,Age,KRAS,ampullary cancer,>65,2,50,0.047,0.044,0.012,0.102,KRAS_13D,13D,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0,0,0,0.003,KRAS_13D,13D,NA
single,Age,KRAS,small cell lung cancer,50-65,0,144,0,0,0,0.002,KRAS_13D,13D,NA
single,Age,KRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,KRAS_13D,13D,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0,KRAS_13D,13D,NA
single,Age,KRAS,germ cell tumor,<40,1,650,0.001,0.001,0,0.005,KRAS_13D,13D,NA
single,Age,KRAS,germ cell tumor,40-50,0,131,0.001,0.001,0,0.006,KRAS_13D,13D,NA
single,Age,KRAS,germ cell tumor,50-65,0,92,0.001,0.001,0,0.006,KRAS_13D,13D,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0.002,0.001,0,0.011,KRAS_13D,13D,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.006,KRAS_13D,13D,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0.001,0,0,0.007,KRAS_13D,13D,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0.001,0,0,0.006,KRAS_13D,13D,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.008,KRAS_13D,13D,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.003,0,0,0.033,KRAS_13D,13D,NA
single,Age,KRAS,penile cancer,>65,0,11,0.003,0,0,0.03,KRAS_13D,13D,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.003,0,0,0.034,KRAS_13D,13D,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0.007,0.006,0,0.016,KRAS_13D,13D,NA
single,Age,KRAS,b cell lymphoma,40-50,1,105,0.008,0.007,0.002,0.021,KRAS_13D,13D,NA
single,Age,KRAS,b cell lymphoma,50-65,1,357,0.006,0.006,0.001,0.013,KRAS_13D,13D,NA
single,Age,KRAS,b cell lymphoma,>65,5,413,0.009,0.008,0.003,0.019,KRAS_13D,13D,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.051,KRAS_13D,13D,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.001,0,0,0.017,KRAS_13D,13D,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.01,KRAS_13D,13D,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.028,KRAS_13D,13D,NA
single,Age,KRAS,lung cancer,>65,0,18,0.003,0,0,0.038,KRAS_13D,13D,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.053,KRAS_13D,13D,NA
single,Age,KRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,appendiceal cancer,40-50,0,62,0,0,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,appendiceal cancer,>65,0,90,0,0,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,colorectal cancer,<40,0,565,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,colorectal cancer,40-50,1,1280,0,0,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,colorectal cancer,50-65,1,2815,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,colorectal cancer,>65,0,2055,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,cancer of unknown primary,<40,0,167,0.001,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,cancer of unknown primary,40-50,0,211,0.001,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,cancer of unknown primary,50-65,1,810,0.001,0.001,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,cancer of unknown primary,>65,0,797,0,0,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,non-small cell lung cancer,<40,0,161,0.001,0.001,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,non-small cell lung cancer,40-50,0,585,0.001,0.001,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,non-small cell lung cancer,50-65,3,3677,0.001,0.001,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,non-small cell lung cancer,>65,3,5698,0.001,0.001,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0.001,0.001,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,breast cancer,<40,0,841,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,breast cancer,40-50,0,1910,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,breast cancer,50-65,0,3989,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,breast cancer,>65,0,2583,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,breast cancer,NA,0,10,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,pancreatic cancer,<40,0,87,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,pancreatic cancer,40-50,0,200,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,pancreatic cancer,50-65,0,1000,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,pancreatic cancer,>65,0,1205,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,leukemia,<40,0,204,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,leukemia,40-50,0,128,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,leukemia,50-65,0,515,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,leukemia,>65,0,720,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,melanoma,<40,0,289,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,melanoma,40-50,0,282,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,melanoma,50-65,0,1016,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,melanoma,>65,0,1259,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,head and neck cancer,50-65,0,799,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,head and neck cancer,>65,0,582,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,uterine cancer,<40,0,57,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,uterine cancer,40-50,0,162,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,uterine cancer,50-65,0,1046,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,uterine cancer,>65,0,988,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,ovarian cancer,<40,0,141,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,ovarian cancer,40-50,0,253,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,ovarian cancer,50-65,0,1092,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,ovarian cancer,>65,0,849,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,esophagogastric cancer,<40,0,122,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,esophagogastric cancer,>65,0,725,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,thyroid cancer,<40,0,150,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,thyroid cancer,50-65,0,374,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,thyroid cancer,>65,0,370,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,cervical cancer,<40,0,85,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,cervical cancer,40-50,0,99,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,cervical cancer,50-65,0,144,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,cervical cancer,>65,0,36,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,kidney cancer,<40,0,191,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,kidney cancer,50-65,0,628,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,kidney cancer,>65,0,440,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,cns cancer,<40,1,1602,0,0,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,cns cancer,40-50,0,687,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,cns cancer,50-65,0,1439,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,cns cancer,>65,0,836,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,prostate cancer,50-65,0,960,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,prostate cancer,>65,0,1402,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.001,0,0,0.006,KRAS_13R,13R,NA
single,Age,KRAS,anal cancer,50-65,0,88,0,0,0,0.004,KRAS_13R,13R,NA
single,Age,KRAS,anal cancer,>65,0,45,0,0,0,0.005,KRAS_13R,13R,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,bladder cancer,<40,0,25,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,bladder cancer,50-65,0,511,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,bladder cancer,>65,0,962,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,small bowel cancer,>65,0,78,0,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.004,KRAS_13R,13R,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0,0,0,0.003,KRAS_13R,13R,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.004,KRAS_13R,13R,NA
single,Age,KRAS,bone cancer,<40,0,342,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,bone cancer,40-50,0,61,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,bone cancer,50-65,0,96,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,bone cancer,>65,0,67,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,KRAS_13R,13R,NA
single,Age,KRAS,vaginal cancer,>65,0,30,0.001,0,0,0.007,KRAS_13R,13R,NA
single,Age,KRAS,thymic tumor,<40,0,14,0.001,0,0,0.006,KRAS_13R,13R,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0,0,0,0.004,KRAS_13R,13R,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.004,KRAS_13R,13R,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.004,KRAS_13R,13R,NA
single,Age,KRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.007,KRAS_13R,13R,NA
single,Age,KRAS,ampullary cancer,50-65,0,40,0,0,0,0.005,KRAS_13R,13R,NA
single,Age,KRAS,ampullary cancer,>65,0,50,0,0,0,0.005,KRAS_13R,13R,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,KRAS_13R,13R,NA
single,Age,KRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,germ cell tumor,<40,0,650,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,germ cell tumor,40-50,0,131,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,germ cell tumor,50-65,0,92,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0,0,0,0.001,KRAS_13R,13R,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,KRAS_13R,13R,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,KRAS_13R,13R,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.005,KRAS_13R,13R,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0,0,0,0.005,KRAS_13R,13R,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.004,0,0,0.045,KRAS_13R,13R,NA
single,Age,KRAS,penile cancer,>65,0,11,0.004,0,0,0.046,KRAS_13R,13R,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.004,0,0,0.047,KRAS_13R,13R,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,b cell lymphoma,40-50,0,105,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,b cell lymphoma,50-65,0,357,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,b cell lymphoma,>65,0,413,0,0,0,0,KRAS_13R,13R,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.045,KRAS_13R,13R,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.022,KRAS_13R,13R,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.009,KRAS_13R,13R,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.019,KRAS_13R,13R,NA
single,Age,KRAS,lung cancer,>65,0,18,0.003,0,0,0.035,KRAS_13R,13R,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.002,0,0,0.025,KRAS_13R,13R,NA
single,Age,KRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,KRAS_13V,13V,NA
single,Age,KRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,colorectal cancer,<40,0,565,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,colorectal cancer,40-50,0,1280,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,colorectal cancer,50-65,0,2815,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,colorectal cancer,>65,2,2055,0.001,0,0,0.002,KRAS_13V,13V,NA
single,Age,KRAS,cancer of unknown primary,<40,0,167,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,cancer of unknown primary,50-65,0,810,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,cancer of unknown primary,>65,0,797,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,non-small cell lung cancer,<40,0,161,0.001,0,0,0.003,KRAS_13V,13V,NA
single,Age,KRAS,non-small cell lung cancer,40-50,1,585,0.001,0.001,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,non-small cell lung cancer,50-65,3,3677,0.001,0.001,0,0.002,KRAS_13V,13V,NA
single,Age,KRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0.002,0,0,0.013,KRAS_13V,13V,NA
single,Age,KRAS,breast cancer,<40,0,841,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,breast cancer,40-50,0,1910,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,breast cancer,50-65,0,3989,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,breast cancer,>65,0,2583,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,breast cancer,NA,0,10,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,pancreatic cancer,<40,0,87,0.001,0.001,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,pancreatic cancer,40-50,0,200,0.001,0.001,0,0.003,KRAS_13V,13V,NA
single,Age,KRAS,pancreatic cancer,50-65,1,1000,0.001,0.001,0,0.003,KRAS_13V,13V,NA
single,Age,KRAS,pancreatic cancer,>65,1,1205,0.001,0.001,0,0.003,KRAS_13V,13V,NA
single,Age,KRAS,leukemia,<40,0,204,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,leukemia,40-50,0,128,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,leukemia,50-65,0,515,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,leukemia,>65,0,720,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,melanoma,<40,0,289,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,melanoma,40-50,0,282,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,melanoma,50-65,0,1016,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,melanoma,>65,0,1259,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,head and neck cancer,50-65,0,799,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,head and neck cancer,>65,0,582,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,uterine cancer,<40,0,57,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,uterine cancer,40-50,0,162,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,uterine cancer,50-65,0,1046,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,uterine cancer,>65,0,988,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,ovarian cancer,<40,0,141,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,ovarian cancer,40-50,0,253,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,ovarian cancer,50-65,0,1092,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,ovarian cancer,>65,0,849,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,esophagogastric cancer,<40,0,122,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,esophagogastric cancer,>65,0,725,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,thyroid cancer,<40,0,150,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,thyroid cancer,50-65,0,374,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,thyroid cancer,>65,0,370,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,cervical cancer,<40,0,85,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,cervical cancer,40-50,0,99,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,cervical cancer,50-65,0,144,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,cervical cancer,>65,0,36,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,kidney cancer,<40,0,191,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,kidney cancer,50-65,0,628,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,kidney cancer,>65,0,440,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,KRAS_13V,13V,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.002,KRAS_13V,13V,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,KRAS_13V,13V,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,KRAS_13V,13V,NA
single,Age,KRAS,cns cancer,<40,0,1602,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,cns cancer,40-50,0,687,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,cns cancer,50-65,0,1439,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,cns cancer,>65,0,836,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,prostate cancer,50-65,0,960,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,prostate cancer,>65,0,1402,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.001,0,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,anal cancer,50-65,0,88,0,0,0,0.003,KRAS_13V,13V,NA
single,Age,KRAS,anal cancer,>65,0,45,0,0,0,0.003,KRAS_13V,13V,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.002,KRAS_13V,13V,NA
single,Age,KRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.002,KRAS_13V,13V,NA
single,Age,KRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,bladder cancer,<40,0,25,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,bladder cancer,50-65,0,511,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,bladder cancer,>65,0,962,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,small bowel cancer,40-50,0,29,0,0,0,0.002,KRAS_13V,13V,NA
single,Age,KRAS,small bowel cancer,50-65,0,96,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,small bowel cancer,>65,0,78,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.006,KRAS_13V,13V,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.007,KRAS_13V,13V,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0.001,0,0,0.006,KRAS_13V,13V,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.006,KRAS_13V,13V,NA
single,Age,KRAS,bone cancer,<40,0,342,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,bone cancer,40-50,0,61,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,bone cancer,50-65,0,96,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,bone cancer,>65,0,67,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.007,KRAS_13V,13V,NA
single,Age,KRAS,vaginal cancer,>65,0,30,0.001,0,0,0.007,KRAS_13V,13V,NA
single,Age,KRAS,thymic tumor,<40,0,14,0,0,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0,0,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.01,KRAS_13V,13V,NA
single,Age,KRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.008,KRAS_13V,13V,NA
single,Age,KRAS,ampullary cancer,>65,0,50,0.001,0,0,0.008,KRAS_13V,13V,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,KRAS_13V,13V,NA
single,Age,KRAS,small cell lung cancer,50-65,0,144,0,0,0,0.002,KRAS_13V,13V,NA
single,Age,KRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0.001,KRAS_13V,13V,NA
single,Age,KRAS,germ cell tumor,<40,0,650,0.001,0,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,germ cell tumor,40-50,1,131,0.004,0.002,0,0.021,KRAS_13V,13V,NA
single,Age,KRAS,germ cell tumor,50-65,0,92,0.001,0.001,0,0.008,KRAS_13V,13V,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0.003,0.001,0,0.023,KRAS_13V,13V,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,KRAS_13V,13V,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,KRAS_13V,13V,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,KRAS_13V,13V,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.003,0,0,0.034,KRAS_13V,13V,NA
single,Age,KRAS,penile cancer,>65,0,11,0.003,0,0,0.034,KRAS_13V,13V,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.004,0,0,0.045,KRAS_13V,13V,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,b cell lymphoma,40-50,0,105,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,b cell lymphoma,50-65,0,357,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,b cell lymphoma,>65,0,413,0,0,0,0,KRAS_13V,13V,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.005,0,0,0.055,KRAS_13V,13V,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.021,KRAS_13V,13V,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,KRAS_13V,13V,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.029,KRAS_13V,13V,NA
single,Age,KRAS,lung cancer,>65,0,18,0.003,0,0,0.032,KRAS_13V,13V,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,KRAS_13V,13V,NA
single,Age,KRAS,appendiceal cancer,<40,1,28,0.016,0.01,0.002,0.07,KRAS_61H,61H,NA
single,Age,KRAS,appendiceal cancer,40-50,0,62,0.008,0.006,0,0.024,KRAS_61H,61H,NA
single,Age,KRAS,appendiceal cancer,50-65,2,161,0.01,0.009,0.002,0.027,KRAS_61H,61H,NA
single,Age,KRAS,appendiceal cancer,>65,0,90,0.007,0.006,0,0.023,KRAS_61H,61H,NA
single,Age,KRAS,colorectal cancer,<40,2,565,0.008,0.009,0.003,0.012,KRAS_61H,61H,NA
single,Age,KRAS,colorectal cancer,40-50,15,1280,0.01,0.01,0.007,0.015,KRAS_61H,61H,NA
single,Age,KRAS,colorectal cancer,50-65,30,2815,0.01,0.01,0.007,0.013,KRAS_61H,61H,NA
single,Age,KRAS,colorectal cancer,>65,17,2055,0.009,0.009,0.006,0.012,KRAS_61H,61H,NA
single,Age,KRAS,cancer of unknown primary,<40,0,167,0.005,0.005,0,0.012,KRAS_61H,61H,NA
single,Age,KRAS,cancer of unknown primary,40-50,0,211,0.005,0.004,0,0.012,KRAS_61H,61H,NA
single,Age,KRAS,cancer of unknown primary,50-65,5,810,0.007,0.006,0.003,0.012,KRAS_61H,61H,NA
single,Age,KRAS,cancer of unknown primary,>65,10,797,0.01,0.01,0.005,0.019,KRAS_61H,61H,NA
single,Age,KRAS,non-small cell lung cancer,<40,0,161,0.012,0.012,0.005,0.017,KRAS_61H,61H,NA
single,Age,KRAS,non-small cell lung cancer,40-50,8,585,0.013,0.013,0.009,0.018,KRAS_61H,61H,NA
single,Age,KRAS,non-small cell lung cancer,50-65,52,3677,0.013,0.013,0.011,0.017,KRAS_61H,61H,NA
single,Age,KRAS,non-small cell lung cancer,>65,71,5698,0.013,0.013,0.01,0.015,KRAS_61H,61H,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0.013,0.013,0.006,0.02,KRAS_61H,61H,NA
single,Age,KRAS,breast cancer,<40,0,841,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,breast cancer,40-50,0,1910,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,breast cancer,50-65,0,3989,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,breast cancer,>65,0,2583,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,breast cancer,NA,0,10,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,soft tissue sarcoma,<40,0,672,0,0,0,0.002,KRAS_61H,61H,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0.002,KRAS_61H,61H,NA
single,Age,KRAS,soft tissue sarcoma,50-65,1,951,0.001,0,0,0.003,KRAS_61H,61H,NA
single,Age,KRAS,soft tissue sarcoma,>65,0,777,0,0,0,0.002,KRAS_61H,61H,NA
single,Age,KRAS,pancreatic cancer,<40,0,87,0.022,0.023,0.001,0.044,KRAS_61H,61H,NA
single,Age,KRAS,pancreatic cancer,40-50,8,200,0.036,0.035,0.019,0.061,KRAS_61H,61H,NA
single,Age,KRAS,pancreatic cancer,50-65,25,1000,0.027,0.027,0.018,0.038,KRAS_61H,61H,NA
single,Age,KRAS,pancreatic cancer,>65,53,1205,0.041,0.041,0.031,0.054,KRAS_61H,61H,NA
single,Age,KRAS,leukemia,<40,1,204,0.003,0.003,0.001,0.01,KRAS_61H,61H,NA
single,Age,KRAS,leukemia,40-50,1,128,0.004,0.003,0.001,0.012,KRAS_61H,61H,NA
single,Age,KRAS,leukemia,50-65,1,515,0.003,0.002,0.001,0.006,KRAS_61H,61H,NA
single,Age,KRAS,leukemia,>65,1,720,0.003,0.002,0,0.006,KRAS_61H,61H,NA
single,Age,KRAS,melanoma,<40,0,289,0,0,0,0.002,KRAS_61H,61H,NA
single,Age,KRAS,melanoma,40-50,0,282,0,0,0,0.002,KRAS_61H,61H,NA
single,Age,KRAS,melanoma,50-65,0,1016,0,0,0,0.002,KRAS_61H,61H,NA
single,Age,KRAS,melanoma,>65,2,1259,0.001,0.001,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,head and neck cancer,50-65,0,799,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,head and neck cancer,>65,0,582,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,uterine cancer,<40,0,57,0.003,0.002,0,0.007,KRAS_61H,61H,NA
single,Age,KRAS,uterine cancer,40-50,0,162,0.003,0.002,0,0.006,KRAS_61H,61H,NA
single,Age,KRAS,uterine cancer,50-65,3,1046,0.003,0.003,0.001,0.006,KRAS_61H,61H,NA
single,Age,KRAS,uterine cancer,>65,3,988,0.003,0.003,0.001,0.006,KRAS_61H,61H,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,KRAS_61H,61H,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,KRAS_61H,61H,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,KRAS_61H,61H,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,KRAS_61H,61H,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,ovarian cancer,<40,2,141,0.007,0.005,0.001,0.024,KRAS_61H,61H,NA
single,Age,KRAS,ovarian cancer,40-50,0,253,0.003,0.003,0,0.007,KRAS_61H,61H,NA
single,Age,KRAS,ovarian cancer,50-65,5,1092,0.004,0.004,0.002,0.008,KRAS_61H,61H,NA
single,Age,KRAS,ovarian cancer,>65,1,849,0.003,0.002,0,0.006,KRAS_61H,61H,NA
single,Age,KRAS,esophagogastric cancer,<40,0,122,0.001,0.001,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,esophagogastric cancer,40-50,0,200,0.001,0.001,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,esophagogastric cancer,50-65,1,752,0.001,0.001,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,esophagogastric cancer,>65,1,725,0.001,0.001,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,thyroid cancer,<40,0,150,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,thyroid cancer,50-65,0,374,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,thyroid cancer,>65,0,370,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,cervical cancer,<40,0,85,0,0,0,0.001,KRAS_61H,61H,NA
single,Age,KRAS,cervical cancer,40-50,0,99,0,0,0,0.001,KRAS_61H,61H,NA
single,Age,KRAS,cervical cancer,50-65,0,144,0,0,0,0.001,KRAS_61H,61H,NA
single,Age,KRAS,cervical cancer,>65,0,36,0,0,0,0.001,KRAS_61H,61H,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0.009,0.009,0.001,0.017,KRAS_61H,61H,NA
single,Age,KRAS,hepatobiliary cancer,40-50,1,110,0.01,0.01,0.003,0.02,KRAS_61H,61H,NA
single,Age,KRAS,hepatobiliary cancer,50-65,5,525,0.01,0.01,0.005,0.017,KRAS_61H,61H,NA
single,Age,KRAS,hepatobiliary cancer,>65,8,601,0.011,0.011,0.006,0.019,KRAS_61H,61H,NA
single,Age,KRAS,kidney cancer,<40,0,191,0.001,0,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0.001,0,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,kidney cancer,50-65,1,628,0.001,0.001,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,kidney cancer,>65,0,440,0.001,0,0,0.003,KRAS_61H,61H,NA
single,Age,KRAS,mature t and nk neoplasms,<40,1,28,0.016,0.01,0.001,0.074,KRAS_61H,61H,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0.009,0.007,0,0.034,KRAS_61H,61H,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0.007,0.006,0,0.025,KRAS_61H,61H,NA
single,Age,KRAS,mature t and nk neoplasms,>65,1,106,0.01,0.008,0.001,0.029,KRAS_61H,61H,NA
single,Age,KRAS,cns cancer,<40,1,1602,0.001,0.001,0,0.002,KRAS_61H,61H,NA
single,Age,KRAS,cns cancer,40-50,1,687,0.001,0.001,0,0.003,KRAS_61H,61H,NA
single,Age,KRAS,cns cancer,50-65,0,1439,0.001,0.001,0,0.002,KRAS_61H,61H,NA
single,Age,KRAS,cns cancer,>65,1,836,0.001,0.001,0,0.003,KRAS_61H,61H,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0.001,0,0,0.005,KRAS_61H,61H,NA
single,Age,KRAS,prostate cancer,50-65,1,960,0.001,0,0,0.003,KRAS_61H,61H,NA
single,Age,KRAS,prostate cancer,>65,0,1402,0,0,0,0.002,KRAS_61H,61H,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.001,0,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,anal cancer,50-65,0,88,0,0,0,0.003,KRAS_61H,61H,NA
single,Age,KRAS,anal cancer,>65,0,45,0,0,0,0.003,KRAS_61H,61H,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0.003,0.001,0,0.019,KRAS_61H,61H,NA
single,Age,KRAS,neuroendocrine tumors,40-50,1,55,0.01,0.005,0,0.05,KRAS_61H,61H,NA
single,Age,KRAS,neuroendocrine tumors,50-65,0,161,0.002,0.001,0,0.01,KRAS_61H,61H,NA
single,Age,KRAS,neuroendocrine tumors,>65,0,121,0.002,0.001,0,0.011,KRAS_61H,61H,NA
single,Age,KRAS,bladder cancer,<40,0,25,0.003,0.001,0,0.018,KRAS_61H,61H,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0.001,0,0,0.009,KRAS_61H,61H,NA
single,Age,KRAS,bladder cancer,50-65,3,511,0.005,0.004,0.001,0.013,KRAS_61H,61H,NA
single,Age,KRAS,bladder cancer,>65,0,962,0.001,0,0,0.003,KRAS_61H,61H,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,3,142,0.017,0.015,0.003,0.045,KRAS_61H,61H,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.008,0.004,0,0.037,KRAS_61H,61H,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0.006,0.003,0,0.028,KRAS_61H,61H,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.006,0.003,0,0.029,KRAS_61H,61H,NA
single,Age,KRAS,small bowel cancer,40-50,2,29,0.039,0.033,0.011,0.113,KRAS_61H,61H,NA
single,Age,KRAS,small bowel cancer,50-65,3,96,0.031,0.029,0.01,0.064,KRAS_61H,61H,NA
single,Age,KRAS,small bowel cancer,>65,1,78,0.027,0.025,0.005,0.058,KRAS_61H,61H,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.006,KRAS_61H,61H,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.007,KRAS_61H,61H,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0.001,0,0,0.006,KRAS_61H,61H,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.006,KRAS_61H,61H,NA
single,Age,KRAS,bone cancer,<40,1,342,0.002,0.002,0,0.008,KRAS_61H,61H,NA
single,Age,KRAS,bone cancer,40-50,0,61,0.002,0.001,0,0.01,KRAS_61H,61H,NA
single,Age,KRAS,bone cancer,50-65,0,96,0.002,0.001,0,0.009,KRAS_61H,61H,NA
single,Age,KRAS,bone cancer,>65,0,67,0.002,0.001,0,0.009,KRAS_61H,61H,NA
single,Age,KRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.007,KRAS_61H,61H,NA
single,Age,KRAS,vaginal cancer,>65,0,30,0.001,0,0,0.007,KRAS_61H,61H,NA
single,Age,KRAS,thymic tumor,<40,0,14,0,0,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0,0,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,ampullary cancer,40-50,0,12,0.018,0.013,0,0.071,KRAS_61H,61H,NA
single,Age,KRAS,ampullary cancer,50-65,0,40,0.015,0.011,0,0.052,KRAS_61H,61H,NA
single,Age,KRAS,ampullary cancer,>65,2,50,0.028,0.023,0.004,0.082,KRAS_61H,61H,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,KRAS_61H,61H,NA
single,Age,KRAS,small cell lung cancer,50-65,0,144,0,0,0,0.002,KRAS_61H,61H,NA
single,Age,KRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,KRAS_61H,61H,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0.001,KRAS_61H,61H,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0.001,KRAS_61H,61H,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0.001,KRAS_61H,61H,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0.001,KRAS_61H,61H,NA
single,Age,KRAS,germ cell tumor,<40,0,650,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,germ cell tumor,40-50,0,131,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,germ cell tumor,50-65,0,92,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0,0,0,0,KRAS_61H,61H,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,KRAS_61H,61H,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,KRAS_61H,61H,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,KRAS_61H,61H,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.003,0,0,0.034,KRAS_61H,61H,NA
single,Age,KRAS,penile cancer,>65,0,11,0.003,0,0,0.034,KRAS_61H,61H,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.004,0,0,0.045,KRAS_61H,61H,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0.009,0.009,0.001,0.02,KRAS_61H,61H,NA
single,Age,KRAS,b cell lymphoma,40-50,2,105,0.012,0.011,0.004,0.031,KRAS_61H,61H,NA
single,Age,KRAS,b cell lymphoma,50-65,2,357,0.009,0.009,0.002,0.018,KRAS_61H,61H,NA
single,Age,KRAS,b cell lymphoma,>65,6,413,0.012,0.011,0.005,0.022,KRAS_61H,61H,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.005,0,0,0.055,KRAS_61H,61H,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.021,KRAS_61H,61H,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,KRAS_61H,61H,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.029,KRAS_61H,61H,NA
single,Age,KRAS,lung cancer,>65,0,18,0.003,0,0,0.032,KRAS_61H,61H,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,KRAS_61H,61H,NA
single,Age,KRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,colorectal cancer,<40,0,565,0.001,0.001,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,colorectal cancer,40-50,1,1280,0.001,0.001,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,colorectal cancer,50-65,3,2815,0.001,0.001,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,colorectal cancer,>65,8,2055,0.003,0.003,0.001,0.006,KRAS_61K,61K,NA
single,Age,KRAS,cancer of unknown primary,<40,0,167,0.001,0,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,cancer of unknown primary,40-50,0,211,0.001,0,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,cancer of unknown primary,50-65,0,810,0,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,cancer of unknown primary,>65,1,797,0.001,0.001,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,non-small cell lung cancer,<40,0,161,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,non-small cell lung cancer,50-65,1,3677,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,non-small cell lung cancer,>65,1,5698,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,breast cancer,<40,0,841,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,breast cancer,40-50,0,1910,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,breast cancer,50-65,0,3989,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,breast cancer,>65,0,2583,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,breast cancer,NA,0,10,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,pancreatic cancer,<40,0,87,0.001,0.001,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,pancreatic cancer,40-50,0,200,0.001,0.001,0,0.004,KRAS_61K,61K,NA
single,Age,KRAS,pancreatic cancer,50-65,2,1000,0.001,0.001,0,0.004,KRAS_61K,61K,NA
single,Age,KRAS,pancreatic cancer,>65,1,1205,0.001,0.001,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,leukemia,<40,0,204,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,leukemia,40-50,0,128,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,leukemia,50-65,0,515,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,leukemia,>65,0,720,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,melanoma,<40,0,289,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,melanoma,40-50,0,282,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,melanoma,50-65,0,1016,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,melanoma,>65,0,1259,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,head and neck cancer,50-65,0,799,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,head and neck cancer,>65,0,582,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,uterine cancer,<40,0,57,0.001,0,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,uterine cancer,40-50,0,162,0.001,0,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,uterine cancer,50-65,0,1046,0,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,uterine cancer,>65,1,988,0.001,0,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,KRAS_61K,61K,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,KRAS_61K,61K,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,KRAS_61K,61K,NA
single,Age,KRAS,ovarian cancer,<40,0,141,0.001,0,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,ovarian cancer,40-50,0,253,0.001,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,ovarian cancer,50-65,1,1092,0.001,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,ovarian cancer,>65,0,849,0,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,esophagogastric cancer,<40,0,122,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,esophagogastric cancer,>65,0,725,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,thyroid cancer,<40,0,150,0.001,0.001,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0.001,0.001,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,thyroid cancer,50-65,1,374,0.002,0.001,0,0.006,KRAS_61K,61K,NA
single,Age,KRAS,thyroid cancer,>65,0,370,0.001,0.001,0,0.004,KRAS_61K,61K,NA
single,Age,KRAS,cervical cancer,<40,0,85,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,cervical cancer,40-50,0,99,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,cervical cancer,50-65,0,144,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,cervical cancer,>65,0,36,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,kidney cancer,<40,0,191,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,kidney cancer,50-65,0,628,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,kidney cancer,>65,0,440,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,cns cancer,<40,2,1602,0.001,0.001,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,cns cancer,40-50,0,687,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,cns cancer,50-65,0,1439,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,cns cancer,>65,0,836,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0.001,0,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,prostate cancer,50-65,0,960,0,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,prostate cancer,>65,1,1402,0.001,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.008,0.005,0,0.041,KRAS_61K,61K,NA
single,Age,KRAS,anal cancer,50-65,1,88,0.009,0.007,0,0.033,KRAS_61K,61K,NA
single,Age,KRAS,anal cancer,>65,0,45,0.007,0.004,0,0.029,KRAS_61K,61K,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0.004,0.002,0,0.017,KRAS_61K,61K,NA
single,Age,KRAS,neuroendocrine tumors,40-50,0,55,0.003,0.002,0,0.014,KRAS_61K,61K,NA
single,Age,KRAS,neuroendocrine tumors,50-65,1,161,0.004,0.003,0,0.016,KRAS_61K,61K,NA
single,Age,KRAS,neuroendocrine tumors,>65,0,121,0.003,0.002,0,0.012,KRAS_61K,61K,NA
single,Age,KRAS,bladder cancer,<40,0,25,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,bladder cancer,50-65,0,511,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,bladder cancer,>65,0,962,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,small bowel cancer,50-65,0,96,0,0,0,0.003,KRAS_61K,61K,NA
single,Age,KRAS,small bowel cancer,>65,0,78,0,0,0,0.002,KRAS_61K,61K,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0,0,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,bone cancer,<40,0,342,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,bone cancer,40-50,0,61,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,bone cancer,50-65,0,96,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,bone cancer,>65,0,67,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.012,KRAS_61K,61K,NA
single,Age,KRAS,vaginal cancer,>65,0,30,0.001,0,0,0.012,KRAS_61K,61K,NA
single,Age,KRAS,thymic tumor,<40,0,14,0.001,0,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0.001,0,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.004,KRAS_61K,61K,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.006,KRAS_61K,61K,NA
single,Age,KRAS,ampullary cancer,50-65,0,40,0,0,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,ampullary cancer,>65,0,50,0,0,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0.001,KRAS_61K,61K,NA
single,Age,KRAS,germ cell tumor,<40,0,650,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,germ cell tumor,40-50,0,131,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,germ cell tumor,50-65,0,92,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,KRAS_61K,61K,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.005,KRAS_61K,61K,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,KRAS_61K,61K,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.006,KRAS_61K,61K,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.002,0,0,0.019,KRAS_61K,61K,NA
single,Age,KRAS,penile cancer,>65,0,11,0.002,0,0,0.02,KRAS_61K,61K,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.003,0,0,0.036,KRAS_61K,61K,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,b cell lymphoma,40-50,0,105,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,b cell lymphoma,50-65,0,357,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,b cell lymphoma,>65,0,413,0,0,0,0,KRAS_61K,61K,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.053,KRAS_61K,61K,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.024,KRAS_61K,61K,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.008,KRAS_61K,61K,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.023,KRAS_61K,61K,NA
single,Age,KRAS,lung cancer,>65,0,18,0.002,0,0,0.02,KRAS_61K,61K,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.005,0,0,0.062,KRAS_61K,61K,NA
single,Age,KRAS,appendiceal cancer,<40,0,28,0.003,0.002,0,0.017,KRAS_61L,61L,NA
single,Age,KRAS,appendiceal cancer,40-50,0,62,0.003,0.002,0,0.014,KRAS_61L,61L,NA
single,Age,KRAS,appendiceal cancer,50-65,0,161,0.002,0.001,0,0.011,KRAS_61L,61L,NA
single,Age,KRAS,appendiceal cancer,>65,1,90,0.006,0.004,0,0.028,KRAS_61L,61L,NA
single,Age,KRAS,colorectal cancer,<40,2,565,0.004,0.003,0.002,0.006,KRAS_61L,61L,NA
single,Age,KRAS,colorectal cancer,40-50,2,1280,0.003,0.003,0.001,0.005,KRAS_61L,61L,NA
single,Age,KRAS,colorectal cancer,50-65,13,2815,0.004,0.004,0.002,0.006,KRAS_61L,61L,NA
single,Age,KRAS,colorectal cancer,>65,7,2055,0.004,0.003,0.002,0.005,KRAS_61L,61L,NA
single,Age,KRAS,cancer of unknown primary,<40,0,167,0.002,0.001,0,0.005,KRAS_61L,61L,NA
single,Age,KRAS,cancer of unknown primary,40-50,0,211,0.002,0.001,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,cancer of unknown primary,50-65,1,810,0.002,0.001,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,cancer of unknown primary,>65,2,797,0.002,0.002,0,0.005,KRAS_61L,61L,NA
single,Age,KRAS,non-small cell lung cancer,<40,0,161,0.003,0.003,0,0.006,KRAS_61L,61L,NA
single,Age,KRAS,non-small cell lung cancer,40-50,0,585,0.002,0.003,0,0.005,KRAS_61L,61L,NA
single,Age,KRAS,non-small cell lung cancer,50-65,11,3677,0.003,0.003,0.002,0.005,KRAS_61L,61L,NA
single,Age,KRAS,non-small cell lung cancer,>65,26,5698,0.004,0.004,0.003,0.006,KRAS_61L,61L,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0.004,0.003,0,0.014,KRAS_61L,61L,NA
single,Age,KRAS,breast cancer,<40,0,841,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,breast cancer,40-50,0,1910,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,breast cancer,50-65,0,3989,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,breast cancer,>65,1,2583,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,breast cancer,NA,0,10,0.001,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,pancreatic cancer,<40,0,87,0.002,0.002,0,0.007,KRAS_61L,61L,NA
single,Age,KRAS,pancreatic cancer,40-50,0,200,0.002,0.002,0,0.006,KRAS_61L,61L,NA
single,Age,KRAS,pancreatic cancer,50-65,3,1000,0.003,0.002,0.001,0.006,KRAS_61L,61L,NA
single,Age,KRAS,pancreatic cancer,>65,3,1205,0.002,0.002,0.001,0.005,KRAS_61L,61L,NA
single,Age,KRAS,leukemia,<40,0,204,0.001,0,0,0.003,KRAS_61L,61L,NA
single,Age,KRAS,leukemia,40-50,0,128,0.001,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,leukemia,50-65,0,515,0.001,0,0,0.003,KRAS_61L,61L,NA
single,Age,KRAS,leukemia,>65,1,720,0.001,0.001,0,0.003,KRAS_61L,61L,NA
single,Age,KRAS,melanoma,<40,0,289,0.001,0,0,0.003,KRAS_61L,61L,NA
single,Age,KRAS,melanoma,40-50,0,282,0.001,0,0,0.003,KRAS_61L,61L,NA
single,Age,KRAS,melanoma,50-65,2,1016,0.001,0.001,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,melanoma,>65,0,1259,0,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,head and neck cancer,50-65,0,799,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,head and neck cancer,>65,0,582,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,uterine cancer,<40,0,57,0.001,0.001,0,0.006,KRAS_61L,61L,NA
single,Age,KRAS,uterine cancer,40-50,0,162,0.001,0.001,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,uterine cancer,50-65,2,1046,0.001,0.001,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,uterine cancer,>65,0,988,0.001,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,ovarian cancer,<40,0,141,0.001,0,0,0.003,KRAS_61L,61L,NA
single,Age,KRAS,ovarian cancer,40-50,0,253,0.001,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,ovarian cancer,50-65,0,1092,0,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,ovarian cancer,>65,1,849,0.001,0,0,0.003,KRAS_61L,61L,NA
single,Age,KRAS,esophagogastric cancer,<40,0,122,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,esophagogastric cancer,>65,0,725,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,thyroid cancer,<40,0,150,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,thyroid cancer,40-50,0,122,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,thyroid cancer,50-65,0,374,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,thyroid cancer,>65,0,370,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,cervical cancer,<40,0,85,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,cervical cancer,40-50,0,99,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,cervical cancer,50-65,0,144,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,cervical cancer,>65,0,36,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0.002,0.001,0,0.005,KRAS_61L,61L,NA
single,Age,KRAS,hepatobiliary cancer,40-50,0,110,0.002,0.001,0,0.006,KRAS_61L,61L,NA
single,Age,KRAS,hepatobiliary cancer,50-65,1,525,0.002,0.001,0,0.005,KRAS_61L,61L,NA
single,Age,KRAS,hepatobiliary cancer,>65,1,601,0.002,0.001,0,0.005,KRAS_61L,61L,NA
single,Age,KRAS,kidney cancer,<40,0,191,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,kidney cancer,50-65,0,628,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,kidney cancer,>65,0,440,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,cns cancer,<40,1,1602,0.001,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,cns cancer,40-50,0,687,0,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,cns cancer,50-65,0,1439,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,cns cancer,>65,1,836,0.001,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0.001,0,0,0.005,KRAS_61L,61L,NA
single,Age,KRAS,prostate cancer,50-65,0,960,0,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,prostate cancer,>65,1,1402,0.001,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.001,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,anal cancer,50-65,0,88,0,0,0,0.003,KRAS_61L,61L,NA
single,Age,KRAS,anal cancer,>65,0,45,0,0,0,0.003,KRAS_61L,61L,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,bladder cancer,<40,0,25,0.001,0,0,0.006,KRAS_61L,61L,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0.001,0,0,0.005,KRAS_61L,61L,NA
single,Age,KRAS,bladder cancer,50-65,0,511,0.001,0,0,0.003,KRAS_61L,61L,NA
single,Age,KRAS,bladder cancer,>65,1,962,0.001,0.001,0,0.003,KRAS_61L,61L,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,small bowel cancer,40-50,0,29,0,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,small bowel cancer,50-65,0,96,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,small bowel cancer,>65,0,78,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.006,KRAS_61L,61L,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.007,KRAS_61L,61L,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0.001,0,0,0.006,KRAS_61L,61L,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.006,KRAS_61L,61L,NA
single,Age,KRAS,bone cancer,<40,0,342,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,bone cancer,40-50,0,61,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,bone cancer,50-65,0,96,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,bone cancer,>65,0,67,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.007,KRAS_61L,61L,NA
single,Age,KRAS,vaginal cancer,>65,0,30,0.001,0,0,0.007,KRAS_61L,61L,NA
single,Age,KRAS,thymic tumor,<40,0,14,0,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.01,KRAS_61L,61L,NA
single,Age,KRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.008,KRAS_61L,61L,NA
single,Age,KRAS,ampullary cancer,>65,0,50,0.001,0,0,0.008,KRAS_61L,61L,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,small cell lung cancer,50-65,0,144,0,0,0,0.002,KRAS_61L,61L,NA
single,Age,KRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0.001,KRAS_61L,61L,NA
single,Age,KRAS,germ cell tumor,<40,0,650,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,germ cell tumor,40-50,0,131,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,germ cell tumor,50-65,0,92,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0,0,0,0,KRAS_61L,61L,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,KRAS_61L,61L,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,KRAS_61L,61L,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.03,0.012,0,0.15,KRAS_61L,61L,NA
single,Age,KRAS,penile cancer,>65,1,11,0.07,0.049,0.002,0.254,KRAS_61L,61L,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.004,0,0,0.045,KRAS_61L,61L,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0.001,0,0,0.008,KRAS_61L,61L,NA
single,Age,KRAS,b cell lymphoma,40-50,1,105,0.005,0.002,0,0.026,KRAS_61L,61L,NA
single,Age,KRAS,b cell lymphoma,50-65,0,357,0.001,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,b cell lymphoma,>65,0,413,0.001,0,0,0.004,KRAS_61L,61L,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.005,0,0,0.055,KRAS_61L,61L,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.021,KRAS_61L,61L,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,KRAS_61L,61L,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.029,KRAS_61L,61L,NA
single,Age,KRAS,lung cancer,>65,0,18,0.003,0,0,0.032,KRAS_61L,61L,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,KRAS_61L,61L,NA
single,Age,KRAS,appendiceal cancer,<40,0,28,0.004,0.002,0,0.016,KRAS_61R,61R,NA
single,Age,KRAS,appendiceal cancer,40-50,0,62,0.003,0.002,0,0.014,KRAS_61R,61R,NA
single,Age,KRAS,appendiceal cancer,50-65,1,161,0.004,0.003,0,0.016,KRAS_61R,61R,NA
single,Age,KRAS,appendiceal cancer,>65,0,90,0.003,0.002,0,0.013,KRAS_61R,61R,NA
single,Age,KRAS,colorectal cancer,<40,0,565,0.003,0.003,0,0.005,KRAS_61R,61R,NA
single,Age,KRAS,colorectal cancer,40-50,5,1280,0.003,0.003,0.002,0.006,KRAS_61R,61R,NA
single,Age,KRAS,colorectal cancer,50-65,8,2815,0.003,0.003,0.002,0.005,KRAS_61R,61R,NA
single,Age,KRAS,colorectal cancer,>65,7,2055,0.003,0.003,0.002,0.005,KRAS_61R,61R,NA
single,Age,KRAS,cancer of unknown primary,<40,0,167,0.001,0,0,0.005,KRAS_61R,61R,NA
single,Age,KRAS,cancer of unknown primary,40-50,0,211,0.001,0,0,0.004,KRAS_61R,61R,NA
single,Age,KRAS,cancer of unknown primary,50-65,3,810,0.003,0.002,0,0.008,KRAS_61R,61R,NA
single,Age,KRAS,cancer of unknown primary,>65,0,797,0.001,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,non-small cell lung cancer,<40,0,161,0.001,0.001,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,non-small cell lung cancer,40-50,0,585,0.001,0.001,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,non-small cell lung cancer,50-65,3,3677,0.001,0.001,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,non-small cell lung cancer,>65,4,5698,0.001,0.001,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,non-small cell lung cancer,NA,0,10,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,breast cancer,<40,0,841,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,breast cancer,40-50,0,1910,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,breast cancer,50-65,0,3989,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,breast cancer,>65,1,2583,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,breast cancer,NA,0,10,0.001,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,pancreatic cancer,<40,0,87,0.01,0.01,0,0.024,KRAS_61R,61R,NA
single,Age,KRAS,pancreatic cancer,40-50,2,200,0.012,0.012,0.003,0.025,KRAS_61R,61R,NA
single,Age,KRAS,pancreatic cancer,50-65,9,1000,0.011,0.01,0.005,0.018,KRAS_61R,61R,NA
single,Age,KRAS,pancreatic cancer,>65,27,1205,0.02,0.02,0.013,0.029,KRAS_61R,61R,NA
single,Age,KRAS,leukemia,<40,0,204,0.001,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,leukemia,40-50,0,128,0.001,0,0,0.004,KRAS_61R,61R,NA
single,Age,KRAS,leukemia,50-65,0,515,0.001,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,leukemia,>65,1,720,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,melanoma,<40,0,289,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,melanoma,40-50,0,282,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,melanoma,50-65,1,1016,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,melanoma,>65,2,1259,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,head and neck cancer,<40,0,140,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,head and neck cancer,40-50,0,216,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,head and neck cancer,50-65,0,799,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,head and neck cancer,>65,0,582,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,uterine cancer,<40,0,57,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,uterine cancer,40-50,0,162,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,uterine cancer,50-65,0,1046,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,uterine cancer,>65,0,988,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,ovarian cancer,<40,0,141,0.001,0,0,0.005,KRAS_61R,61R,NA
single,Age,KRAS,ovarian cancer,40-50,2,253,0.006,0.005,0,0.02,KRAS_61R,61R,NA
single,Age,KRAS,ovarian cancer,50-65,0,1092,0,0,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,ovarian cancer,>65,0,849,0,0,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,esophagogastric cancer,<40,0,122,0.001,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,esophagogastric cancer,40-50,0,200,0.001,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,esophagogastric cancer,50-65,1,752,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,esophagogastric cancer,>65,0,725,0.001,0,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,thyroid cancer,<40,2,150,0.015,0.014,0.007,0.026,KRAS_61R,61R,NA
single,Age,KRAS,thyroid cancer,40-50,2,122,0.015,0.014,0.007,0.027,KRAS_61R,61R,NA
single,Age,KRAS,thyroid cancer,50-65,6,374,0.015,0.015,0.008,0.025,KRAS_61R,61R,NA
single,Age,KRAS,thyroid cancer,>65,5,370,0.015,0.014,0.007,0.024,KRAS_61R,61R,NA
single,Age,KRAS,cervical cancer,<40,0,85,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,cervical cancer,40-50,0,99,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,cervical cancer,50-65,0,144,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,cervical cancer,>65,0,36,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,hepatobiliary cancer,<40,0,138,0.002,0.001,0,0.005,KRAS_61R,61R,NA
single,Age,KRAS,hepatobiliary cancer,40-50,0,110,0.002,0.001,0,0.006,KRAS_61R,61R,NA
single,Age,KRAS,hepatobiliary cancer,50-65,1,525,0.002,0.001,0,0.005,KRAS_61R,61R,NA
single,Age,KRAS,hepatobiliary cancer,>65,1,601,0.002,0.001,0,0.005,KRAS_61R,61R,NA
single,Age,KRAS,kidney cancer,<40,0,191,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,kidney cancer,40-50,0,159,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,kidney cancer,50-65,0,628,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,kidney cancer,>65,0,440,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,cns cancer,<40,1,1602,0.001,0.001,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,cns cancer,40-50,1,687,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,cns cancer,50-65,1,1439,0.001,0.001,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,cns cancer,>65,1,836,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,prostate cancer,40-50,0,70,0.001,0,0,0.005,KRAS_61R,61R,NA
single,Age,KRAS,prostate cancer,50-65,1,960,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,prostate cancer,>65,0,1402,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,anal cancer,40-50,0,12,0.001,0,0,0.006,KRAS_61R,61R,NA
single,Age,KRAS,anal cancer,50-65,0,88,0,0,0,0.004,KRAS_61R,61R,NA
single,Age,KRAS,anal cancer,>65,0,45,0,0,0,0.004,KRAS_61R,61R,NA
single,Age,KRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,bladder cancer,<40,0,25,0.001,0.001,0,0.006,KRAS_61R,61R,NA
single,Age,KRAS,bladder cancer,40-50,0,78,0.001,0,0,0.004,KRAS_61R,61R,NA
single,Age,KRAS,bladder cancer,50-65,0,511,0.001,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,bladder cancer,>65,1,962,0.001,0.001,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,small bowel cancer,50-65,0,96,0,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,small bowel cancer,>65,0,78,0,0,0,0.003,KRAS_61R,61R,NA
single,Age,KRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.005,KRAS_61R,61R,NA
single,Age,KRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.006,KRAS_61R,61R,NA
single,Age,KRAS,sex cord stromal tumor,50-65,0,37,0,0,0,0.005,KRAS_61R,61R,NA
single,Age,KRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.006,KRAS_61R,61R,NA
single,Age,KRAS,bone cancer,<40,0,342,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,bone cancer,40-50,0,61,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,bone cancer,50-65,0,96,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,bone cancer,>65,0,67,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.006,KRAS_61R,61R,NA
single,Age,KRAS,vaginal cancer,>65,0,30,0.001,0,0,0.006,KRAS_61R,61R,NA
single,Age,KRAS,thymic tumor,<40,0,14,0.001,0,0,0.006,KRAS_61R,61R,NA
single,Age,KRAS,thymic tumor,40-50,0,28,0,0,0,0.005,KRAS_61R,61R,NA
single,Age,KRAS,thymic tumor,50-65,0,72,0,0,0,0.004,KRAS_61R,61R,NA
single,Age,KRAS,thymic tumor,>65,0,40,0,0,0,0.005,KRAS_61R,61R,NA
single,Age,KRAS,ampullary cancer,40-50,0,12,0.016,0.009,0,0.074,KRAS_61R,61R,NA
single,Age,KRAS,ampullary cancer,50-65,2,40,0.036,0.028,0.004,0.111,KRAS_61R,61R,NA
single,Age,KRAS,ampullary cancer,>65,0,50,0.011,0.007,0,0.047,KRAS_61R,61R,NA
single,Age,KRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,mesothelioma,<40,0,30,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,mesothelioma,40-50,0,29,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,mesothelioma,50-65,0,122,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,mesothelioma,>65,0,316,0,0,0,0.001,KRAS_61R,61R,NA
single,Age,KRAS,germ cell tumor,<40,0,650,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,germ cell tumor,40-50,0,131,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,germ cell tumor,50-65,0,92,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,germ cell tumor,>65,0,12,0,0,0,0,KRAS_61R,61R,NA
single,Age,KRAS,nerve sheath tumor,<40,0,77,0,0,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,nerve sheath tumor,>65,0,13,0,0,0,0.002,KRAS_61R,61R,NA
single,Age,KRAS,penile cancer,50-65,0,11,0.002,0,0,0.016,KRAS_61R,61R,NA
single,Age,KRAS,penile cancer,>65,0,11,0.002,0,0,0.016,KRAS_61R,61R,NA
single,Age,KRAS,pineal tumor,<40,0,14,0.003,0,0,0.039,KRAS_61R,61R,NA
single,Age,KRAS,b cell lymphoma,<40,0,87,0.003,0.002,0,0.011,KRAS_61R,61R,NA
single,Age,KRAS,b cell lymphoma,40-50,1,105,0.005,0.004,0.001,0.021,KRAS_61R,61R,NA
single,Age,KRAS,b cell lymphoma,50-65,2,357,0.004,0.003,0.001,0.012,KRAS_61R,61R,NA
single,Age,KRAS,b cell lymphoma,>65,0,413,0.002,0.002,0,0.007,KRAS_61R,61R,NA
single,Age,KRAS,non-hodgkin lymphoma,>65,0,14,0.002,0,0,0.026,KRAS_61R,61R,NA
single,Age,KRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.001,0,0,0.015,KRAS_61R,61R,NA
single,Age,KRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,KRAS_61R,61R,NA
single,Age,KRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.021,KRAS_61R,61R,NA
single,Age,KRAS,lung cancer,>65,0,18,0.002,0,0,0.026,KRAS_61R,61R,NA
single,Age,KRAS,peritoneal cancer,>65,0,11,0.003,0,0,0.039,KRAS_61R,61R,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,HRAS_12A,12A,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.002,HRAS_12A,12A,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,colorectal cancer,>65,0,2052,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,cancer of unknown primary,>65,0,795,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,breast cancer,50-65,0,3989,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,breast cancer,>65,0,2583,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,breast cancer,NA,0,10,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,pancreatic cancer,50-65,0,999,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,melanoma,<40,0,289,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,melanoma,40-50,0,282,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,melanoma,50-65,0,1016,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,melanoma,>65,0,1259,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,head and neck cancer,<40,0,140,0.001,0,0,0.003,HRAS_12A,12A,NA
single,Age,HRAS,head and neck cancer,40-50,0,216,0.001,0,0,0.003,HRAS_12A,12A,NA
single,Age,HRAS,head and neck cancer,50-65,1,799,0.001,0.001,0,0.003,HRAS_12A,12A,NA
single,Age,HRAS,head and neck cancer,>65,0,582,0.001,0,0,0.002,HRAS_12A,12A,NA
single,Age,HRAS,uterine cancer,<40,0,56,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,uterine cancer,50-65,0,1043,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,uterine cancer,>65,0,986,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,HRAS_12A,12A,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.005,HRAS_12A,12A,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.005,HRAS_12A,12A,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.005,HRAS_12A,12A,NA
single,Age,HRAS,soft tissue sarcoma,<40,0,667,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,soft tissue sarcoma,>65,0,766,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,ovarian cancer,50-65,0,1092,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,thyroid cancer,<40,0,150,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,thyroid cancer,40-50,0,122,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,thyroid cancer,50-65,0,374,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,thyroid cancer,>65,0,370,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,cns cancer,<40,0,1602,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,prostate cancer,50-65,0,960,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,prostate cancer,>65,0,1402,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,anal cancer,40-50,0,12,0.001,0,0,0.007,HRAS_12A,12A,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.004,HRAS_12A,12A,NA
single,Age,HRAS,anal cancer,>65,0,45,0,0,0,0.005,HRAS_12A,12A,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,bladder cancer,<40,0,25,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,bladder cancer,40-50,0,78,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,bladder cancer,50-65,0,511,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,bladder cancer,>65,0,961,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.004,HRAS_12A,12A,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.003,HRAS_12A,12A,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.004,HRAS_12A,12A,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.006,HRAS_12A,12A,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.009,HRAS_12A,12A,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0.001,0,0,0.007,HRAS_12A,12A,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.007,HRAS_12A,12A,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.01,HRAS_12A,12A,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.01,HRAS_12A,12A,NA
single,Age,HRAS,thymic tumor,<40,0,14,0,0,0,0.004,HRAS_12A,12A,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0,0,0,0.003,HRAS_12A,12A,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0,0,0,0.003,HRAS_12A,12A,NA
single,Age,HRAS,thymic tumor,>65,0,39,0,0,0,0.003,HRAS_12A,12A,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.008,HRAS_12A,12A,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.006,HRAS_12A,12A,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0.001,0,0,0.006,HRAS_12A,12A,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0.001,HRAS_12A,12A,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,HRAS_12A,12A,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.004,HRAS_12A,12A,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.004,HRAS_12A,12A,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.004,HRAS_12A,12A,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.003,0,0,0.032,HRAS_12A,12A,NA
single,Age,HRAS,penile cancer,>65,0,11,0.003,0,0,0.033,HRAS_12A,12A,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.003,0,0,0.035,HRAS_12A,12A,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_12A,12A,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.042,HRAS_12A,12A,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.001,0,0,0.01,HRAS_12A,12A,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.007,HRAS_12A,12A,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.027,HRAS_12A,12A,NA
single,Age,HRAS,lung cancer,>65,0,18,0.003,0,0,0.038,HRAS_12A,12A,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.054,HRAS_12A,12A,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,HRAS_12C,12C,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.002,HRAS_12C,12C,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,colorectal cancer,>65,0,2052,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,cancer of unknown primary,>65,0,795,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,breast cancer,50-65,2,3989,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,breast cancer,>65,0,2583,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,breast cancer,NA,0,10,0.001,0,0,0.004,HRAS_12C,12C,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,pancreatic cancer,50-65,0,999,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,melanoma,<40,0,289,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,melanoma,40-50,0,282,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,melanoma,50-65,0,1016,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,melanoma,>65,0,1259,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,head and neck cancer,<40,0,140,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,head and neck cancer,40-50,0,216,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,head and neck cancer,50-65,0,799,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,head and neck cancer,>65,0,582,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,uterine cancer,<40,0,56,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,uterine cancer,50-65,0,1043,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,uterine cancer,>65,0,986,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0.003,0.001,0,0.015,HRAS_12C,12C,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0.003,0.001,0,0.018,HRAS_12C,12C,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,1,149,0.004,0.002,0,0.016,HRAS_12C,12C,NA
single,Age,HRAS,non-melanoma skin cancers,>65,0,317,0.002,0.001,0,0.007,HRAS_12C,12C,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.004,HRAS_12C,12C,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,HRAS_12C,12C,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.003,HRAS_12C,12C,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,HRAS_12C,12C,NA
single,Age,HRAS,soft tissue sarcoma,<40,0,667,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,soft tissue sarcoma,>65,0,766,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,ovarian cancer,50-65,0,1092,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,thyroid cancer,<40,0,150,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,thyroid cancer,40-50,0,122,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,thyroid cancer,50-65,0,374,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,thyroid cancer,>65,0,370,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,cns cancer,<40,0,1602,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,prostate cancer,50-65,0,960,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,prostate cancer,>65,0,1402,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,anal cancer,40-50,0,12,0,0,0,0.004,HRAS_12C,12C,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.003,HRAS_12C,12C,NA
single,Age,HRAS,anal cancer,>65,0,45,0,0,0,0.003,HRAS_12C,12C,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.002,HRAS_12C,12C,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,bladder cancer,<40,0,25,0.002,0.002,0,0.01,HRAS_12C,12C,NA
single,Age,HRAS,bladder cancer,40-50,0,78,0.002,0.002,0,0.008,HRAS_12C,12C,NA
single,Age,HRAS,bladder cancer,50-65,2,511,0.003,0.002,0,0.007,HRAS_12C,12C,NA
single,Age,HRAS,bladder cancer,>65,1,961,0.002,0.002,0,0.005,HRAS_12C,12C,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,HRAS_12C,12C,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.002,HRAS_12C,12C,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.002,HRAS_12C,12C,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.002,HRAS_12C,12C,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.007,HRAS_12C,12C,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.007,HRAS_12C,12C,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0.001,0,0,0.006,HRAS_12C,12C,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.007,HRAS_12C,12C,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0,0,0,0.005,HRAS_12C,12C,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0,0,0,0.005,HRAS_12C,12C,NA
single,Age,HRAS,thymic tumor,<40,0,14,0,0,0,0.005,HRAS_12C,12C,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0,0,0,0.004,HRAS_12C,12C,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0,0,0,0.004,HRAS_12C,12C,NA
single,Age,HRAS,thymic tumor,>65,0,39,0,0,0,0.004,HRAS_12C,12C,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.004,HRAS_12C,12C,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0,0,0,0.003,HRAS_12C,12C,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0,0,0,0.003,HRAS_12C,12C,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0.004,0.002,0,0.02,HRAS_12C,12C,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0.003,0.002,0,0.011,HRAS_12C,12C,NA
single,Age,HRAS,small cell lung cancer,>65,1,224,0.004,0.003,0,0.013,HRAS_12C,12C,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,HRAS_12C,12C,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,HRAS_12C,12C,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,HRAS_12C,12C,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0.002,HRAS_12C,12C,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0.001,HRAS_12C,12C,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.005,HRAS_12C,12C,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.005,HRAS_12C,12C,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0.001,0,0,0.005,HRAS_12C,12C,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.006,HRAS_12C,12C,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.003,0,0,0.031,HRAS_12C,12C,NA
single,Age,HRAS,penile cancer,>65,0,11,0.003,0,0,0.031,HRAS_12C,12C,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.003,0,0,0.042,HRAS_12C,12C,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_12C,12C,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.003,0,0,0.041,HRAS_12C,12C,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.025,HRAS_12C,12C,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.011,HRAS_12C,12C,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.025,HRAS_12C,12C,NA
single,Age,HRAS,lung cancer,>65,0,18,0.003,0,0,0.034,HRAS_12C,12C,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.047,HRAS_12C,12C,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,colorectal cancer,50-65,1,2814,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,colorectal cancer,>65,2,2052,0.001,0,0,0.002,HRAS_12D,12D,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,cancer of unknown primary,>65,0,795,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,non-small cell lung cancer,>65,1,5698,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0.001,0,0,0.002,HRAS_12D,12D,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,breast cancer,50-65,2,3989,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,breast cancer,>65,1,2583,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,breast cancer,NA,0,10,0.001,0,0,0.002,HRAS_12D,12D,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,pancreatic cancer,50-65,0,999,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,melanoma,<40,0,289,0.002,0.002,0,0.005,HRAS_12D,12D,NA
single,Age,HRAS,melanoma,40-50,1,282,0.003,0.002,0.001,0.007,HRAS_12D,12D,NA
single,Age,HRAS,melanoma,50-65,1,1016,0.002,0.002,0,0.005,HRAS_12D,12D,NA
single,Age,HRAS,melanoma,>65,5,1259,0.003,0.003,0.001,0.006,HRAS_12D,12D,NA
single,Age,HRAS,head and neck cancer,<40,0,140,0.001,0.001,0,0.005,HRAS_12D,12D,NA
single,Age,HRAS,head and neck cancer,40-50,0,216,0.001,0.001,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,head and neck cancer,50-65,2,799,0.002,0.001,0,0.005,HRAS_12D,12D,NA
single,Age,HRAS,head and neck cancer,>65,0,582,0.001,0.001,0,0.003,HRAS_12D,12D,NA
single,Age,HRAS,uterine cancer,<40,0,56,0.001,0.001,0,0.007,HRAS_12D,12D,NA
single,Age,HRAS,uterine cancer,40-50,1,162,0.002,0.001,0,0.012,HRAS_12D,12D,NA
single,Age,HRAS,uterine cancer,50-65,0,1043,0.001,0.001,0,0.002,HRAS_12D,12D,NA
single,Age,HRAS,uterine cancer,>65,1,986,0.001,0.001,0,0.003,HRAS_12D,12D,NA
single,Age,HRAS,non-melanoma skin cancers,<40,1,27,0.02,0.007,0,0.1,HRAS_12D,12D,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0.004,0.001,0,0.026,HRAS_12D,12D,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,0,149,0.002,0.001,0,0.008,HRAS_12D,12D,NA
single,Age,HRAS,non-melanoma skin cancers,>65,0,317,0.001,0,0,0.006,HRAS_12D,12D,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,HRAS_12D,12D,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.005,HRAS_12D,12D,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,soft tissue sarcoma,<40,0,667,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0,0,0,0.002,HRAS_12D,12D,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,soft tissue sarcoma,>65,1,766,0.001,0.001,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,ovarian cancer,50-65,0,1092,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,thyroid cancer,<40,0,150,0.001,0.001,0,0.005,HRAS_12D,12D,NA
single,Age,HRAS,thyroid cancer,40-50,0,122,0.001,0.001,0,0.005,HRAS_12D,12D,NA
single,Age,HRAS,thyroid cancer,50-65,1,374,0.002,0.001,0,0.006,HRAS_12D,12D,NA
single,Age,HRAS,thyroid cancer,>65,0,370,0.001,0.001,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,cns cancer,<40,0,1602,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,prostate cancer,50-65,0,960,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,prostate cancer,>65,0,1402,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,anal cancer,40-50,0,12,0.001,0,0,0.005,HRAS_12D,12D,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,anal cancer,>65,0,45,0,0,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,bladder cancer,<40,1,25,0.014,0.008,0.002,0.068,HRAS_12D,12D,NA
single,Age,HRAS,bladder cancer,40-50,2,78,0.013,0.008,0.003,0.046,HRAS_12D,12D,NA
single,Age,HRAS,bladder cancer,50-65,1,511,0.005,0.004,0.001,0.01,HRAS_12D,12D,NA
single,Age,HRAS,bladder cancer,>65,5,961,0.006,0.006,0.002,0.011,HRAS_12D,12D,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,HRAS_12D,12D,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,HRAS_12D,12D,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.002,HRAS_12D,12D,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,HRAS_12D,12D,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.008,HRAS_12D,12D,NA
single,Age,HRAS,thymic tumor,<40,0,14,0,0,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0,0,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0,0,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,thymic tumor,>65,0,39,0,0,0,0.004,HRAS_12D,12D,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.008,HRAS_12D,12D,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.007,HRAS_12D,12D,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0.001,0,0,0.007,HRAS_12D,12D,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,HRAS_12D,12D,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,HRAS_12D,12D,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,HRAS_12D,12D,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0.002,HRAS_12D,12D,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0,0,0,0.001,HRAS_12D,12D,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.003,0,0,0.032,HRAS_12D,12D,NA
single,Age,HRAS,penile cancer,>65,0,11,0.003,0,0,0.031,HRAS_12D,12D,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.003,0,0,0.035,HRAS_12D,12D,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_12D,12D,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.047,HRAS_12D,12D,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.018,HRAS_12D,12D,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,HRAS_12D,12D,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.025,HRAS_12D,12D,NA
single,Age,HRAS,lung cancer,>65,0,18,0.003,0,0,0.031,HRAS_12D,12D,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,HRAS_12D,12D,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,colorectal cancer,>65,0,2052,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,cancer of unknown primary,>65,0,795,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,breast cancer,50-65,0,3989,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,breast cancer,>65,0,2583,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,breast cancer,NA,0,10,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,pancreatic cancer,50-65,0,999,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,melanoma,<40,0,289,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,melanoma,40-50,0,282,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,melanoma,50-65,0,1016,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,melanoma,>65,0,1259,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,head and neck cancer,<40,0,140,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,head and neck cancer,40-50,0,216,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,head and neck cancer,50-65,0,799,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,head and neck cancer,>65,0,582,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,uterine cancer,<40,0,56,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,uterine cancer,50-65,0,1043,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,uterine cancer,>65,0,986,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,HRAS_12F,12F,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.005,HRAS_12F,12F,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,HRAS_12F,12F,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,HRAS_12F,12F,NA
single,Age,HRAS,soft tissue sarcoma,<40,0,667,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,soft tissue sarcoma,>65,0,766,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,ovarian cancer,50-65,0,1092,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,thyroid cancer,<40,0,150,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,thyroid cancer,40-50,0,122,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,thyroid cancer,50-65,0,374,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,thyroid cancer,>65,0,370,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,cns cancer,<40,0,1602,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,prostate cancer,50-65,0,960,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,prostate cancer,>65,0,1402,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,anal cancer,40-50,0,12,0.001,0,0,0.005,HRAS_12F,12F,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.004,HRAS_12F,12F,NA
single,Age,HRAS,anal cancer,>65,0,45,0,0,0,0.004,HRAS_12F,12F,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,bladder cancer,<40,0,25,0.001,0.001,0,0.007,HRAS_12F,12F,NA
single,Age,HRAS,bladder cancer,40-50,0,78,0.001,0,0,0.005,HRAS_12F,12F,NA
single,Age,HRAS,bladder cancer,50-65,0,511,0.001,0,0,0.003,HRAS_12F,12F,NA
single,Age,HRAS,bladder cancer,>65,1,961,0.001,0.001,0,0.003,HRAS_12F,12F,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,HRAS_12F,12F,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,HRAS_12F,12F,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.002,HRAS_12F,12F,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.004,HRAS_12F,12F,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.004,HRAS_12F,12F,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.004,HRAS_12F,12F,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.004,HRAS_12F,12F,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,HRAS_12F,12F,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.008,HRAS_12F,12F,NA
single,Age,HRAS,thymic tumor,<40,0,14,0,0,0,0.004,HRAS_12F,12F,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0,0,0,0.004,HRAS_12F,12F,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0,0,0,0.004,HRAS_12F,12F,NA
single,Age,HRAS,thymic tumor,>65,0,39,0,0,0,0.004,HRAS_12F,12F,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.008,HRAS_12F,12F,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.007,HRAS_12F,12F,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0.001,0,0,0.007,HRAS_12F,12F,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,HRAS_12F,12F,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,HRAS_12F,12F,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,HRAS_12F,12F,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0.002,HRAS_12F,12F,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0,0,0,0.001,HRAS_12F,12F,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.003,0,0,0.032,HRAS_12F,12F,NA
single,Age,HRAS,penile cancer,>65,0,11,0.003,0,0,0.031,HRAS_12F,12F,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.003,0,0,0.035,HRAS_12F,12F,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_12F,12F,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.047,HRAS_12F,12F,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.018,HRAS_12F,12F,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,HRAS_12F,12F,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.025,HRAS_12F,12F,NA
single,Age,HRAS,lung cancer,>65,0,18,0.003,0,0,0.031,HRAS_12F,12F,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,HRAS_12F,12F,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,HRAS_12R,12R,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,colorectal cancer,>65,0,2052,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,cancer of unknown primary,>65,0,795,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,breast cancer,50-65,0,3989,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,breast cancer,>65,0,2583,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,breast cancer,NA,0,10,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,pancreatic cancer,50-65,0,999,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,melanoma,<40,0,289,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,melanoma,40-50,0,282,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,melanoma,50-65,0,1016,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,melanoma,>65,0,1259,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,head and neck cancer,<40,0,140,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,head and neck cancer,40-50,0,216,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,head and neck cancer,50-65,0,799,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,head and neck cancer,>65,0,582,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,uterine cancer,<40,0,56,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,uterine cancer,50-65,0,1043,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,uterine cancer,>65,0,986,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,HRAS_12R,12R,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,HRAS_12R,12R,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.003,HRAS_12R,12R,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,HRAS_12R,12R,NA
single,Age,HRAS,soft tissue sarcoma,<40,0,667,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,soft tissue sarcoma,>65,0,766,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,ovarian cancer,50-65,0,1092,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,thyroid cancer,<40,0,150,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,thyroid cancer,40-50,0,122,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,thyroid cancer,50-65,0,374,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,thyroid cancer,>65,0,370,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0.002,HRAS_12R,12R,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0.002,HRAS_12R,12R,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0.002,HRAS_12R,12R,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0.002,HRAS_12R,12R,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,cns cancer,<40,0,1602,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,prostate cancer,50-65,0,960,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,prostate cancer,>65,0,1402,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,anal cancer,40-50,0,12,0.001,0,0,0.005,HRAS_12R,12R,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.004,HRAS_12R,12R,NA
single,Age,HRAS,anal cancer,>65,0,45,0,0,0,0.004,HRAS_12R,12R,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,bladder cancer,<40,0,25,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,bladder cancer,40-50,0,78,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,bladder cancer,50-65,0,511,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,bladder cancer,>65,0,961,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,HRAS_12R,12R,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.002,HRAS_12R,12R,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.002,HRAS_12R,12R,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.002,HRAS_12R,12R,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.004,HRAS_12R,12R,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.003,HRAS_12R,12R,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.003,HRAS_12R,12R,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.006,HRAS_12R,12R,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.007,HRAS_12R,12R,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.006,HRAS_12R,12R,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.006,HRAS_12R,12R,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.009,HRAS_12R,12R,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.009,HRAS_12R,12R,NA
single,Age,HRAS,thymic tumor,<40,0,14,0.001,0,0,0.005,HRAS_12R,12R,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0,0,0,0.005,HRAS_12R,12R,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0,0,0,0.004,HRAS_12R,12R,NA
single,Age,HRAS,thymic tumor,>65,0,39,0,0,0,0.005,HRAS_12R,12R,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.009,HRAS_12R,12R,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.007,HRAS_12R,12R,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0.001,0,0,0.006,HRAS_12R,12R,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,HRAS_12R,12R,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,HRAS_12R,12R,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.002,HRAS_12R,12R,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0.001,HRAS_12R,12R,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,HRAS_12R,12R,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.004,HRAS_12R,12R,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.005,HRAS_12R,12R,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.006,HRAS_12R,12R,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.002,0,0,0.019,HRAS_12R,12R,NA
single,Age,HRAS,penile cancer,>65,0,11,0.002,0,0,0.019,HRAS_12R,12R,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.004,0,0,0.046,HRAS_12R,12R,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.003,0,0,0.039,HRAS_12R,12R,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.019,HRAS_12R,12R,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.009,HRAS_12R,12R,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.021,HRAS_12R,12R,NA
single,Age,HRAS,lung cancer,>65,0,18,0,0,0,0,HRAS_12R,12R,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.005,0,0,0.062,HRAS_12R,12R,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,colorectal cancer,>65,1,2052,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0.001,0,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,cancer of unknown primary,40-50,1,211,0.002,0.001,0,0.012,HRAS_12S,12S,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,cancer of unknown primary,>65,0,795,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,breast cancer,<40,1,840,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,breast cancer,50-65,1,3989,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,breast cancer,>65,1,2583,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,breast cancer,NA,0,10,0.001,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,pancreatic cancer,50-65,0,999,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,melanoma,<40,0,289,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,melanoma,40-50,0,282,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,melanoma,50-65,0,1016,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,melanoma,>65,0,1259,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,head and neck cancer,<40,1,140,0.007,0.006,0.002,0.014,HRAS_12S,12S,NA
single,Age,HRAS,head and neck cancer,40-50,2,216,0.007,0.006,0.003,0.015,HRAS_12S,12S,NA
single,Age,HRAS,head and neck cancer,50-65,3,799,0.006,0.006,0.002,0.01,HRAS_12S,12S,NA
single,Age,HRAS,head and neck cancer,>65,5,582,0.007,0.007,0.003,0.013,HRAS_12S,12S,NA
single,Age,HRAS,uterine cancer,<40,0,56,0.001,0.001,0,0.004,HRAS_12S,12S,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0.001,0.001,0,0.004,HRAS_12S,12S,NA
single,Age,HRAS,uterine cancer,50-65,1,1043,0.001,0.001,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,uterine cancer,>65,1,986,0.001,0.001,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0.005,0.003,0,0.024,HRAS_12S,12S,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,1,20,0.016,0.006,0.001,0.101,HRAS_12S,12S,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,0,149,0.003,0.003,0,0.012,HRAS_12S,12S,NA
single,Age,HRAS,non-melanoma skin cancers,>65,1,317,0.004,0.003,0,0.012,HRAS_12S,12S,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,soft tissue sarcoma,<40,0,667,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,soft tissue sarcoma,>65,0,766,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0.001,0,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,ovarian cancer,50-65,1,1092,0.001,0,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0.001,0,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0.001,0,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,esophagogastric cancer,50-65,0,752,0.001,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,esophagogastric cancer,>65,1,725,0.001,0.001,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,thyroid cancer,<40,0,150,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,thyroid cancer,40-50,0,122,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,thyroid cancer,50-65,0,374,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,thyroid cancer,>65,0,370,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,cns cancer,<40,0,1602,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,prostate cancer,50-65,0,960,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,prostate cancer,>65,0,1402,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,anal cancer,40-50,0,12,0.001,0,0,0.005,HRAS_12S,12S,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.004,HRAS_12S,12S,NA
single,Age,HRAS,anal cancer,>65,0,45,0,0,0,0.004,HRAS_12S,12S,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,bladder cancer,<40,1,25,0.018,0.006,0.001,0.097,HRAS_12S,12S,NA
single,Age,HRAS,bladder cancer,40-50,1,78,0.008,0.004,0,0.034,HRAS_12S,12S,NA
single,Age,HRAS,bladder cancer,50-65,0,511,0.001,0.001,0,0.005,HRAS_12S,12S,NA
single,Age,HRAS,bladder cancer,>65,1,961,0.002,0.001,0,0.005,HRAS_12S,12S,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.004,HRAS_12S,12S,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.003,HRAS_12S,12S,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.006,HRAS_12S,12S,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.007,HRAS_12S,12S,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.006,HRAS_12S,12S,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.006,HRAS_12S,12S,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.009,HRAS_12S,12S,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.009,HRAS_12S,12S,NA
single,Age,HRAS,thymic tumor,<40,0,14,0.007,0.004,0,0.037,HRAS_12S,12S,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0.006,0.003,0,0.03,HRAS_12S,12S,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0.005,0.003,0,0.024,HRAS_12S,12S,NA
single,Age,HRAS,thymic tumor,>65,1,39,0.014,0.008,0,0.062,HRAS_12S,12S,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.009,HRAS_12S,12S,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.007,HRAS_12S,12S,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0.001,0,0,0.006,HRAS_12S,12S,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.002,HRAS_12S,12S,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0.001,HRAS_12S,12S,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,HRAS_12S,12S,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.004,HRAS_12S,12S,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.005,HRAS_12S,12S,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.006,HRAS_12S,12S,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.002,0,0,0.019,HRAS_12S,12S,NA
single,Age,HRAS,penile cancer,>65,0,11,0.002,0,0,0.019,HRAS_12S,12S,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.004,0,0,0.046,HRAS_12S,12S,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.003,0,0,0.039,HRAS_12S,12S,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.019,HRAS_12S,12S,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.009,HRAS_12S,12S,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.021,HRAS_12S,12S,NA
single,Age,HRAS,lung cancer,>65,0,18,0,0,0,0,HRAS_12S,12S,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.005,0,0,0.062,HRAS_12S,12S,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,colorectal cancer,>65,0,2052,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0.001,0,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,cancer of unknown primary,40-50,0,211,0.001,0,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,cancer of unknown primary,>65,1,795,0.001,0.001,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,breast cancer,50-65,1,3989,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,breast cancer,>65,0,2583,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,breast cancer,NA,0,10,0.001,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,pancreatic cancer,50-65,0,999,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,melanoma,<40,0,289,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,melanoma,40-50,0,282,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,melanoma,50-65,0,1016,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,melanoma,>65,0,1259,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,head and neck cancer,<40,0,140,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,head and neck cancer,40-50,0,216,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,head and neck cancer,50-65,0,799,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,head and neck cancer,>65,0,582,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,uterine cancer,<40,0,56,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,uterine cancer,50-65,0,1043,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,uterine cancer,>65,0,986,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,HRAS_12V,12V,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.006,HRAS_12V,12V,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.005,HRAS_12V,12V,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0.001,0,0,0.006,HRAS_12V,12V,NA
single,Age,HRAS,soft tissue sarcoma,<40,2,667,0.002,0.001,0,0.007,HRAS_12V,12V,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0.001,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,soft tissue sarcoma,>65,0,766,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,ovarian cancer,50-65,0,1092,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,thyroid cancer,<40,0,150,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,thyroid cancer,40-50,0,122,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,thyroid cancer,50-65,0,374,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,thyroid cancer,>65,0,370,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,cervical cancer,<40,0,85,0.003,0.002,0,0.013,HRAS_12V,12V,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0.003,0.002,0,0.012,HRAS_12V,12V,NA
single,Age,HRAS,cervical cancer,50-65,1,144,0.004,0.003,0,0.017,HRAS_12V,12V,NA
single,Age,HRAS,cervical cancer,>65,0,36,0.003,0.002,0,0.015,HRAS_12V,12V,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,cns cancer,<40,0,1602,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,prostate cancer,50-65,0,960,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,prostate cancer,>65,0,1402,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,anal cancer,40-50,0,12,0,0,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,anal cancer,>65,0,45,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,bladder cancer,<40,0,25,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,bladder cancer,40-50,0,78,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,bladder cancer,50-65,0,511,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,bladder cancer,>65,0,961,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.005,HRAS_12V,12V,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.005,HRAS_12V,12V,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.005,HRAS_12V,12V,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.005,HRAS_12V,12V,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.011,HRAS_12V,12V,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.011,HRAS_12V,12V,NA
single,Age,HRAS,thymic tumor,<40,0,14,0,0,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,thymic tumor,>65,0,39,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.004,HRAS_12V,12V,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0,0,0,0.004,HRAS_12V,12V,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0,0,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0,0,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,HRAS_12V,12V,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0.002,HRAS_12V,12V,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.003,HRAS_12V,12V,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0,0,0,0.004,HRAS_12V,12V,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.003,0,0,0.033,HRAS_12V,12V,NA
single,Age,HRAS,penile cancer,>65,0,11,0.003,0,0,0.03,HRAS_12V,12V,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.003,0,0,0.034,HRAS_12V,12V,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_12V,12V,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.051,HRAS_12V,12V,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.001,0,0,0.017,HRAS_12V,12V,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.01,HRAS_12V,12V,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.028,HRAS_12V,12V,NA
single,Age,HRAS,lung cancer,>65,0,18,0.003,0,0,0.038,HRAS_12V,12V,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.053,HRAS_12V,12V,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,colorectal cancer,>65,0,2052,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,cancer of unknown primary,>65,0,795,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,breast cancer,50-65,0,3989,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,breast cancer,>65,0,2583,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,breast cancer,NA,0,10,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,pancreatic cancer,50-65,0,999,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,melanoma,<40,0,289,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,melanoma,40-50,0,282,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,melanoma,50-65,0,1016,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,melanoma,>65,1,1259,0.001,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,head and neck cancer,<40,0,140,0.001,0,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,head and neck cancer,40-50,0,216,0.001,0,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,head and neck cancer,50-65,1,799,0.001,0.001,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,head and neck cancer,>65,0,582,0.001,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,uterine cancer,<40,0,56,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,uterine cancer,50-65,0,1043,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,uterine cancer,>65,0,986,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,HRAS_13C,13C,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.006,HRAS_13C,13C,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.005,HRAS_13C,13C,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0.001,0,0,0.006,HRAS_13C,13C,NA
single,Age,HRAS,soft tissue sarcoma,<40,0,667,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,soft tissue sarcoma,>65,0,766,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,ovarian cancer,50-65,0,1092,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,thyroid cancer,<40,0,150,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,thyroid cancer,40-50,0,122,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,thyroid cancer,50-65,0,374,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,thyroid cancer,>65,0,370,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,cns cancer,<40,1,1602,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,prostate cancer,50-65,0,960,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,prostate cancer,>65,0,1402,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,anal cancer,40-50,0,12,0,0,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,anal cancer,>65,0,45,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,bladder cancer,<40,0,25,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,bladder cancer,40-50,0,78,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,bladder cancer,50-65,0,511,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,bladder cancer,>65,0,961,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.005,HRAS_13C,13C,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.005,HRAS_13C,13C,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.005,HRAS_13C,13C,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.005,HRAS_13C,13C,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.011,HRAS_13C,13C,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.011,HRAS_13C,13C,NA
single,Age,HRAS,thymic tumor,<40,0,14,0,0,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,thymic tumor,>65,0,39,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.004,HRAS_13C,13C,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0,0,0,0.004,HRAS_13C,13C,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0,0,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0,0,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,HRAS_13C,13C,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0.002,HRAS_13C,13C,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.003,HRAS_13C,13C,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0,0,0,0.004,HRAS_13C,13C,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.003,0,0,0.033,HRAS_13C,13C,NA
single,Age,HRAS,penile cancer,>65,0,11,0.003,0,0,0.03,HRAS_13C,13C,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.003,0,0,0.034,HRAS_13C,13C,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_13C,13C,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.051,HRAS_13C,13C,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.001,0,0,0.017,HRAS_13C,13C,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.01,HRAS_13C,13C,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.028,HRAS_13C,13C,NA
single,Age,HRAS,lung cancer,>65,0,18,0.003,0,0,0.038,HRAS_13C,13C,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.053,HRAS_13C,13C,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,HRAS_13D,13D,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.002,HRAS_13D,13D,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.002,HRAS_13D,13D,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,colorectal cancer,>65,0,2052,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,cancer of unknown primary,>65,0,795,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,breast cancer,50-65,0,3989,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,breast cancer,>65,0,2583,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,breast cancer,NA,0,10,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,pancreatic cancer,50-65,0,999,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,melanoma,<40,0,289,0.002,0.002,0,0.005,HRAS_13D,13D,NA
single,Age,HRAS,melanoma,40-50,0,282,0.002,0.002,0,0.005,HRAS_13D,13D,NA
single,Age,HRAS,melanoma,50-65,3,1016,0.002,0.002,0.001,0.005,HRAS_13D,13D,NA
single,Age,HRAS,melanoma,>65,3,1259,0.002,0.002,0.001,0.005,HRAS_13D,13D,NA
single,Age,HRAS,head and neck cancer,<40,0,140,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,head and neck cancer,40-50,0,216,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,head and neck cancer,50-65,0,799,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,head and neck cancer,>65,0,582,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,uterine cancer,<40,0,56,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,uterine cancer,50-65,0,1043,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,uterine cancer,>65,0,986,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,soft tissue sarcoma,<40,0,667,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,soft tissue sarcoma,>65,0,766,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0.001,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0.002,HRAS_13D,13D,NA
single,Age,HRAS,ovarian cancer,50-65,1,1092,0.001,0,0,0.002,HRAS_13D,13D,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0.002,HRAS_13D,13D,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0.001,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0.001,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,esophagogastric cancer,50-65,1,752,0.001,0.001,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0.001,0,0,0.002,HRAS_13D,13D,NA
single,Age,HRAS,thyroid cancer,<40,0,150,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,thyroid cancer,40-50,0,122,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,thyroid cancer,50-65,0,374,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,thyroid cancer,>65,0,370,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,cns cancer,<40,0,1602,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0.001,0.001,0,0.005,HRAS_13D,13D,NA
single,Age,HRAS,prostate cancer,50-65,1,960,0.001,0.001,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,prostate cancer,>65,1,1402,0.001,0.001,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,anal cancer,40-50,0,12,0.001,0,0,0.006,HRAS_13D,13D,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.004,HRAS_13D,13D,NA
single,Age,HRAS,anal cancer,>65,0,45,0,0,0,0.005,HRAS_13D,13D,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,bladder cancer,<40,0,25,0.002,0,0,0.013,HRAS_13D,13D,NA
single,Age,HRAS,bladder cancer,40-50,0,78,0.001,0,0,0.007,HRAS_13D,13D,NA
single,Age,HRAS,bladder cancer,50-65,2,511,0.003,0.002,0,0.009,HRAS_13D,13D,NA
single,Age,HRAS,bladder cancer,>65,0,961,0.001,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,HRAS_13D,13D,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,HRAS_13D,13D,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.004,HRAS_13D,13D,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.005,HRAS_13D,13D,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.005,HRAS_13D,13D,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.004,HRAS_13D,13D,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,HRAS_13D,13D,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.007,HRAS_13D,13D,NA
single,Age,HRAS,thymic tumor,<40,0,14,0.008,0.005,0,0.035,HRAS_13D,13D,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0.007,0.004,0,0.03,HRAS_13D,13D,NA
single,Age,HRAS,thymic tumor,50-65,1,71,0.009,0.006,0,0.035,HRAS_13D,13D,NA
single,Age,HRAS,thymic tumor,>65,0,39,0.007,0.004,0,0.028,HRAS_13D,13D,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.007,HRAS_13D,13D,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0,0,0,0.005,HRAS_13D,13D,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0,0,0,0.005,HRAS_13D,13D,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,HRAS_13D,13D,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,HRAS_13D,13D,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0.002,HRAS_13D,13D,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0.001,HRAS_13D,13D,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0,0,0,0.003,HRAS_13D,13D,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.004,0,0,0.045,HRAS_13D,13D,NA
single,Age,HRAS,penile cancer,>65,0,11,0.004,0,0,0.046,HRAS_13D,13D,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.004,0,0,0.047,HRAS_13D,13D,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_13D,13D,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.045,HRAS_13D,13D,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.022,HRAS_13D,13D,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.009,HRAS_13D,13D,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.019,HRAS_13D,13D,NA
single,Age,HRAS,lung cancer,>65,0,18,0.003,0,0,0.035,HRAS_13D,13D,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.002,0,0,0.025,HRAS_13D,13D,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,colorectal cancer,>65,0,2052,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0.001,0.001,0,0.005,HRAS_13R,13R,NA
single,Age,HRAS,cancer of unknown primary,40-50,0,211,0.001,0.001,0,0.005,HRAS_13R,13R,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0.001,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,cancer of unknown primary,>65,3,795,0.003,0.002,0.001,0.008,HRAS_13R,13R,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,non-small cell lung cancer,50-65,1,3677,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,non-small cell lung cancer,>65,3,5698,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0.001,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,breast cancer,50-65,5,3989,0.001,0.001,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,breast cancer,>65,0,2583,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,breast cancer,NA,0,10,0.002,0,0,0.016,HRAS_13R,13R,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0.001,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0.001,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,pancreatic cancer,50-65,1,999,0.001,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,melanoma,<40,0,289,0.001,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,melanoma,40-50,0,282,0.001,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,melanoma,50-65,2,1016,0.001,0.001,0,0.004,HRAS_13R,13R,NA
single,Age,HRAS,melanoma,>65,0,1259,0,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,head and neck cancer,<40,0,140,0.005,0.005,0.001,0.011,HRAS_13R,13R,NA
single,Age,HRAS,head and neck cancer,40-50,2,216,0.006,0.006,0.002,0.014,HRAS_13R,13R,NA
single,Age,HRAS,head and neck cancer,50-65,5,799,0.006,0.006,0.003,0.011,HRAS_13R,13R,NA
single,Age,HRAS,head and neck cancer,>65,3,582,0.006,0.005,0.002,0.011,HRAS_13R,13R,NA
single,Age,HRAS,uterine cancer,<40,0,56,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,uterine cancer,50-65,0,1043,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,uterine cancer,>65,0,986,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0.003,0.001,0,0.013,HRAS_13R,13R,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0.003,0.001,0,0.014,HRAS_13R,13R,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,0,149,0.002,0.001,0,0.009,HRAS_13R,13R,NA
single,Age,HRAS,non-melanoma skin cancers,>65,1,317,0.003,0.002,0,0.009,HRAS_13R,13R,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,soft tissue sarcoma,<40,2,667,0.002,0.002,0,0.006,HRAS_13R,13R,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0.001,0.001,0,0.004,HRAS_13R,13R,NA
single,Age,HRAS,soft tissue sarcoma,50-65,2,936,0.002,0.002,0,0.004,HRAS_13R,13R,NA
single,Age,HRAS,soft tissue sarcoma,>65,0,766,0.001,0.001,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,ovarian cancer,50-65,0,1092,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,thyroid cancer,<40,1,150,0.003,0.002,0,0.012,HRAS_13R,13R,NA
single,Age,HRAS,thyroid cancer,40-50,0,122,0.002,0.002,0,0.008,HRAS_13R,13R,NA
single,Age,HRAS,thyroid cancer,50-65,1,374,0.002,0.002,0,0.007,HRAS_13R,13R,NA
single,Age,HRAS,thyroid cancer,>65,0,370,0.002,0.001,0,0.006,HRAS_13R,13R,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,cns cancer,<40,1,1602,0,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0.001,0,0,0.005,HRAS_13R,13R,NA
single,Age,HRAS,prostate cancer,50-65,0,960,0,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,prostate cancer,>65,1,1402,0.001,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,anal cancer,40-50,0,12,0.001,0,0,0.006,HRAS_13R,13R,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.004,HRAS_13R,13R,NA
single,Age,HRAS,anal cancer,>65,0,45,0,0,0,0.005,HRAS_13R,13R,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,bladder cancer,<40,0,25,0.005,0.005,0,0.014,HRAS_13R,13R,NA
single,Age,HRAS,bladder cancer,40-50,0,78,0.005,0.004,0,0.012,HRAS_13R,13R,NA
single,Age,HRAS,bladder cancer,50-65,2,511,0.005,0.005,0.001,0.01,HRAS_13R,13R,NA
single,Age,HRAS,bladder cancer,>65,6,961,0.005,0.005,0.002,0.01,HRAS_13R,13R,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.004,HRAS_13R,13R,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.005,HRAS_13R,13R,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.005,HRAS_13R,13R,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.004,HRAS_13R,13R,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,HRAS_13R,13R,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.007,HRAS_13R,13R,NA
single,Age,HRAS,thymic tumor,<40,0,14,0,0,0,0.005,HRAS_13R,13R,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0,0,0,0.004,HRAS_13R,13R,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0,0,0,0.004,HRAS_13R,13R,NA
single,Age,HRAS,thymic tumor,>65,0,39,0,0,0,0.004,HRAS_13R,13R,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.007,HRAS_13R,13R,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0,0,0,0.005,HRAS_13R,13R,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0,0,0,0.005,HRAS_13R,13R,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0.002,HRAS_13R,13R,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0.001,HRAS_13R,13R,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,germ cell tumor,<40,1,649,0.001,0.001,0,0.005,HRAS_13R,13R,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0.001,0.001,0,0.006,HRAS_13R,13R,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0.001,0.001,0,0.006,HRAS_13R,13R,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0.002,0.001,0,0.012,HRAS_13R,13R,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0,0,0,0.003,HRAS_13R,13R,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.004,0,0,0.045,HRAS_13R,13R,NA
single,Age,HRAS,penile cancer,>65,0,11,0.004,0,0,0.046,HRAS_13R,13R,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.004,0,0,0.047,HRAS_13R,13R,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_13R,13R,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.045,HRAS_13R,13R,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.022,HRAS_13R,13R,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.009,HRAS_13R,13R,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.019,HRAS_13R,13R,NA
single,Age,HRAS,lung cancer,>65,0,18,0.003,0,0,0.035,HRAS_13R,13R,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.002,0,0,0.025,HRAS_13R,13R,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,HRAS_13V,13V,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,colorectal cancer,>65,0,2052,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0.001,0,0,0.003,HRAS_13V,13V,NA
single,Age,HRAS,cancer of unknown primary,40-50,0,211,0.001,0,0,0.003,HRAS_13V,13V,NA
single,Age,HRAS,cancer of unknown primary,50-65,1,809,0.001,0.001,0,0.003,HRAS_13V,13V,NA
single,Age,HRAS,cancer of unknown primary,>65,0,795,0,0,0,0.002,HRAS_13V,13V,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0.001,0,0,0.003,HRAS_13V,13V,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,non-small cell lung cancer,>65,6,5698,0.001,0.001,0,0.002,HRAS_13V,13V,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0.002,0,0,0.013,HRAS_13V,13V,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,breast cancer,50-65,0,3989,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,breast cancer,>65,1,2583,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,breast cancer,NA,0,10,0.001,0,0,0.002,HRAS_13V,13V,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,pancreatic cancer,50-65,0,999,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,melanoma,<40,0,289,0.001,0.001,0,0.003,HRAS_13V,13V,NA
single,Age,HRAS,melanoma,40-50,0,282,0.001,0.001,0,0.003,HRAS_13V,13V,NA
single,Age,HRAS,melanoma,50-65,0,1016,0.001,0,0,0.002,HRAS_13V,13V,NA
single,Age,HRAS,melanoma,>65,3,1259,0.002,0.001,0,0.005,HRAS_13V,13V,NA
single,Age,HRAS,head and neck cancer,<40,1,140,0.003,0.002,0,0.01,HRAS_13V,13V,NA
single,Age,HRAS,head and neck cancer,40-50,0,216,0.002,0.002,0,0.005,HRAS_13V,13V,NA
single,Age,HRAS,head and neck cancer,50-65,1,799,0.002,0.002,0,0.005,HRAS_13V,13V,NA
single,Age,HRAS,head and neck cancer,>65,1,582,0.002,0.002,0,0.005,HRAS_13V,13V,NA
single,Age,HRAS,uterine cancer,<40,0,56,0.001,0,0,0.003,HRAS_13V,13V,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0.001,0,0,0.003,HRAS_13V,13V,NA
single,Age,HRAS,uterine cancer,50-65,1,1043,0.001,0,0,0.003,HRAS_13V,13V,NA
single,Age,HRAS,uterine cancer,>65,0,986,0,0,0,0.002,HRAS_13V,13V,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0.005,0.003,0,0.017,HRAS_13V,13V,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0.005,0.004,0,0.019,HRAS_13V,13V,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,1,149,0.005,0.004,0.001,0.016,HRAS_13V,13V,NA
single,Age,HRAS,non-melanoma skin cancers,>65,1,317,0.004,0.003,0,0.012,HRAS_13V,13V,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.004,HRAS_13V,13V,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,HRAS_13V,13V,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,HRAS_13V,13V,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,HRAS_13V,13V,NA
single,Age,HRAS,soft tissue sarcoma,<40,0,667,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,soft tissue sarcoma,>65,0,766,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,ovarian cancer,50-65,0,1092,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,thyroid cancer,<40,0,150,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,thyroid cancer,40-50,0,122,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,thyroid cancer,50-65,0,374,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,thyroid cancer,>65,0,370,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,cns cancer,<40,0,1602,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,prostate cancer,50-65,0,960,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,prostate cancer,>65,0,1402,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,anal cancer,40-50,0,12,0.001,0,0,0.004,HRAS_13V,13V,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.003,HRAS_13V,13V,NA
single,Age,HRAS,anal cancer,>65,0,45,0,0,0,0.003,HRAS_13V,13V,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.002,HRAS_13V,13V,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.002,HRAS_13V,13V,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,bladder cancer,<40,0,25,0.003,0.002,0,0.01,HRAS_13V,13V,NA
single,Age,HRAS,bladder cancer,40-50,0,78,0.002,0.002,0,0.008,HRAS_13V,13V,NA
single,Age,HRAS,bladder cancer,50-65,2,511,0.003,0.002,0,0.007,HRAS_13V,13V,NA
single,Age,HRAS,bladder cancer,>65,1,961,0.002,0.002,0,0.005,HRAS_13V,13V,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.002,HRAS_13V,13V,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.007,HRAS_13V,13V,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.008,HRAS_13V,13V,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0.001,0,0,0.007,HRAS_13V,13V,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.007,HRAS_13V,13V,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.007,HRAS_13V,13V,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.007,HRAS_13V,13V,NA
single,Age,HRAS,thymic tumor,<40,0,14,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,thymic tumor,>65,0,39,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.01,HRAS_13V,13V,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.008,HRAS_13V,13V,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0.001,0,0,0.008,HRAS_13V,13V,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0.004,0.002,0,0.018,HRAS_13V,13V,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0.002,0.001,0,0.011,HRAS_13V,13V,NA
single,Age,HRAS,small cell lung cancer,>65,1,224,0.004,0.003,0,0.013,HRAS_13V,13V,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0.001,HRAS_13V,13V,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,HRAS_13V,13V,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.005,HRAS_13V,13V,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.004,HRAS_13V,13V,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,HRAS_13V,13V,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.003,0,0,0.034,HRAS_13V,13V,NA
single,Age,HRAS,penile cancer,>65,0,11,0.003,0,0,0.034,HRAS_13V,13V,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.004,0,0,0.045,HRAS_13V,13V,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_13V,13V,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.005,0,0,0.055,HRAS_13V,13V,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.021,HRAS_13V,13V,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,HRAS_13V,13V,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.029,HRAS_13V,13V,NA
single,Age,HRAS,lung cancer,>65,0,18,0.003,0,0,0.032,HRAS_13V,13V,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,HRAS_13V,13V,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,HRAS_61H,61H,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.002,HRAS_61H,61H,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.002,HRAS_61H,61H,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,colorectal cancer,>65,0,2052,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,cancer of unknown primary,>65,0,795,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0.002,HRAS_61H,61H,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,non-small cell lung cancer,>65,2,5698,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0.001,0,0,0.006,HRAS_61H,61H,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,breast cancer,50-65,0,3989,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,breast cancer,>65,0,2583,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,breast cancer,NA,0,10,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,pancreatic cancer,50-65,0,999,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,melanoma,<40,0,289,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,melanoma,40-50,0,282,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,melanoma,50-65,0,1016,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,melanoma,>65,0,1259,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,head and neck cancer,<40,0,140,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,head and neck cancer,40-50,0,216,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,head and neck cancer,50-65,0,799,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,head and neck cancer,>65,0,582,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,uterine cancer,<40,0,56,0.001,0,0,0.004,HRAS_61H,61H,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0.001,0,0,0.003,HRAS_61H,61H,NA
single,Age,HRAS,uterine cancer,50-65,1,1043,0.001,0,0,0.003,HRAS_61H,61H,NA
single,Age,HRAS,uterine cancer,>65,0,986,0,0,0,0.002,HRAS_61H,61H,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,HRAS_61H,61H,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,HRAS_61H,61H,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.003,HRAS_61H,61H,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,HRAS_61H,61H,NA
single,Age,HRAS,soft tissue sarcoma,<40,0,667,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,soft tissue sarcoma,>65,0,766,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,ovarian cancer,50-65,0,1092,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,thyroid cancer,<40,0,150,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,thyroid cancer,40-50,0,122,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,thyroid cancer,50-65,0,374,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,thyroid cancer,>65,0,370,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,cns cancer,<40,0,1602,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,prostate cancer,50-65,0,960,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,prostate cancer,>65,0,1402,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,anal cancer,40-50,0,12,0.001,0,0,0.006,HRAS_61H,61H,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.004,HRAS_61H,61H,NA
single,Age,HRAS,anal cancer,>65,0,45,0,0,0,0.004,HRAS_61H,61H,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.002,HRAS_61H,61H,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,bladder cancer,<40,0,25,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,bladder cancer,40-50,0,78,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,bladder cancer,50-65,0,511,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,bladder cancer,>65,0,961,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,HRAS_61H,61H,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.002,HRAS_61H,61H,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.002,HRAS_61H,61H,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.002,HRAS_61H,61H,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,HRAS_61H,61H,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.003,HRAS_61H,61H,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.003,HRAS_61H,61H,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.005,HRAS_61H,61H,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.005,HRAS_61H,61H,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.005,HRAS_61H,61H,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.005,HRAS_61H,61H,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.006,HRAS_61H,61H,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.006,HRAS_61H,61H,NA
single,Age,HRAS,thymic tumor,<40,0,14,0,0,0,0.004,HRAS_61H,61H,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0,0,0,0.004,HRAS_61H,61H,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0,0,0,0.003,HRAS_61H,61H,NA
single,Age,HRAS,thymic tumor,>65,0,39,0,0,0,0.003,HRAS_61H,61H,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.006,HRAS_61H,61H,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0,0,0,0.005,HRAS_61H,61H,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0,0,0,0.004,HRAS_61H,61H,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,HRAS_61H,61H,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0.001,HRAS_61H,61H,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,HRAS_61H,61H,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.005,HRAS_61H,61H,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.004,HRAS_61H,61H,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,HRAS_61H,61H,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.002,0,0,0.016,HRAS_61H,61H,NA
single,Age,HRAS,penile cancer,>65,0,11,0.002,0,0,0.016,HRAS_61H,61H,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.003,0,0,0.039,HRAS_61H,61H,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_61H,61H,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.002,0,0,0.026,HRAS_61H,61H,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.001,0,0,0.015,HRAS_61H,61H,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,HRAS_61H,61H,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.021,HRAS_61H,61H,NA
single,Age,HRAS,lung cancer,>65,0,18,0.002,0,0,0.026,HRAS_61H,61H,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.003,0,0,0.039,HRAS_61H,61H,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,HRAS_61K,61K,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,colorectal cancer,>65,0,2052,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,cancer of unknown primary,<40,1,166,0.003,0.002,0,0.012,HRAS_61K,61K,NA
single,Age,HRAS,cancer of unknown primary,40-50,1,211,0.003,0.002,0,0.01,HRAS_61K,61K,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0.001,0.001,0,0.004,HRAS_61K,61K,NA
single,Age,HRAS,cancer of unknown primary,>65,1,795,0.002,0.001,0,0.004,HRAS_61K,61K,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,breast cancer,50-65,0,3989,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,breast cancer,>65,2,2583,0.001,0,0,0.002,HRAS_61K,61K,NA
single,Age,HRAS,breast cancer,NA,0,10,0.001,0,0,0.008,HRAS_61K,61K,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0.001,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0.001,0,0,0.002,HRAS_61K,61K,NA
single,Age,HRAS,pancreatic cancer,50-65,1,999,0.001,0,0,0.002,HRAS_61K,61K,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0.002,HRAS_61K,61K,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,melanoma,<40,0,289,0.003,0.002,0,0.006,HRAS_61K,61K,NA
single,Age,HRAS,melanoma,40-50,1,282,0.003,0.003,0.001,0.007,HRAS_61K,61K,NA
single,Age,HRAS,melanoma,50-65,4,1016,0.003,0.003,0.001,0.006,HRAS_61K,61K,NA
single,Age,HRAS,melanoma,>65,3,1259,0.003,0.003,0.001,0.005,HRAS_61K,61K,NA
single,Age,HRAS,head and neck cancer,<40,1,140,0.004,0.003,0.001,0.011,HRAS_61K,61K,NA
single,Age,HRAS,head and neck cancer,40-50,0,216,0.003,0.002,0,0.007,HRAS_61K,61K,NA
single,Age,HRAS,head and neck cancer,50-65,3,799,0.003,0.003,0.001,0.007,HRAS_61K,61K,NA
single,Age,HRAS,head and neck cancer,>65,1,582,0.003,0.003,0.001,0.006,HRAS_61K,61K,NA
single,Age,HRAS,uterine cancer,<40,0,56,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,uterine cancer,50-65,0,1043,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,uterine cancer,>65,0,986,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0.005,0.003,0,0.017,HRAS_61K,61K,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0.005,0.003,0,0.018,HRAS_61K,61K,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,1,149,0.005,0.004,0.001,0.015,HRAS_61K,61K,NA
single,Age,HRAS,non-melanoma skin cancers,>65,1,317,0.004,0.003,0,0.012,HRAS_61K,61K,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,HRAS_61K,61K,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,HRAS_61K,61K,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,HRAS_61K,61K,NA
single,Age,HRAS,soft tissue sarcoma,<40,1,667,0.001,0,0,0.004,HRAS_61K,61K,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0,0,0,0.002,HRAS_61K,61K,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0.002,HRAS_61K,61K,NA
single,Age,HRAS,soft tissue sarcoma,>65,0,766,0,0,0,0.002,HRAS_61K,61K,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,ovarian cancer,50-65,0,1092,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,thyroid cancer,<40,3,150,0.013,0.012,0.006,0.028,HRAS_61K,61K,NA
single,Age,HRAS,thyroid cancer,40-50,1,122,0.012,0.011,0.004,0.023,HRAS_61K,61K,NA
single,Age,HRAS,thyroid cancer,50-65,5,374,0.012,0.012,0.006,0.022,HRAS_61K,61K,NA
single,Age,HRAS,thyroid cancer,>65,3,370,0.011,0.011,0.004,0.02,HRAS_61K,61K,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0.001,0,0,0.005,HRAS_61K,61K,NA
single,Age,HRAS,hepatobiliary cancer,40-50,1,110,0.005,0.002,0,0.025,HRAS_61K,61K,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0.001,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,cns cancer,<40,0,1602,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0.003,0.002,0,0.011,HRAS_61K,61K,NA
single,Age,HRAS,prostate cancer,50-65,4,960,0.003,0.003,0.001,0.007,HRAS_61K,61K,NA
single,Age,HRAS,prostate cancer,>65,2,1402,0.002,0.002,0,0.005,HRAS_61K,61K,NA
single,Age,HRAS,anal cancer,40-50,0,12,0.001,0,0,0.008,HRAS_61K,61K,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.005,HRAS_61K,61K,NA
single,Age,HRAS,anal cancer,>65,0,45,0.001,0,0,0.006,HRAS_61K,61K,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,bladder cancer,<40,0,25,0.003,0.002,0,0.017,HRAS_61K,61K,NA
single,Age,HRAS,bladder cancer,40-50,0,78,0.002,0.002,0,0.01,HRAS_61K,61K,NA
single,Age,HRAS,bladder cancer,50-65,0,511,0.002,0.001,0,0.006,HRAS_61K,61K,NA
single,Age,HRAS,bladder cancer,>65,5,961,0.004,0.004,0.001,0.009,HRAS_61K,61K,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,HRAS_61K,61K,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.002,HRAS_61K,61K,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.002,HRAS_61K,61K,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.006,HRAS_61K,61K,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.006,HRAS_61K,61K,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.006,HRAS_61K,61K,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.006,HRAS_61K,61K,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.012,HRAS_61K,61K,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.012,HRAS_61K,61K,NA
single,Age,HRAS,thymic tumor,<40,0,14,0,0,0,0.004,HRAS_61K,61K,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0,0,0,0.004,HRAS_61K,61K,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,thymic tumor,>65,0,39,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.006,HRAS_61K,61K,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0,0,0,0.005,HRAS_61K,61K,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0,0,0,0.005,HRAS_61K,61K,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.004,HRAS_61K,61K,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0.001,HRAS_61K,61K,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0,0,0,0.003,HRAS_61K,61K,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.002,0,0,0.019,HRAS_61K,61K,NA
single,Age,HRAS,penile cancer,>65,0,11,0.002,0,0,0.02,HRAS_61K,61K,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.003,0,0,0.036,HRAS_61K,61K,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_61K,61K,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.053,HRAS_61K,61K,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.024,HRAS_61K,61K,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.008,HRAS_61K,61K,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.023,HRAS_61K,61K,NA
single,Age,HRAS,lung cancer,>65,0,18,0.002,0,0,0.02,HRAS_61K,61K,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.005,0,0,0.062,HRAS_61K,61K,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,HRAS_61L,61L,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,colorectal cancer,>65,0,2052,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,cancer of unknown primary,>65,0,795,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,breast cancer,40-50,0,1910,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,breast cancer,50-65,0,3989,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,breast cancer,>65,0,2583,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,breast cancer,NA,0,10,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,pancreatic cancer,50-65,0,999,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,pancreatic cancer,>65,0,1205,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,melanoma,<40,0,289,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,melanoma,40-50,0,282,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,melanoma,50-65,0,1016,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,melanoma,>65,0,1259,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,head and neck cancer,<40,0,140,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,head and neck cancer,40-50,0,216,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,head and neck cancer,50-65,0,799,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,head and neck cancer,>65,0,582,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,uterine cancer,<40,0,56,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,uterine cancer,50-65,0,1043,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,uterine cancer,>65,0,986,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.004,HRAS_61L,61L,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,HRAS_61L,61L,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,HRAS_61L,61L,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,HRAS_61L,61L,NA
single,Age,HRAS,soft tissue sarcoma,<40,1,667,0.001,0,0,0.003,HRAS_61L,61L,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0,0,0,0.002,HRAS_61L,61L,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0.002,HRAS_61L,61L,NA
single,Age,HRAS,soft tissue sarcoma,>65,0,766,0,0,0,0.002,HRAS_61L,61L,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,ovarian cancer,50-65,0,1092,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,thyroid cancer,<40,0,150,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,thyroid cancer,40-50,0,122,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,thyroid cancer,50-65,0,374,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,thyroid cancer,>65,0,370,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,cns cancer,<40,0,1602,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,prostate cancer,50-65,0,960,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,prostate cancer,>65,0,1402,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,anal cancer,40-50,0,12,0.001,0,0,0.004,HRAS_61L,61L,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.003,HRAS_61L,61L,NA
single,Age,HRAS,anal cancer,>65,0,45,0,0,0,0.003,HRAS_61L,61L,NA
single,Age,HRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.002,HRAS_61L,61L,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.002,HRAS_61L,61L,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,bladder cancer,<40,0,25,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,bladder cancer,40-50,0,78,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,bladder cancer,50-65,0,511,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,bladder cancer,>65,0,961,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.002,HRAS_61L,61L,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.007,HRAS_61L,61L,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.008,HRAS_61L,61L,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0.001,0,0,0.007,HRAS_61L,61L,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.007,HRAS_61L,61L,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.007,HRAS_61L,61L,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.007,HRAS_61L,61L,NA
single,Age,HRAS,thymic tumor,<40,0,14,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,thymic tumor,>65,0,39,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.01,HRAS_61L,61L,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.008,HRAS_61L,61L,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0.001,0,0,0.008,HRAS_61L,61L,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,HRAS_61L,61L,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0,0,0,0.002,HRAS_61L,61L,NA
single,Age,HRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0.001,HRAS_61L,61L,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,HRAS_61L,61L,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.005,HRAS_61L,61L,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.004,HRAS_61L,61L,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,HRAS_61L,61L,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.003,0,0,0.034,HRAS_61L,61L,NA
single,Age,HRAS,penile cancer,>65,0,11,0.003,0,0,0.034,HRAS_61L,61L,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.004,0,0,0.045,HRAS_61L,61L,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_61L,61L,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.005,0,0,0.055,HRAS_61L,61L,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.021,HRAS_61L,61L,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,HRAS_61L,61L,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.029,HRAS_61L,61L,NA
single,Age,HRAS,lung cancer,>65,0,18,0.003,0,0,0.032,HRAS_61L,61L,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,HRAS_61L,61L,NA
single,Age,HRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,HRAS_61R,61R,NA
single,Age,HRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,colorectal cancer,<40,0,565,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,colorectal cancer,40-50,0,1280,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,colorectal cancer,50-65,0,2814,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,colorectal cancer,>65,0,2052,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,cancer of unknown primary,<40,0,166,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,cancer of unknown primary,50-65,0,809,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,cancer of unknown primary,>65,0,795,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,non-small cell lung cancer,<40,0,161,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,non-small cell lung cancer,50-65,1,3677,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,non-small cell lung cancer,>65,2,5698,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,non-small cell lung cancer,NA,0,10,0.001,0,0,0.002,HRAS_61R,61R,NA
single,Age,HRAS,breast cancer,<40,0,840,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,breast cancer,40-50,2,1910,0.001,0.001,0,0.002,HRAS_61R,61R,NA
single,Age,HRAS,breast cancer,50-65,0,3989,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,breast cancer,>65,2,2583,0.001,0,0,0.002,HRAS_61R,61R,NA
single,Age,HRAS,breast cancer,NA,0,10,0.001,0,0,0.006,HRAS_61R,61R,NA
single,Age,HRAS,pancreatic cancer,<40,0,87,0.001,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,pancreatic cancer,40-50,0,200,0,0,0,0.002,HRAS_61R,61R,NA
single,Age,HRAS,pancreatic cancer,50-65,0,999,0,0,0,0.002,HRAS_61R,61R,NA
single,Age,HRAS,pancreatic cancer,>65,1,1205,0.001,0,0,0.002,HRAS_61R,61R,NA
single,Age,HRAS,leukemia,<40,0,203,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,leukemia,40-50,0,127,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,leukemia,50-65,0,511,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,leukemia,>65,0,719,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,melanoma,<40,1,289,0.002,0.002,0,0.006,HRAS_61R,61R,NA
single,Age,HRAS,melanoma,40-50,0,282,0.002,0.002,0,0.004,HRAS_61R,61R,NA
single,Age,HRAS,melanoma,50-65,3,1016,0.002,0.002,0.001,0.005,HRAS_61R,61R,NA
single,Age,HRAS,melanoma,>65,1,1259,0.002,0.001,0,0.004,HRAS_61R,61R,NA
single,Age,HRAS,head and neck cancer,<40,0,140,0.005,0.005,0,0.01,HRAS_61R,61R,NA
single,Age,HRAS,head and neck cancer,40-50,1,216,0.005,0.005,0.001,0.011,HRAS_61R,61R,NA
single,Age,HRAS,head and neck cancer,50-65,6,799,0.006,0.006,0.002,0.011,HRAS_61R,61R,NA
single,Age,HRAS,head and neck cancer,>65,2,582,0.005,0.005,0.001,0.009,HRAS_61R,61R,NA
single,Age,HRAS,uterine cancer,<40,0,56,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,uterine cancer,40-50,0,162,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,uterine cancer,50-65,0,1043,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,uterine cancer,>65,0,986,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,non-melanoma skin cancers,<40,0,27,0.003,0.001,0,0.017,HRAS_61R,61R,NA
single,Age,HRAS,non-melanoma skin cancers,40-50,0,20,0.003,0.001,0,0.017,HRAS_61R,61R,NA
single,Age,HRAS,non-melanoma skin cancers,50-65,1,149,0.004,0.002,0,0.017,HRAS_61R,61R,NA
single,Age,HRAS,non-melanoma skin cancers,>65,0,317,0.002,0.001,0,0.007,HRAS_61R,61R,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,<40,0,86,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,HRAS_61R,61R,NA
single,Age,HRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,HRAS_61R,61R,NA
single,Age,HRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,HRAS_61R,61R,NA
single,Age,HRAS,soft tissue sarcoma,<40,0,667,0,0,0,0.002,HRAS_61R,61R,NA
single,Age,HRAS,soft tissue sarcoma,40-50,0,363,0,0,0,0.002,HRAS_61R,61R,NA
single,Age,HRAS,soft tissue sarcoma,50-65,0,936,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,soft tissue sarcoma,>65,1,766,0.001,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,ovarian cancer,<40,0,141,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,ovarian cancer,40-50,0,253,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,ovarian cancer,50-65,0,1092,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,ovarian cancer,>65,0,849,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,esophagogastric cancer,<40,0,122,0.001,0,0,0.004,HRAS_61R,61R,NA
single,Age,HRAS,esophagogastric cancer,40-50,0,200,0.001,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,esophagogastric cancer,50-65,1,752,0.001,0.001,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,esophagogastric cancer,>65,0,725,0.001,0,0,0.002,HRAS_61R,61R,NA
single,Age,HRAS,thyroid cancer,<40,4,150,0.029,0.028,0.015,0.046,HRAS_61R,61R,NA
single,Age,HRAS,thyroid cancer,40-50,2,122,0.027,0.027,0.011,0.043,HRAS_61R,61R,NA
single,Age,HRAS,thyroid cancer,50-65,9,374,0.028,0.027,0.016,0.041,HRAS_61R,61R,NA
single,Age,HRAS,thyroid cancer,>65,15,370,0.033,0.032,0.021,0.052,HRAS_61R,61R,NA
single,Age,HRAS,cervical cancer,<40,0,85,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,cervical cancer,40-50,0,99,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,cervical cancer,50-65,0,144,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,cervical cancer,>65,0,36,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,kidney cancer,<40,0,191,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,kidney cancer,40-50,0,159,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,kidney cancer,50-65,0,628,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,kidney cancer,>65,0,440,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,cns cancer,<40,0,1602,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,cns cancer,40-50,0,687,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,cns cancer,50-65,0,1438,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,cns cancer,>65,0,836,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,prostate cancer,40-50,0,70,0.003,0.002,0,0.011,HRAS_61R,61R,NA
single,Age,HRAS,prostate cancer,50-65,4,960,0.003,0.003,0.001,0.007,HRAS_61R,61R,NA
single,Age,HRAS,prostate cancer,>65,2,1402,0.002,0.002,0,0.005,HRAS_61R,61R,NA
single,Age,HRAS,anal cancer,40-50,0,12,0.001,0,0,0.008,HRAS_61R,61R,NA
single,Age,HRAS,anal cancer,50-65,0,88,0,0,0,0.005,HRAS_61R,61R,NA
single,Age,HRAS,anal cancer,>65,0,45,0.001,0,0,0.006,HRAS_61R,61R,NA
single,Age,HRAS,neuroendocrine tumors,<40,1,22,0.024,0.009,0,0.124,HRAS_61R,61R,NA
single,Age,HRAS,neuroendocrine tumors,40-50,0,55,0.003,0.001,0,0.015,HRAS_61R,61R,NA
single,Age,HRAS,neuroendocrine tumors,50-65,0,161,0.002,0.001,0,0.01,HRAS_61R,61R,NA
single,Age,HRAS,neuroendocrine tumors,>65,0,121,0.002,0.001,0,0.011,HRAS_61R,61R,NA
single,Age,HRAS,bladder cancer,<40,0,25,0.011,0.01,0.001,0.026,HRAS_61R,61R,NA
single,Age,HRAS,bladder cancer,40-50,2,78,0.013,0.011,0.005,0.036,HRAS_61R,61R,NA
single,Age,HRAS,bladder cancer,50-65,3,511,0.009,0.009,0.003,0.016,HRAS_61R,61R,NA
single,Age,HRAS,bladder cancer,>65,11,961,0.011,0.01,0.006,0.017,HRAS_61R,61R,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,HRAS_61R,61R,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.002,HRAS_61R,61R,NA
single,Age,HRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,small bowel cancer,50-65,0,96,0,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,small bowel cancer,>65,0,78,0,0,0,0.002,HRAS_61R,61R,NA
single,Age,HRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.006,HRAS_61R,61R,NA
single,Age,HRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.006,HRAS_61R,61R,NA
single,Age,HRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.006,HRAS_61R,61R,NA
single,Age,HRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.006,HRAS_61R,61R,NA
single,Age,HRAS,bone cancer,<40,0,335,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,bone cancer,40-50,0,60,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,bone cancer,50-65,0,93,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,bone cancer,>65,0,63,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.012,HRAS_61R,61R,NA
single,Age,HRAS,vaginal cancer,>65,0,30,0.001,0,0,0.012,HRAS_61R,61R,NA
single,Age,HRAS,thymic tumor,<40,0,14,0.008,0.005,0,0.037,HRAS_61R,61R,NA
single,Age,HRAS,thymic tumor,40-50,0,28,0.007,0.004,0,0.032,HRAS_61R,61R,NA
single,Age,HRAS,thymic tumor,50-65,0,71,0.006,0.004,0,0.025,HRAS_61R,61R,NA
single,Age,HRAS,thymic tumor,>65,1,39,0.012,0.007,0,0.052,HRAS_61R,61R,NA
single,Age,HRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.006,HRAS_61R,61R,NA
single,Age,HRAS,ampullary cancer,50-65,0,40,0,0,0,0.005,HRAS_61R,61R,NA
single,Age,HRAS,ampullary cancer,>65,0,50,0,0,0,0.005,HRAS_61R,61R,NA
single,Age,HRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.004,HRAS_61R,61R,NA
single,Age,HRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,mature t and nk neoplasms,>65,0,105,0,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,mesothelioma,<40,0,30,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,mesothelioma,40-50,0,29,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,mesothelioma,50-65,0,122,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,mesothelioma,>65,0,316,0,0,0,0.001,HRAS_61R,61R,NA
single,Age,HRAS,germ cell tumor,<40,0,649,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,germ cell tumor,40-50,0,131,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,germ cell tumor,50-65,0,92,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,germ cell tumor,>65,0,12,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,nerve sheath tumor,40-50,0,26,0,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,nerve sheath tumor,50-65,0,35,0,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,nerve sheath tumor,>65,0,13,0,0,0,0.003,HRAS_61R,61R,NA
single,Age,HRAS,penile cancer,50-65,0,11,0.002,0,0,0.019,HRAS_61R,61R,NA
single,Age,HRAS,penile cancer,>65,0,11,0.002,0,0,0.02,HRAS_61R,61R,NA
single,Age,HRAS,pineal tumor,<40,0,14,0.003,0,0,0.036,HRAS_61R,61R,NA
single,Age,HRAS,b cell lymphoma,<40,0,87,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,b cell lymphoma,40-50,0,105,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,b cell lymphoma,50-65,0,356,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,b cell lymphoma,>65,0,413,0,0,0,0,HRAS_61R,61R,NA
single,Age,HRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.053,HRAS_61R,61R,NA
single,Age,HRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.024,HRAS_61R,61R,NA
single,Age,HRAS,retinoblastoma,<40,0,51,0.001,0,0,0.008,HRAS_61R,61R,NA
single,Age,HRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.023,HRAS_61R,61R,NA
single,Age,HRAS,lung cancer,>65,0,18,0.002,0,0,0.02,HRAS_61R,61R,NA
single,Age,HRAS,peritoneal cancer,>65,0,11,0.005,0,0,0.062,HRAS_61R,61R,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,NRAS_12A,12A,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0,0,0,0.002,NRAS_12A,12A,NA
single,Age,NRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,colorectal cancer,<40,0,565,0.001,0,0,0.002,NRAS_12A,12A,NA
single,Age,NRAS,colorectal cancer,40-50,0,1280,0,0,0,0.002,NRAS_12A,12A,NA
single,Age,NRAS,colorectal cancer,50-65,1,2814,0.001,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,colorectal cancer,>65,4,2052,0.001,0.001,0,0.004,NRAS_12A,12A,NA
single,Age,NRAS,cancer of unknown primary,<40,0,167,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,cancer of unknown primary,50-65,0,810,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,cancer of unknown primary,>65,0,796,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,non-small cell lung cancer,>65,2,5698,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0.001,0,0,0.003,NRAS_12A,12A,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,breast cancer,50-65,0,3989,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,pancreatic cancer,50-65,0,999,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,pancreatic cancer,>65,0,1205,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,leukemia,<40,1,204,0.008,0.007,0.001,0.017,NRAS_12A,12A,NA
single,Age,NRAS,leukemia,40-50,2,128,0.011,0.009,0.003,0.028,NRAS_12A,12A,NA
single,Age,NRAS,leukemia,50-65,1,515,0.006,0.006,0.001,0.013,NRAS_12A,12A,NA
single,Age,NRAS,leukemia,>65,10,720,0.011,0.011,0.006,0.02,NRAS_12A,12A,NA
single,Age,NRAS,melanoma,<40,0,289,0.001,0.001,0,0.005,NRAS_12A,12A,NA
single,Age,NRAS,melanoma,40-50,2,282,0.004,0.003,0.001,0.014,NRAS_12A,12A,NA
single,Age,NRAS,melanoma,50-65,0,1016,0.001,0.001,0,0.003,NRAS_12A,12A,NA
single,Age,NRAS,melanoma,>65,3,1259,0.002,0.002,0.001,0.005,NRAS_12A,12A,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,head and neck cancer,50-65,0,799,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,head and neck cancer,>65,0,582,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,uterine cancer,<40,0,57,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,uterine cancer,40-50,0,162,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,uterine cancer,50-65,0,1046,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,uterine cancer,>65,0,987,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.003,0.003,0,0.011,NRAS_12A,12A,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.003,0.003,0,0.01,NRAS_12A,12A,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,3,373,0.005,0.004,0.001,0.014,NRAS_12A,12A,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,1,664,0.003,0.003,0,0.007,NRAS_12A,12A,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,NRAS_12A,12A,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.005,NRAS_12A,12A,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.005,NRAS_12A,12A,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.005,NRAS_12A,12A,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,ovarian cancer,40-50,0,253,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,ovarian cancer,50-65,0,1092,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,ovarian cancer,>65,0,849,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0.001,0,0,0.004,NRAS_12A,12A,NA
single,Age,NRAS,esophagogastric cancer,40-50,1,200,0.002,0.001,0,0.013,NRAS_12A,12A,NA
single,Age,NRAS,esophagogastric cancer,50-65,0,752,0,0,0,0.002,NRAS_12A,12A,NA
single,Age,NRAS,esophagogastric cancer,>65,0,725,0,0,0,0.002,NRAS_12A,12A,NA
single,Age,NRAS,thyroid cancer,<40,0,150,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,thyroid cancer,40-50,0,122,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,thyroid cancer,50-65,0,374,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,thyroid cancer,>65,0,370,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,cervical cancer,<40,0,85,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,cervical cancer,>65,0,36,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,NRAS_12A,12A,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,NRAS_12A,12A,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,NRAS_12A,12A,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,NRAS_12A,12A,NA
single,Age,NRAS,cns cancer,<40,0,1602,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,cns cancer,40-50,0,687,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,cns cancer,50-65,0,1439,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,cns cancer,>65,0,836,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,prostate cancer,>65,0,1402,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,anal cancer,40-50,0,12,0.001,0,0,0.007,NRAS_12A,12A,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.004,NRAS_12A,12A,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.005,NRAS_12A,12A,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,bladder cancer,<40,0,25,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,bladder cancer,50-65,0,511,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,bladder cancer,>65,0,961,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,2,142,0.011,0.009,0.001,0.031,NRAS_12A,12A,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.008,0.005,0,0.032,NRAS_12A,12A,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0.007,0.005,0,0.025,NRAS_12A,12A,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.007,0.005,0,0.026,NRAS_12A,12A,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.004,NRAS_12A,12A,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.003,NRAS_12A,12A,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.004,NRAS_12A,12A,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.006,NRAS_12A,12A,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.009,NRAS_12A,12A,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0.001,0,0,0.007,NRAS_12A,12A,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.007,NRAS_12A,12A,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.01,NRAS_12A,12A,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.01,NRAS_12A,12A,NA
single,Age,NRAS,thymic tumor,<40,0,14,0.001,0,0,0.005,NRAS_12A,12A,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0,0,0,0.004,NRAS_12A,12A,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.004,NRAS_12A,12A,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.004,NRAS_12A,12A,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.008,NRAS_12A,12A,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.006,NRAS_12A,12A,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0.001,0,0,0.006,NRAS_12A,12A,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0.001,NRAS_12A,12A,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,germ cell tumor,<40,1,650,0.001,0.001,0,0.005,NRAS_12A,12A,NA
single,Age,NRAS,germ cell tumor,40-50,0,131,0.001,0.001,0,0.006,NRAS_12A,12A,NA
single,Age,NRAS,germ cell tumor,50-65,0,92,0.001,0.001,0,0.007,NRAS_12A,12A,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0.002,0.001,0,0.011,NRAS_12A,12A,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,NRAS_12A,12A,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,NRAS_12A,12A,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,NRAS_12A,12A,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,NRAS_12A,12A,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.003,0,0,0.032,NRAS_12A,12A,NA
single,Age,NRAS,penile cancer,>65,0,11,0.003,0,0,0.033,NRAS_12A,12A,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.003,0,0,0.035,NRAS_12A,12A,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,b cell lymphoma,50-65,0,357,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,b cell lymphoma,>65,0,413,0,0,0,0,NRAS_12A,12A,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.042,NRAS_12A,12A,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.001,0,0,0.01,NRAS_12A,12A,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.007,NRAS_12A,12A,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.027,NRAS_12A,12A,NA
single,Age,NRAS,lung cancer,>65,0,18,0.003,0,0,0.038,NRAS_12A,12A,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.054,NRAS_12A,12A,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0.004,0.002,0,0.016,NRAS_12C,12C,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0.003,0.002,0,0.014,NRAS_12C,12C,NA
single,Age,NRAS,appendiceal cancer,50-65,1,161,0.004,0.003,0,0.016,NRAS_12C,12C,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0.003,0.002,0,0.013,NRAS_12C,12C,NA
single,Age,NRAS,colorectal cancer,<40,1,565,0.002,0.002,0.001,0.005,NRAS_12C,12C,NA
single,Age,NRAS,colorectal cancer,40-50,3,1280,0.002,0.002,0.001,0.005,NRAS_12C,12C,NA
single,Age,NRAS,colorectal cancer,50-65,3,2814,0.002,0.002,0.001,0.003,NRAS_12C,12C,NA
single,Age,NRAS,colorectal cancer,>65,9,2052,0.003,0.003,0.002,0.006,NRAS_12C,12C,NA
single,Age,NRAS,cancer of unknown primary,<40,1,167,0.002,0.001,0,0.011,NRAS_12C,12C,NA
single,Age,NRAS,cancer of unknown primary,40-50,0,211,0.001,0.001,0,0.004,NRAS_12C,12C,NA
single,Age,NRAS,cancer of unknown primary,50-65,1,810,0.001,0.001,0,0.004,NRAS_12C,12C,NA
single,Age,NRAS,cancer of unknown primary,>65,0,796,0.001,0.001,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,non-small cell lung cancer,50-65,1,3677,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,non-small cell lung cancer,>65,2,5698,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0.001,0,0,0.002,NRAS_12C,12C,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,breast cancer,50-65,0,3989,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0.001,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0.001,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,pancreatic cancer,50-65,0,999,0,0,0,0.002,NRAS_12C,12C,NA
single,Age,NRAS,pancreatic cancer,>65,1,1205,0.001,0,0,0.002,NRAS_12C,12C,NA
single,Age,NRAS,leukemia,<40,3,204,0.009,0.007,0.002,0.026,NRAS_12C,12C,NA
single,Age,NRAS,leukemia,40-50,1,128,0.006,0.005,0.001,0.02,NRAS_12C,12C,NA
single,Age,NRAS,leukemia,50-65,0,515,0.003,0.003,0,0.009,NRAS_12C,12C,NA
single,Age,NRAS,leukemia,>65,4,720,0.005,0.005,0.002,0.011,NRAS_12C,12C,NA
single,Age,NRAS,melanoma,<40,0,289,0.004,0.004,0,0.008,NRAS_12C,12C,NA
single,Age,NRAS,melanoma,40-50,1,282,0.004,0.004,0.001,0.009,NRAS_12C,12C,NA
single,Age,NRAS,melanoma,50-65,3,1016,0.004,0.004,0.001,0.007,NRAS_12C,12C,NA
single,Age,NRAS,melanoma,>65,8,1259,0.005,0.005,0.002,0.009,NRAS_12C,12C,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0.001,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0.001,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,head and neck cancer,50-65,0,799,0.001,0,0,0.002,NRAS_12C,12C,NA
single,Age,NRAS,head and neck cancer,>65,1,582,0.001,0.001,0,0.004,NRAS_12C,12C,NA
single,Age,NRAS,uterine cancer,<40,0,57,0.003,0.002,0,0.008,NRAS_12C,12C,NA
single,Age,NRAS,uterine cancer,40-50,1,162,0.003,0.002,0.001,0.01,NRAS_12C,12C,NA
single,Age,NRAS,uterine cancer,50-65,3,1046,0.003,0.002,0.001,0.006,NRAS_12C,12C,NA
single,Age,NRAS,uterine cancer,>65,1,987,0.002,0.002,0,0.005,NRAS_12C,12C,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.001,0.001,0,0.005,NRAS_12C,12C,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.001,0.001,0,0.005,NRAS_12C,12C,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0.001,0.001,0,0.004,NRAS_12C,12C,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,1,664,0.001,0.001,0,0.004,NRAS_12C,12C,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,ovarian cancer,40-50,0,253,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,ovarian cancer,50-65,0,1092,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,ovarian cancer,>65,0,849,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,esophagogastric cancer,>65,0,725,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,thyroid cancer,<40,0,150,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,thyroid cancer,40-50,0,122,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,thyroid cancer,50-65,0,374,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,thyroid cancer,>65,0,370,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,cervical cancer,<40,0,85,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,cervical cancer,>65,0,36,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0.001,0.001,0,0.005,NRAS_12C,12C,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0.001,0.001,0,0.006,NRAS_12C,12C,NA
single,Age,NRAS,hepatobiliary cancer,50-65,0,525,0.001,0.001,0,0.004,NRAS_12C,12C,NA
single,Age,NRAS,hepatobiliary cancer,>65,2,601,0.002,0.002,0,0.007,NRAS_12C,12C,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,NRAS_12C,12C,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,NRAS_12C,12C,NA
single,Age,NRAS,cns cancer,<40,0,1602,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,cns cancer,40-50,1,687,0.001,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,cns cancer,50-65,1,1439,0.001,0,0,0.002,NRAS_12C,12C,NA
single,Age,NRAS,cns cancer,>65,0,836,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,prostate cancer,>65,0,1402,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,anal cancer,40-50,0,12,0,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,bladder cancer,<40,0,25,0.001,0.001,0,0.007,NRAS_12C,12C,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0.001,0,0,0.005,NRAS_12C,12C,NA
single,Age,NRAS,bladder cancer,50-65,0,511,0.001,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,bladder cancer,>65,1,961,0.001,0.001,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,1,142,0.006,0.004,0,0.02,NRAS_12C,12C,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.005,0.002,0,0.023,NRAS_12C,12C,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0.004,0.002,0,0.018,NRAS_12C,12C,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.004,0.002,0,0.018,NRAS_12C,12C,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.002,NRAS_12C,12C,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.007,NRAS_12C,12C,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.008,NRAS_12C,12C,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0.001,0,0,0.007,NRAS_12C,12C,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.007,NRAS_12C,12C,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.012,NRAS_12C,12C,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.011,NRAS_12C,12C,NA
single,Age,NRAS,thymic tumor,<40,0,14,0,0,0,0.005,NRAS_12C,12C,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0,0,0,0.004,NRAS_12C,12C,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.004,NRAS_12C,12C,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.004,NRAS_12C,12C,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.01,NRAS_12C,12C,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.008,NRAS_12C,12C,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0.001,0,0,0.007,NRAS_12C,12C,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0.001,NRAS_12C,12C,NA
single,Age,NRAS,germ cell tumor,<40,1,650,0.001,0.001,0,0.005,NRAS_12C,12C,NA
single,Age,NRAS,germ cell tumor,40-50,0,131,0.001,0.001,0,0.006,NRAS_12C,12C,NA
single,Age,NRAS,germ cell tumor,50-65,0,92,0.001,0.001,0,0.006,NRAS_12C,12C,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0.002,0.001,0,0.01,NRAS_12C,12C,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.002,NRAS_12C,12C,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.002,NRAS_12C,12C,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0,0,0,0.003,NRAS_12C,12C,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.002,0,0,0.025,NRAS_12C,12C,NA
single,Age,NRAS,penile cancer,>65,0,11,0.002,0,0,0.025,NRAS_12C,12C,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.003,0,0,0.041,NRAS_12C,12C,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,b cell lymphoma,50-65,0,357,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,b cell lymphoma,>65,0,413,0,0,0,0,NRAS_12C,12C,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.053,NRAS_12C,12C,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.001,0,0,0.014,NRAS_12C,12C,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.014,NRAS_12C,12C,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.02,NRAS_12C,12C,NA
single,Age,NRAS,lung cancer,>65,0,18,0.003,0,0,0.039,NRAS_12C,12C,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.003,0,0,0.035,NRAS_12C,12C,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,colorectal cancer,<40,5,565,0.008,0.008,0.005,0.013,NRAS_12D,12D,NA
single,Age,NRAS,colorectal cancer,40-50,13,1280,0.009,0.008,0.006,0.013,NRAS_12D,12D,NA
single,Age,NRAS,colorectal cancer,50-65,16,2814,0.007,0.007,0.004,0.01,NRAS_12D,12D,NA
single,Age,NRAS,colorectal cancer,>65,19,2052,0.008,0.008,0.006,0.012,NRAS_12D,12D,NA
single,Age,NRAS,cancer of unknown primary,<40,0,167,0.002,0.001,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,cancer of unknown primary,40-50,0,211,0.002,0.001,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,cancer of unknown primary,50-65,1,810,0.002,0.001,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,cancer of unknown primary,>65,2,796,0.002,0.002,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0.001,0.001,0,0.002,NRAS_12D,12D,NA
single,Age,NRAS,non-small cell lung cancer,40-50,0,585,0.001,0.001,0,0.002,NRAS_12D,12D,NA
single,Age,NRAS,non-small cell lung cancer,50-65,4,3677,0.001,0.001,0,0.002,NRAS_12D,12D,NA
single,Age,NRAS,non-small cell lung cancer,>65,4,5698,0.001,0.001,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0.001,0.001,0,0.003,NRAS_12D,12D,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,breast cancer,50-65,0,3989,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,soft tissue sarcoma,<40,1,672,0.001,0.001,0,0.003,NRAS_12D,12D,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0.001,0.001,0,0.003,NRAS_12D,12D,NA
single,Age,NRAS,soft tissue sarcoma,50-65,0,951,0.001,0.001,0,0.002,NRAS_12D,12D,NA
single,Age,NRAS,soft tissue sarcoma,>65,1,777,0.001,0.001,0,0.003,NRAS_12D,12D,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0.001,0,0,0.003,NRAS_12D,12D,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0.001,0,0,0.002,NRAS_12D,12D,NA
single,Age,NRAS,pancreatic cancer,50-65,0,999,0,0,0,0.002,NRAS_12D,12D,NA
single,Age,NRAS,pancreatic cancer,>65,1,1205,0.001,0,0,0.002,NRAS_12D,12D,NA
single,Age,NRAS,leukemia,<40,8,204,0.045,0.044,0.03,0.061,NRAS_12D,12D,NA
single,Age,NRAS,leukemia,40-50,8,128,0.048,0.047,0.033,0.072,NRAS_12D,12D,NA
single,Age,NRAS,leukemia,50-65,24,515,0.046,0.045,0.034,0.06,NRAS_12D,12D,NA
single,Age,NRAS,leukemia,>65,31,720,0.045,0.044,0.034,0.057,NRAS_12D,12D,NA
single,Age,NRAS,melanoma,<40,0,289,0.005,0.005,0,0.009,NRAS_12D,12D,NA
single,Age,NRAS,melanoma,40-50,1,282,0.005,0.005,0.001,0.01,NRAS_12D,12D,NA
single,Age,NRAS,melanoma,50-65,6,1016,0.006,0.006,0.003,0.01,NRAS_12D,12D,NA
single,Age,NRAS,melanoma,>65,10,1259,0.007,0.006,0.004,0.011,NRAS_12D,12D,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0.001,0.001,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0.001,0.001,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,head and neck cancer,50-65,3,799,0.003,0.002,0.001,0.008,NRAS_12D,12D,NA
single,Age,NRAS,head and neck cancer,>65,0,582,0.001,0.001,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,uterine cancer,<40,0,57,0.003,0.002,0,0.013,NRAS_12D,12D,NA
single,Age,NRAS,uterine cancer,40-50,0,162,0.002,0.002,0,0.008,NRAS_12D,12D,NA
single,Age,NRAS,uterine cancer,50-65,7,1046,0.005,0.005,0.002,0.011,NRAS_12D,12D,NA
single,Age,NRAS,uterine cancer,>65,1,987,0.002,0.002,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0.003,0.001,0,0.012,NRAS_12D,12D,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0.003,0.001,0,0.014,NRAS_12D,12D,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0.002,0.001,0,0.008,NRAS_12D,12D,NA
single,Age,NRAS,non-melanoma skin cancers,>65,1,317,0.003,0.002,0,0.009,NRAS_12D,12D,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,3,87,0.02,0.018,0.009,0.044,NRAS_12D,12D,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.015,0.015,0.002,0.027,NRAS_12D,12D,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,5,373,0.016,0.015,0.007,0.026,NRAS_12D,12D,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,12,664,0.017,0.017,0.01,0.027,NRAS_12D,12D,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0.001,0.001,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,ovarian cancer,40-50,1,253,0.002,0.001,0,0.007,NRAS_12D,12D,NA
single,Age,NRAS,ovarian cancer,50-65,1,1092,0.001,0.001,0,0.003,NRAS_12D,12D,NA
single,Age,NRAS,ovarian cancer,>65,0,849,0.001,0.001,0,0.003,NRAS_12D,12D,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,esophagogastric cancer,>65,0,725,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,thyroid cancer,<40,0,150,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,thyroid cancer,40-50,0,122,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,thyroid cancer,50-65,0,374,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,thyroid cancer,>65,0,370,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,cervical cancer,<40,0,85,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,cervical cancer,>65,0,36,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0.001,0,0,0.007,NRAS_12D,12D,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0.002,0,0,0.008,NRAS_12D,12D,NA
single,Age,NRAS,hepatobiliary cancer,50-65,0,525,0.001,0,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,hepatobiliary cancer,>65,4,601,0.006,0.005,0.001,0.013,NRAS_12D,12D,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,NRAS_12D,12D,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,NRAS_12D,12D,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,NRAS_12D,12D,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,NRAS_12D,12D,NA
single,Age,NRAS,cns cancer,<40,2,1602,0.001,0.001,0,0.003,NRAS_12D,12D,NA
single,Age,NRAS,cns cancer,40-50,0,687,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,cns cancer,50-65,0,1439,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,cns cancer,>65,0,836,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,prostate cancer,>65,0,1402,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,anal cancer,40-50,0,12,0.001,0,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0.004,0.002,0,0.018,NRAS_12D,12D,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0.003,0.002,0,0.014,NRAS_12D,12D,NA
single,Age,NRAS,neuroendocrine tumors,50-65,1,161,0.004,0.003,0,0.015,NRAS_12D,12D,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0.003,0.002,0,0.012,NRAS_12D,12D,NA
single,Age,NRAS,bladder cancer,<40,0,25,0.001,0,0,0.01,NRAS_12D,12D,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0.001,0,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,bladder cancer,50-65,1,511,0.001,0.001,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,bladder cancer,>65,0,961,0.001,0,0,0.002,NRAS_12D,12D,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,10,142,0.066,0.064,0.03,0.114,NRAS_12D,12D,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.011,0.001,0,0.068,NRAS_12D,12D,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0.006,0.001,0,0.043,NRAS_12D,12D,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.007,0.001,0,0.046,NRAS_12D,12D,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,NRAS_12D,12D,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,NRAS_12D,12D,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.002,NRAS_12D,12D,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0,NRAS_12D,12D,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,NRAS_12D,12D,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.008,NRAS_12D,12D,NA
single,Age,NRAS,thymic tumor,<40,0,14,0.001,0,0,0.006,NRAS_12D,12D,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0.001,0,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.008,NRAS_12D,12D,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.007,NRAS_12D,12D,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0.001,0,0,0.007,NRAS_12D,12D,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0.001,NRAS_12D,12D,NA
single,Age,NRAS,germ cell tumor,<40,1,650,0.002,0.002,0,0.006,NRAS_12D,12D,NA
single,Age,NRAS,germ cell tumor,40-50,1,131,0.004,0.003,0,0.016,NRAS_12D,12D,NA
single,Age,NRAS,germ cell tumor,50-65,0,92,0.002,0.002,0,0.009,NRAS_12D,12D,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0.003,0.002,0,0.016,NRAS_12D,12D,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,NRAS_12D,12D,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,NRAS_12D,12D,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.003,0,0,0.032,NRAS_12D,12D,NA
single,Age,NRAS,penile cancer,>65,0,11,0.003,0,0,0.031,NRAS_12D,12D,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.003,0,0,0.035,NRAS_12D,12D,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0.001,0.001,0,0.006,NRAS_12D,12D,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0.001,0.001,0,0.006,NRAS_12D,12D,NA
single,Age,NRAS,b cell lymphoma,50-65,1,357,0.002,0.001,0,0.007,NRAS_12D,12D,NA
single,Age,NRAS,b cell lymphoma,>65,0,413,0.001,0.001,0,0.004,NRAS_12D,12D,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.047,NRAS_12D,12D,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,1,27,0.043,0.032,0.002,0.141,NRAS_12D,12D,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,NRAS_12D,12D,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.025,NRAS_12D,12D,NA
single,Age,NRAS,lung cancer,>65,0,18,0.003,0,0,0.031,NRAS_12D,12D,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,NRAS_12D,12D,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,colorectal cancer,<40,0,565,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,colorectal cancer,40-50,0,1280,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,colorectal cancer,50-65,0,2814,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,colorectal cancer,>65,0,2052,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,cancer of unknown primary,<40,0,167,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,cancer of unknown primary,50-65,0,810,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,cancer of unknown primary,>65,0,796,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,breast cancer,50-65,0,3989,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,pancreatic cancer,50-65,0,999,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,pancreatic cancer,>65,0,1205,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,leukemia,<40,0,204,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,leukemia,40-50,0,128,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,leukemia,50-65,0,515,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,leukemia,>65,0,720,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,melanoma,<40,0,289,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,melanoma,40-50,0,282,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,melanoma,50-65,0,1016,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,melanoma,>65,0,1259,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,head and neck cancer,50-65,0,799,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,head and neck cancer,>65,0,582,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,uterine cancer,<40,0,57,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,uterine cancer,40-50,0,162,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,uterine cancer,50-65,0,1046,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,uterine cancer,>65,0,987,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,NRAS_12F,12F,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.005,NRAS_12F,12F,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,NRAS_12F,12F,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,NRAS_12F,12F,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,ovarian cancer,40-50,0,253,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,ovarian cancer,50-65,0,1092,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,ovarian cancer,>65,0,849,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,esophagogastric cancer,>65,0,725,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,thyroid cancer,<40,0,150,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,thyroid cancer,40-50,0,122,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,thyroid cancer,50-65,0,374,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,thyroid cancer,>65,0,370,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,cervical cancer,<40,0,85,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,cervical cancer,>65,0,36,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,NRAS_12F,12F,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,NRAS_12F,12F,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,NRAS_12F,12F,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,NRAS_12F,12F,NA
single,Age,NRAS,cns cancer,<40,0,1602,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,cns cancer,40-50,0,687,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,cns cancer,50-65,0,1439,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,cns cancer,>65,0,836,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,prostate cancer,>65,0,1402,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,anal cancer,40-50,0,12,0.001,0,0,0.005,NRAS_12F,12F,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.004,NRAS_12F,12F,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.004,NRAS_12F,12F,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,bladder cancer,<40,0,25,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,bladder cancer,50-65,0,511,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,bladder cancer,>65,0,961,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,NRAS_12F,12F,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,NRAS_12F,12F,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.002,NRAS_12F,12F,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.004,NRAS_12F,12F,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.004,NRAS_12F,12F,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.004,NRAS_12F,12F,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.004,NRAS_12F,12F,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,NRAS_12F,12F,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.008,NRAS_12F,12F,NA
single,Age,NRAS,thymic tumor,<40,0,14,0.001,0,0,0.006,NRAS_12F,12F,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0.001,0,0,0.005,NRAS_12F,12F,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.004,NRAS_12F,12F,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.005,NRAS_12F,12F,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.008,NRAS_12F,12F,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.007,NRAS_12F,12F,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0.001,0,0,0.007,NRAS_12F,12F,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,germ cell tumor,<40,0,650,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,germ cell tumor,40-50,0,131,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,germ cell tumor,50-65,0,92,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0,0,0,0.001,NRAS_12F,12F,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,NRAS_12F,12F,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,NRAS_12F,12F,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,NRAS_12F,12F,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,NRAS_12F,12F,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.003,0,0,0.032,NRAS_12F,12F,NA
single,Age,NRAS,penile cancer,>65,0,11,0.003,0,0,0.031,NRAS_12F,12F,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.003,0,0,0.035,NRAS_12F,12F,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,b cell lymphoma,50-65,0,357,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,b cell lymphoma,>65,0,413,0,0,0,0,NRAS_12F,12F,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.047,NRAS_12F,12F,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.018,NRAS_12F,12F,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,NRAS_12F,12F,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.025,NRAS_12F,12F,NA
single,Age,NRAS,lung cancer,>65,0,18,0.003,0,0,0.031,NRAS_12F,12F,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,NRAS_12F,12F,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,colorectal cancer,<40,0,565,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,colorectal cancer,40-50,0,1280,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,colorectal cancer,50-65,0,2814,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,colorectal cancer,>65,0,2052,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,cancer of unknown primary,<40,0,167,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,cancer of unknown primary,50-65,0,810,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,cancer of unknown primary,>65,0,796,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,breast cancer,50-65,0,3989,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,pancreatic cancer,50-65,0,999,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,pancreatic cancer,>65,0,1205,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,leukemia,<40,0,204,0.002,0.002,0,0.005,NRAS_12R,12R,NA
single,Age,NRAS,leukemia,40-50,0,128,0.002,0.002,0,0.006,NRAS_12R,12R,NA
single,Age,NRAS,leukemia,50-65,1,515,0.002,0.002,0,0.005,NRAS_12R,12R,NA
single,Age,NRAS,leukemia,>65,2,720,0.002,0.002,0,0.006,NRAS_12R,12R,NA
single,Age,NRAS,melanoma,<40,0,289,0.001,0.001,0,0.003,NRAS_12R,12R,NA
single,Age,NRAS,melanoma,40-50,0,282,0.001,0.001,0,0.003,NRAS_12R,12R,NA
single,Age,NRAS,melanoma,50-65,1,1016,0.001,0.001,0,0.003,NRAS_12R,12R,NA
single,Age,NRAS,melanoma,>65,2,1259,0.001,0.001,0,0.003,NRAS_12R,12R,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0.001,0,0,0.003,NRAS_12R,12R,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0.001,0,0,0.003,NRAS_12R,12R,NA
single,Age,NRAS,head and neck cancer,50-65,0,799,0.001,0,0,0.002,NRAS_12R,12R,NA
single,Age,NRAS,head and neck cancer,>65,1,582,0.001,0.001,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,uterine cancer,<40,0,57,0.001,0,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,uterine cancer,40-50,0,162,0.001,0,0,0.003,NRAS_12R,12R,NA
single,Age,NRAS,uterine cancer,50-65,1,1046,0.001,0,0,0.002,NRAS_12R,12R,NA
single,Age,NRAS,uterine cancer,>65,0,987,0,0,0,0.002,NRAS_12R,12R,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.002,0.001,0,0.01,NRAS_12R,12R,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.002,0.001,0,0.01,NRAS_12R,12R,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0.002,0.001,0,0.007,NRAS_12R,12R,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,5,664,0.006,0.006,0.002,0.014,NRAS_12R,12R,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,NRAS_12R,12R,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.005,NRAS_12R,12R,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,ovarian cancer,40-50,0,253,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,ovarian cancer,50-65,0,1092,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,ovarian cancer,>65,0,849,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,esophagogastric cancer,>65,0,725,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,thyroid cancer,<40,0,150,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,thyroid cancer,40-50,0,122,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,thyroid cancer,50-65,0,374,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,thyroid cancer,>65,0,370,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,cervical cancer,<40,0,85,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,cervical cancer,>65,0,36,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,NRAS_12R,12R,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,NRAS_12R,12R,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,NRAS_12R,12R,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,NRAS_12R,12R,NA
single,Age,NRAS,cns cancer,<40,0,1602,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,cns cancer,40-50,0,687,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,cns cancer,50-65,0,1439,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,cns cancer,>65,0,836,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,prostate cancer,>65,0,1402,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,anal cancer,40-50,0,12,0.001,0,0,0.005,NRAS_12R,12R,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,bladder cancer,<40,0,25,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,bladder cancer,50-65,0,511,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,bladder cancer,>65,0,961,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,NRAS_12R,12R,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,NRAS_12R,12R,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.002,NRAS_12R,12R,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,NRAS_12R,12R,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.008,NRAS_12R,12R,NA
single,Age,NRAS,thymic tumor,<40,0,14,0.001,0,0,0.006,NRAS_12R,12R,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0.001,0,0,0.005,NRAS_12R,12R,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.005,NRAS_12R,12R,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.008,NRAS_12R,12R,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.007,NRAS_12R,12R,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0.001,0,0,0.007,NRAS_12R,12R,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,germ cell tumor,<40,0,650,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,germ cell tumor,40-50,0,131,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,germ cell tumor,50-65,0,92,0,0,0,0,NRAS_12R,12R,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0,0,0,0.001,NRAS_12R,12R,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,NRAS_12R,12R,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,NRAS_12R,12R,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.003,0,0,0.032,NRAS_12R,12R,NA
single,Age,NRAS,penile cancer,>65,0,11,0.003,0,0,0.031,NRAS_12R,12R,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.003,0,0,0.035,NRAS_12R,12R,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0.001,0.001,0,0.006,NRAS_12R,12R,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0.001,0.001,0,0.006,NRAS_12R,12R,NA
single,Age,NRAS,b cell lymphoma,50-65,0,357,0.001,0.001,0,0.004,NRAS_12R,12R,NA
single,Age,NRAS,b cell lymphoma,>65,1,413,0.002,0.001,0,0.006,NRAS_12R,12R,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.047,NRAS_12R,12R,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.018,NRAS_12R,12R,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,NRAS_12R,12R,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.025,NRAS_12R,12R,NA
single,Age,NRAS,lung cancer,>65,0,18,0.003,0,0,0.031,NRAS_12R,12R,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,NRAS_12R,12R,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,appendiceal cancer,50-65,0,161,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,colorectal cancer,<40,0,565,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,colorectal cancer,40-50,0,1280,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,colorectal cancer,50-65,0,2814,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,colorectal cancer,>65,1,2052,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,cancer of unknown primary,<40,0,167,0.001,0,0,0.003,NRAS_12S,12S,NA
single,Age,NRAS,cancer of unknown primary,40-50,0,211,0.001,0,0,0.003,NRAS_12S,12S,NA
single,Age,NRAS,cancer of unknown primary,50-65,0,810,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,cancer of unknown primary,>65,1,796,0.001,0.001,0,0.003,NRAS_12S,12S,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,non-small cell lung cancer,50-65,1,3677,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,non-small cell lung cancer,>65,1,5698,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,breast cancer,50-65,1,3989,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,breast cancer,NA,0,10,0.001,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,pancreatic cancer,50-65,0,999,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,pancreatic cancer,>65,0,1205,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,leukemia,<40,1,204,0.004,0.004,0.001,0.011,NRAS_12S,12S,NA
single,Age,NRAS,leukemia,40-50,1,128,0.005,0.004,0.001,0.014,NRAS_12S,12S,NA
single,Age,NRAS,leukemia,50-65,3,515,0.004,0.004,0.001,0.01,NRAS_12S,12S,NA
single,Age,NRAS,leukemia,>65,1,720,0.003,0.003,0.001,0.007,NRAS_12S,12S,NA
single,Age,NRAS,melanoma,<40,0,289,0.002,0.002,0,0.005,NRAS_12S,12S,NA
single,Age,NRAS,melanoma,40-50,1,282,0.002,0.002,0.001,0.007,NRAS_12S,12S,NA
single,Age,NRAS,melanoma,50-65,1,1016,0.002,0.002,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,melanoma,>65,4,1259,0.002,0.002,0.001,0.005,NRAS_12S,12S,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,head and neck cancer,50-65,0,799,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,head and neck cancer,>65,0,582,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,uterine cancer,<40,0,57,0.001,0.001,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,uterine cancer,40-50,0,162,0.001,0.001,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,uterine cancer,50-65,1,1046,0.001,0.001,0,0.003,NRAS_12S,12S,NA
single,Age,NRAS,uterine cancer,>65,1,987,0.001,0.001,0,0.003,NRAS_12S,12S,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.005,0.005,0,0.014,NRAS_12S,12S,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.005,0.005,0,0.014,NRAS_12S,12S,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,1,373,0.005,0.005,0,0.012,NRAS_12S,12S,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,7,664,0.008,0.008,0.003,0.017,NRAS_12S,12S,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,NRAS_12S,12S,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,NRAS_12S,12S,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,NRAS_12S,12S,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,ovarian cancer,40-50,0,253,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,ovarian cancer,50-65,0,1092,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,ovarian cancer,>65,0,849,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0.001,0,0,0.003,NRAS_12S,12S,NA
single,Age,NRAS,esophagogastric cancer,40-50,0,200,0.001,0,0,0.003,NRAS_12S,12S,NA
single,Age,NRAS,esophagogastric cancer,50-65,1,752,0.001,0.001,0,0.003,NRAS_12S,12S,NA
single,Age,NRAS,esophagogastric cancer,>65,0,725,0.001,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,thyroid cancer,<40,0,150,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,thyroid cancer,40-50,0,122,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,thyroid cancer,50-65,0,374,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,thyroid cancer,>65,0,370,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,cervical cancer,<40,0,85,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,cervical cancer,>65,0,36,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0.002,0.001,0,0.005,NRAS_12S,12S,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0.002,0.001,0,0.005,NRAS_12S,12S,NA
single,Age,NRAS,hepatobiliary cancer,50-65,1,525,0.002,0.001,0,0.005,NRAS_12S,12S,NA
single,Age,NRAS,hepatobiliary cancer,>65,1,601,0.002,0.001,0,0.005,NRAS_12S,12S,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,cns cancer,<40,1,1602,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,cns cancer,40-50,0,687,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,cns cancer,50-65,0,1439,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,cns cancer,>65,0,836,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,prostate cancer,>65,0,1402,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,anal cancer,40-50,0,12,0.001,0,0,0.006,NRAS_12S,12S,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,bladder cancer,<40,0,25,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,bladder cancer,50-65,0,511,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,bladder cancer,>65,0,961,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,4,142,0.022,0.02,0.006,0.052,NRAS_12S,12S,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.012,0.009,0,0.045,NRAS_12S,12S,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0.01,0.007,0,0.035,NRAS_12S,12S,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.01,0.007,0,0.036,NRAS_12S,12S,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.002,NRAS_12S,12S,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.005,NRAS_12S,12S,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,NRAS_12S,12S,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.008,NRAS_12S,12S,NA
single,Age,NRAS,thymic tumor,<40,0,14,0.001,0,0,0.005,NRAS_12S,12S,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0,0,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.007,NRAS_12S,12S,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.006,NRAS_12S,12S,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0.001,0,0,0.006,NRAS_12S,12S,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0.001,NRAS_12S,12S,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0,NRAS_12S,12S,NA
single,Age,NRAS,germ cell tumor,<40,0,650,0.001,0,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,germ cell tumor,40-50,1,131,0.004,0.002,0,0.019,NRAS_12S,12S,NA
single,Age,NRAS,germ cell tumor,50-65,0,92,0.001,0.001,0,0.008,NRAS_12S,12S,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0.003,0.001,0,0.024,NRAS_12S,12S,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.005,NRAS_12S,12S,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,NRAS_12S,12S,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0,0,0,0.005,NRAS_12S,12S,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.003,0,0,0.034,NRAS_12S,12S,NA
single,Age,NRAS,penile cancer,>65,0,11,0.003,0,0,0.036,NRAS_12S,12S,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.004,0,0,0.051,NRAS_12S,12S,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0.002,0.002,0,0.008,NRAS_12S,12S,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0.002,0.002,0,0.008,NRAS_12S,12S,NA
single,Age,NRAS,b cell lymphoma,50-65,1,357,0.002,0.002,0,0.007,NRAS_12S,12S,NA
single,Age,NRAS,b cell lymphoma,>65,1,413,0.002,0.002,0,0.007,NRAS_12S,12S,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.044,NRAS_12S,12S,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,1,27,0.042,0.032,0.002,0.138,NRAS_12S,12S,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.01,NRAS_12S,12S,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.023,NRAS_12S,12S,NA
single,Age,NRAS,lung cancer,>65,0,18,0.002,0,0,0.027,NRAS_12S,12S,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.006,0,0,0.067,NRAS_12S,12S,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,colorectal cancer,<40,1,565,0.001,0.001,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,colorectal cancer,40-50,1,1280,0.001,0.001,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,colorectal cancer,50-65,1,2814,0.001,0.001,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,colorectal cancer,>65,4,2052,0.001,0.001,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,cancer of unknown primary,<40,0,167,0.002,0.001,0,0.005,NRAS_12V,12V,NA
single,Age,NRAS,cancer of unknown primary,40-50,0,211,0.002,0.001,0,0.004,NRAS_12V,12V,NA
single,Age,NRAS,cancer of unknown primary,50-65,2,810,0.002,0.002,0,0.005,NRAS_12V,12V,NA
single,Age,NRAS,cancer of unknown primary,>65,1,796,0.002,0.001,0,0.004,NRAS_12V,12V,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,non-small cell lung cancer,50-65,1,3677,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,non-small cell lung cancer,>65,2,5698,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0.001,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,breast cancer,50-65,0,3989,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,soft tissue sarcoma,<40,0,672,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,soft tissue sarcoma,>65,1,777,0.001,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,pancreatic cancer,50-65,0,999,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,pancreatic cancer,>65,0,1205,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,leukemia,<40,0,204,0.004,0.004,0,0.01,NRAS_12V,12V,NA
single,Age,NRAS,leukemia,40-50,1,128,0.006,0.005,0.001,0.016,NRAS_12V,12V,NA
single,Age,NRAS,leukemia,50-65,1,515,0.004,0.004,0.001,0.009,NRAS_12V,12V,NA
single,Age,NRAS,leukemia,>65,6,720,0.006,0.006,0.002,0.013,NRAS_12V,12V,NA
single,Age,NRAS,melanoma,<40,0,289,0.001,0.001,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,melanoma,40-50,0,282,0.001,0.001,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,melanoma,50-65,2,1016,0.001,0.001,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,melanoma,>65,1,1259,0.001,0.001,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,head and neck cancer,50-65,0,799,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,head and neck cancer,>65,0,582,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,uterine cancer,<40,0,57,0.001,0,0,0.007,NRAS_12V,12V,NA
single,Age,NRAS,uterine cancer,40-50,1,162,0.004,0.002,0,0.018,NRAS_12V,12V,NA
single,Age,NRAS,uterine cancer,50-65,0,1046,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,uterine cancer,>65,0,987,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.003,0.002,0,0.008,NRAS_12V,12V,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.003,0.002,0,0.008,NRAS_12V,12V,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,1,373,0.003,0.002,0,0.007,NRAS_12V,12V,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,2,664,0.003,0.002,0.001,0.007,NRAS_12V,12V,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,NRAS_12V,12V,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.006,NRAS_12V,12V,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.005,NRAS_12V,12V,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0.001,0,0,0.006,NRAS_12V,12V,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,ovarian cancer,40-50,0,253,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,ovarian cancer,50-65,0,1092,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,ovarian cancer,>65,0,849,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,esophagogastric cancer,>65,0,725,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,thyroid cancer,<40,0,150,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,thyroid cancer,40-50,0,122,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,thyroid cancer,50-65,0,374,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,thyroid cancer,>65,0,370,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,cervical cancer,<40,0,85,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,cervical cancer,>65,0,36,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0.001,0,0,0.004,NRAS_12V,12V,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0.001,0,0,0.004,NRAS_12V,12V,NA
single,Age,NRAS,hepatobiliary cancer,50-65,1,525,0.001,0.001,0,0.005,NRAS_12V,12V,NA
single,Age,NRAS,hepatobiliary cancer,>65,0,601,0.001,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,cns cancer,<40,0,1602,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,cns cancer,40-50,0,687,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,cns cancer,50-65,0,1439,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,cns cancer,>65,0,836,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,prostate cancer,>65,0,1402,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,anal cancer,40-50,0,12,0,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,bladder cancer,<40,0,25,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,bladder cancer,50-65,0,511,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,bladder cancer,>65,0,961,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.005,NRAS_12V,12V,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.005,NRAS_12V,12V,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.005,NRAS_12V,12V,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.005,NRAS_12V,12V,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.011,NRAS_12V,12V,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.011,NRAS_12V,12V,NA
single,Age,NRAS,thymic tumor,<40,0,14,0,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.004,NRAS_12V,12V,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0,0,0,0.004,NRAS_12V,12V,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0,0,0,0.003,NRAS_12V,12V,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0,0,0,0.002,NRAS_12V,12V,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,NRAS_12V,12V,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0,NRAS_12V,12V,NA
single,Age,NRAS,germ cell tumor,<40,2,650,0.003,0.002,0,0.007,NRAS_12V,12V,NA
single,Age,NRAS,germ cell tumor,40-50,0,131,0.002,0.002,0,0.008,NRAS_12V,12V,NA
single,Age,NRAS,germ cell tumor,50-65,0,92,0.002,0.002,0,0.008,NRAS_12V,12V,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0.003,0.002,0,0.014,NRAS_12V,12V,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.006,NRAS_12V,12V,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0.001,0,0,0.007,NRAS_12V,12V,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0.001,0,0,0.006,NRAS_12V,12V,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.008,NRAS_12V,12V,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.003,0,0,0.033,NRAS_12V,12V,NA
single,Age,NRAS,penile cancer,>65,0,11,0.003,0,0,0.03,NRAS_12V,12V,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.003,0,0,0.034,NRAS_12V,12V,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0.001,0.001,0,0.006,NRAS_12V,12V,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0.001,0.001,0,0.005,NRAS_12V,12V,NA
single,Age,NRAS,b cell lymphoma,50-65,1,357,0.002,0.001,0,0.007,NRAS_12V,12V,NA
single,Age,NRAS,b cell lymphoma,>65,0,413,0.001,0.001,0,0.004,NRAS_12V,12V,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,1,14,0.08,0.061,0.004,0.26,NRAS_12V,12V,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.001,0,0,0.017,NRAS_12V,12V,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.01,NRAS_12V,12V,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.028,NRAS_12V,12V,NA
single,Age,NRAS,lung cancer,>65,0,18,0.003,0,0,0.038,NRAS_12V,12V,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.053,NRAS_12V,12V,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,colorectal cancer,<40,0,565,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,colorectal cancer,40-50,1,1280,0.001,0,0,0.002,NRAS_13C,13C,NA
single,Age,NRAS,colorectal cancer,50-65,1,2814,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,colorectal cancer,>65,1,2052,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,cancer of unknown primary,<40,0,167,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,cancer of unknown primary,50-65,0,810,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,cancer of unknown primary,>65,0,796,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,breast cancer,50-65,0,3989,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,pancreatic cancer,50-65,0,999,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,pancreatic cancer,>65,0,1205,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,leukemia,<40,1,204,0.002,0.001,0,0.013,NRAS_13C,13C,NA
single,Age,NRAS,leukemia,40-50,0,128,0.001,0,0,0.004,NRAS_13C,13C,NA
single,Age,NRAS,leukemia,50-65,0,515,0.001,0,0,0.003,NRAS_13C,13C,NA
single,Age,NRAS,leukemia,>65,0,720,0,0,0,0.002,NRAS_13C,13C,NA
single,Age,NRAS,melanoma,<40,0,289,0.001,0.001,0,0.004,NRAS_13C,13C,NA
single,Age,NRAS,melanoma,40-50,1,282,0.002,0.002,0,0.008,NRAS_13C,13C,NA
single,Age,NRAS,melanoma,50-65,0,1016,0.001,0.001,0,0.003,NRAS_13C,13C,NA
single,Age,NRAS,melanoma,>65,3,1259,0.002,0.002,0,0.004,NRAS_13C,13C,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,head and neck cancer,50-65,0,799,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,head and neck cancer,>65,0,582,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,uterine cancer,<40,0,57,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,uterine cancer,40-50,0,162,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,uterine cancer,50-65,0,1046,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,uterine cancer,>65,0,987,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.002,0.001,0,0.01,NRAS_13C,13C,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.003,0.001,0,0.011,NRAS_13C,13C,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0.002,0.001,0,0.007,NRAS_13C,13C,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,5,664,0.006,0.006,0.002,0.014,NRAS_13C,13C,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.005,NRAS_13C,13C,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.006,NRAS_13C,13C,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.005,NRAS_13C,13C,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0.001,0,0,0.006,NRAS_13C,13C,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,ovarian cancer,40-50,0,253,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,ovarian cancer,50-65,0,1092,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,ovarian cancer,>65,0,849,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,esophagogastric cancer,>65,0,725,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,thyroid cancer,<40,0,150,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,thyroid cancer,40-50,0,122,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,thyroid cancer,50-65,0,374,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,thyroid cancer,>65,0,370,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,cervical cancer,<40,0,85,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,cervical cancer,>65,0,36,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,NRAS_13C,13C,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,NRAS_13C,13C,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,NRAS_13C,13C,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,NRAS_13C,13C,NA
single,Age,NRAS,cns cancer,<40,0,1602,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,cns cancer,40-50,0,687,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,cns cancer,50-65,0,1439,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,cns cancer,>65,0,836,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,prostate cancer,>65,0,1402,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,anal cancer,40-50,0,12,0,0,0,0.003,NRAS_13C,13C,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.002,NRAS_13C,13C,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.002,NRAS_13C,13C,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,bladder cancer,<40,0,25,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,bladder cancer,50-65,0,511,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,bladder cancer,>65,0,961,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.002,NRAS_13C,13C,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.003,NRAS_13C,13C,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.003,NRAS_13C,13C,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.002,NRAS_13C,13C,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,NRAS_13C,13C,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,NRAS_13C,13C,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.002,NRAS_13C,13C,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.005,NRAS_13C,13C,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.005,NRAS_13C,13C,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.005,NRAS_13C,13C,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.005,NRAS_13C,13C,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.011,NRAS_13C,13C,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.011,NRAS_13C,13C,NA
single,Age,NRAS,thymic tumor,<40,0,14,0,0,0,0.003,NRAS_13C,13C,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0,0,0,0.003,NRAS_13C,13C,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.003,NRAS_13C,13C,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.003,NRAS_13C,13C,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.004,NRAS_13C,13C,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0,0,0,0.004,NRAS_13C,13C,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0,0,0,0.003,NRAS_13C,13C,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0,0,0,0.003,NRAS_13C,13C,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0,0,0,0.002,NRAS_13C,13C,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,germ cell tumor,<40,0,650,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,germ cell tumor,40-50,0,131,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,germ cell tumor,50-65,0,92,0,0,0,0,NRAS_13C,13C,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0,0,0,0.001,NRAS_13C,13C,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.006,NRAS_13C,13C,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0.001,0,0,0.007,NRAS_13C,13C,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0.001,0,0,0.006,NRAS_13C,13C,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.008,NRAS_13C,13C,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.003,0,0,0.033,NRAS_13C,13C,NA
single,Age,NRAS,penile cancer,>65,0,11,0.003,0,0,0.03,NRAS_13C,13C,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.003,0,0,0.034,NRAS_13C,13C,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0.001,0.001,0,0.006,NRAS_13C,13C,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0.001,0.001,0,0.005,NRAS_13C,13C,NA
single,Age,NRAS,b cell lymphoma,50-65,1,357,0.002,0.001,0,0.007,NRAS_13C,13C,NA
single,Age,NRAS,b cell lymphoma,>65,0,413,0.001,0.001,0,0.004,NRAS_13C,13C,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.051,NRAS_13C,13C,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.001,0,0,0.017,NRAS_13C,13C,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.01,NRAS_13C,13C,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.028,NRAS_13C,13C,NA
single,Age,NRAS,lung cancer,>65,0,18,0.003,0,0,0.038,NRAS_13C,13C,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.053,NRAS_13C,13C,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,NRAS_13D,13D,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0,0,0,0.002,NRAS_13D,13D,NA
single,Age,NRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0,0,0,0.002,NRAS_13D,13D,NA
single,Age,NRAS,colorectal cancer,<40,1,565,0.002,0.002,0.001,0.004,NRAS_13D,13D,NA
single,Age,NRAS,colorectal cancer,40-50,2,1280,0.002,0.002,0.001,0.003,NRAS_13D,13D,NA
single,Age,NRAS,colorectal cancer,50-65,3,2814,0.002,0.002,0.001,0.003,NRAS_13D,13D,NA
single,Age,NRAS,colorectal cancer,>65,6,2052,0.002,0.002,0.001,0.004,NRAS_13D,13D,NA
single,Age,NRAS,cancer of unknown primary,<40,0,167,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,cancer of unknown primary,50-65,0,810,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,cancer of unknown primary,>65,0,796,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,non-small cell lung cancer,>65,0,5698,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,breast cancer,50-65,1,3989,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,soft tissue sarcoma,<40,2,672,0.002,0.001,0,0.006,NRAS_13D,13D,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0.001,0.001,0,0.003,NRAS_13D,13D,NA
single,Age,NRAS,soft tissue sarcoma,50-65,0,951,0.001,0.001,0,0.003,NRAS_13D,13D,NA
single,Age,NRAS,soft tissue sarcoma,>65,1,777,0.001,0.001,0,0.004,NRAS_13D,13D,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,pancreatic cancer,50-65,0,999,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,pancreatic cancer,>65,0,1205,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,leukemia,<40,6,204,0.022,0.021,0.013,0.037,NRAS_13D,13D,NA
single,Age,NRAS,leukemia,40-50,2,128,0.02,0.02,0.011,0.033,NRAS_13D,13D,NA
single,Age,NRAS,leukemia,50-65,10,515,0.02,0.02,0.013,0.03,NRAS_13D,13D,NA
single,Age,NRAS,leukemia,>65,14,720,0.02,0.02,0.013,0.029,NRAS_13D,13D,NA
single,Age,NRAS,melanoma,<40,0,289,0.002,0.002,0,0.006,NRAS_13D,13D,NA
single,Age,NRAS,melanoma,40-50,0,282,0.002,0.002,0,0.006,NRAS_13D,13D,NA
single,Age,NRAS,melanoma,50-65,4,1016,0.003,0.003,0.001,0.007,NRAS_13D,13D,NA
single,Age,NRAS,melanoma,>65,4,1259,0.003,0.003,0.001,0.006,NRAS_13D,13D,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,head and neck cancer,50-65,0,799,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,head and neck cancer,>65,0,582,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,uterine cancer,<40,1,57,0.012,0.007,0,0.056,NRAS_13D,13D,NA
single,Age,NRAS,uterine cancer,40-50,0,162,0.001,0,0,0.004,NRAS_13D,13D,NA
single,Age,NRAS,uterine cancer,50-65,0,1046,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,uterine cancer,>65,0,987,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,3,87,0.016,0.011,0.004,0.055,NRAS_13D,13D,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.007,0.006,0,0.018,NRAS_13D,13D,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,3,373,0.008,0.007,0.003,0.017,NRAS_13D,13D,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,3,664,0.006,0.006,0.002,0.013,NRAS_13D,13D,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,NRAS_13D,13D,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.003,NRAS_13D,13D,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.003,NRAS_13D,13D,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.003,NRAS_13D,13D,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,ovarian cancer,40-50,0,253,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,ovarian cancer,50-65,0,1092,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,ovarian cancer,>65,0,849,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0.001,0,0,0.003,NRAS_13D,13D,NA
single,Age,NRAS,esophagogastric cancer,40-50,0,200,0.001,0,0,0.003,NRAS_13D,13D,NA
single,Age,NRAS,esophagogastric cancer,50-65,1,752,0.001,0.001,0,0.003,NRAS_13D,13D,NA
single,Age,NRAS,esophagogastric cancer,>65,0,725,0.001,0,0,0.002,NRAS_13D,13D,NA
single,Age,NRAS,thyroid cancer,<40,0,150,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,thyroid cancer,40-50,0,122,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,thyroid cancer,50-65,0,374,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,thyroid cancer,>65,0,370,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,cervical cancer,<40,0,85,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,cervical cancer,>65,0,36,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,NRAS_13D,13D,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,NRAS_13D,13D,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,NRAS_13D,13D,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,NRAS_13D,13D,NA
single,Age,NRAS,cns cancer,<40,0,1602,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,cns cancer,40-50,0,687,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,cns cancer,50-65,1,1439,0,0,0,0.002,NRAS_13D,13D,NA
single,Age,NRAS,cns cancer,>65,0,836,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,prostate cancer,>65,0,1402,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,anal cancer,40-50,0,12,0.001,0,0,0.006,NRAS_13D,13D,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.004,NRAS_13D,13D,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.005,NRAS_13D,13D,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0.004,0.002,0,0.018,NRAS_13D,13D,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0.003,0.002,0,0.013,NRAS_13D,13D,NA
single,Age,NRAS,neuroendocrine tumors,50-65,1,161,0.004,0.003,0,0.016,NRAS_13D,13D,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0.003,0.002,0,0.012,NRAS_13D,13D,NA
single,Age,NRAS,bladder cancer,<40,0,25,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,bladder cancer,50-65,0,511,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,bladder cancer,>65,0,961,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,5,142,0.028,0.026,0.01,0.057,NRAS_13D,13D,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.021,0.02,0,0.057,NRAS_13D,13D,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,1,48,0.023,0.021,0.003,0.057,NRAS_13D,13D,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.019,0.018,0,0.048,NRAS_13D,13D,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,NRAS_13D,13D,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,NRAS_13D,13D,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.003,NRAS_13D,13D,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.004,NRAS_13D,13D,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.005,NRAS_13D,13D,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.005,NRAS_13D,13D,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.004,NRAS_13D,13D,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,NRAS_13D,13D,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.007,NRAS_13D,13D,NA
single,Age,NRAS,thymic tumor,<40,0,14,0.001,0,0,0.006,NRAS_13D,13D,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0,0,0,0.004,NRAS_13D,13D,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.004,NRAS_13D,13D,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.004,NRAS_13D,13D,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.007,NRAS_13D,13D,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0,0,0,0.005,NRAS_13D,13D,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0,0,0,0.005,NRAS_13D,13D,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,NRAS_13D,13D,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0.001,NRAS_13D,13D,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0,NRAS_13D,13D,NA
single,Age,NRAS,germ cell tumor,<40,1,650,0.001,0.001,0,0.005,NRAS_13D,13D,NA
single,Age,NRAS,germ cell tumor,40-50,0,131,0.001,0.001,0,0.006,NRAS_13D,13D,NA
single,Age,NRAS,germ cell tumor,50-65,0,92,0.001,0.001,0,0.007,NRAS_13D,13D,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0.002,0.001,0,0.013,NRAS_13D,13D,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,NRAS_13D,13D,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,NRAS_13D,13D,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.005,NRAS_13D,13D,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0,0,0,0.005,NRAS_13D,13D,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.004,0,0,0.045,NRAS_13D,13D,NA
single,Age,NRAS,penile cancer,>65,0,11,0.004,0,0,0.046,NRAS_13D,13D,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.004,0,0,0.047,NRAS_13D,13D,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0.002,0.002,0,0.008,NRAS_13D,13D,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0.002,0.002,0,0.007,NRAS_13D,13D,NA
single,Age,NRAS,b cell lymphoma,50-65,1,357,0.002,0.002,0,0.007,NRAS_13D,13D,NA
single,Age,NRAS,b cell lymphoma,>65,1,413,0.002,0.002,0,0.007,NRAS_13D,13D,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.045,NRAS_13D,13D,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.022,NRAS_13D,13D,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.009,NRAS_13D,13D,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.019,NRAS_13D,13D,NA
single,Age,NRAS,lung cancer,>65,0,18,0.003,0,0,0.035,NRAS_13D,13D,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.002,0,0,0.025,NRAS_13D,13D,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0.004,0.002,0,0.016,NRAS_13R,13R,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0.003,0.002,0,0.014,NRAS_13R,13R,NA
single,Age,NRAS,appendiceal cancer,50-65,1,161,0.004,0.003,0,0.015,NRAS_13R,13R,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0.003,0.002,0,0.013,NRAS_13R,13R,NA
single,Age,NRAS,colorectal cancer,<40,0,565,0.002,0.002,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,colorectal cancer,40-50,1,1280,0.002,0.002,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,colorectal cancer,50-65,13,2814,0.004,0.004,0.002,0.007,NRAS_13R,13R,NA
single,Age,NRAS,colorectal cancer,>65,5,2052,0.003,0.002,0.001,0.005,NRAS_13R,13R,NA
single,Age,NRAS,cancer of unknown primary,<40,1,167,0.003,0.003,0.001,0.01,NRAS_13R,13R,NA
single,Age,NRAS,cancer of unknown primary,40-50,1,211,0.003,0.003,0.001,0.008,NRAS_13R,13R,NA
single,Age,NRAS,cancer of unknown primary,50-65,2,810,0.003,0.002,0.001,0.006,NRAS_13R,13R,NA
single,Age,NRAS,cancer of unknown primary,>65,1,796,0.002,0.002,0.001,0.005,NRAS_13R,13R,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,non-small cell lung cancer,>65,2,5698,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0.001,0,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,breast cancer,50-65,0,3989,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,pancreatic cancer,50-65,0,999,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,pancreatic cancer,>65,0,1205,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,leukemia,<40,1,204,0.005,0.004,0.001,0.011,NRAS_13R,13R,NA
single,Age,NRAS,leukemia,40-50,0,128,0.004,0.004,0,0.01,NRAS_13R,13R,NA
single,Age,NRAS,leukemia,50-65,3,515,0.005,0.005,0.002,0.01,NRAS_13R,13R,NA
single,Age,NRAS,leukemia,>65,3,720,0.005,0.004,0.002,0.009,NRAS_13R,13R,NA
single,Age,NRAS,melanoma,<40,1,289,0.007,0.006,0.002,0.012,NRAS_13R,13R,NA
single,Age,NRAS,melanoma,40-50,1,282,0.007,0.006,0.002,0.012,NRAS_13R,13R,NA
single,Age,NRAS,melanoma,50-65,9,1016,0.008,0.007,0.004,0.012,NRAS_13R,13R,NA
single,Age,NRAS,melanoma,>65,9,1259,0.007,0.007,0.004,0.011,NRAS_13R,13R,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0.001,0.001,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0.001,0.001,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,head and neck cancer,50-65,1,799,0.001,0.001,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,head and neck cancer,>65,1,582,0.001,0.001,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,uterine cancer,<40,0,57,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,uterine cancer,40-50,0,162,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,uterine cancer,50-65,0,1046,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,uterine cancer,>65,0,987,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.001,0.001,0,0.005,NRAS_13R,13R,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.001,0.001,0,0.005,NRAS_13R,13R,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0.001,0,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,1,664,0.001,0.001,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0.008,0.004,0,0.034,NRAS_13R,13R,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0.007,0.004,0,0.034,NRAS_13R,13R,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0.007,0.004,0,0.03,NRAS_13R,13R,NA
single,Age,NRAS,adrenocortical carcinoma,>65,1,26,0.018,0.01,0.001,0.088,NRAS_13R,13R,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,ovarian cancer,40-50,0,253,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,ovarian cancer,50-65,0,1092,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,ovarian cancer,>65,0,849,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,esophagogastric cancer,>65,0,725,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,thyroid cancer,<40,0,150,0.001,0,0,0.006,NRAS_13R,13R,NA
single,Age,NRAS,thyroid cancer,40-50,0,122,0.001,0.001,0,0.006,NRAS_13R,13R,NA
single,Age,NRAS,thyroid cancer,50-65,0,374,0.001,0,0,0.005,NRAS_13R,13R,NA
single,Age,NRAS,thyroid cancer,>65,2,370,0.004,0.003,0,0.013,NRAS_13R,13R,NA
single,Age,NRAS,cervical cancer,<40,0,85,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,cervical cancer,>65,0,36,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0.002,0.002,0,0.006,NRAS_13R,13R,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0.002,0.002,0,0.007,NRAS_13R,13R,NA
single,Age,NRAS,hepatobiliary cancer,50-65,2,525,0.003,0.002,0.001,0.007,NRAS_13R,13R,NA
single,Age,NRAS,hepatobiliary cancer,>65,1,601,0.002,0.002,0,0.006,NRAS_13R,13R,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.003,NRAS_13R,13R,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.003,NRAS_13R,13R,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,NRAS_13R,13R,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,NRAS_13R,13R,NA
single,Age,NRAS,cns cancer,<40,0,1602,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,cns cancer,40-50,0,687,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,cns cancer,50-65,0,1439,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,cns cancer,>65,0,836,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,prostate cancer,>65,0,1402,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,anal cancer,40-50,0,12,0.001,0,0,0.006,NRAS_13R,13R,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.005,NRAS_13R,13R,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,bladder cancer,<40,0,25,0.002,0.001,0,0.01,NRAS_13R,13R,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0.001,0.001,0,0.006,NRAS_13R,13R,NA
single,Age,NRAS,bladder cancer,50-65,0,511,0.001,0.001,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,bladder cancer,>65,2,961,0.002,0.001,0,0.005,NRAS_13R,13R,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,1,142,0.005,0.004,0,0.019,NRAS_13R,13R,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.005,0.003,0,0.023,NRAS_13R,13R,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0.005,0.003,0,0.019,NRAS_13R,13R,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.005,0.003,0,0.02,NRAS_13R,13R,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.003,NRAS_13R,13R,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,NRAS_13R,13R,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.003,NRAS_13R,13R,NA
single,Age,NRAS,sex cord stromal tumor,<40,1,29,0.018,0.011,0.001,0.079,NRAS_13R,13R,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0.01,0.006,0,0.043,NRAS_13R,13R,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0.009,0.005,0,0.036,NRAS_13R,13R,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0.009,0.005,0,0.039,NRAS_13R,13R,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.008,NRAS_13R,13R,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.007,NRAS_13R,13R,NA
single,Age,NRAS,thymic tumor,<40,0,14,0.001,0,0,0.006,NRAS_13R,13R,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0,0,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.007,NRAS_13R,13R,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0,0,0,0.005,NRAS_13R,13R,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0,0,0,0.005,NRAS_13R,13R,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,NRAS_13R,13R,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0.001,NRAS_13R,13R,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0,NRAS_13R,13R,NA
single,Age,NRAS,germ cell tumor,<40,1,650,0.002,0.002,0,0.006,NRAS_13R,13R,NA
single,Age,NRAS,germ cell tumor,40-50,1,131,0.004,0.003,0,0.014,NRAS_13R,13R,NA
single,Age,NRAS,germ cell tumor,50-65,0,92,0.003,0.002,0,0.009,NRAS_13R,13R,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0.004,0.002,0,0.015,NRAS_13R,13R,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.005,NRAS_13R,13R,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0,0,0,0.005,NRAS_13R,13R,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.004,0,0,0.045,NRAS_13R,13R,NA
single,Age,NRAS,penile cancer,>65,0,11,0.004,0,0,0.046,NRAS_13R,13R,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.004,0,0,0.047,NRAS_13R,13R,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0.001,0.001,0,0.006,NRAS_13R,13R,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0.001,0.001,0,0.006,NRAS_13R,13R,NA
single,Age,NRAS,b cell lymphoma,50-65,1,357,0.002,0.001,0,0.006,NRAS_13R,13R,NA
single,Age,NRAS,b cell lymphoma,>65,0,413,0.001,0.001,0,0.004,NRAS_13R,13R,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,1,14,0.08,0.061,0.004,0.26,NRAS_13R,13R,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.022,NRAS_13R,13R,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.009,NRAS_13R,13R,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.019,NRAS_13R,13R,NA
single,Age,NRAS,lung cancer,>65,0,18,0.003,0,0,0.035,NRAS_13R,13R,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.002,0,0,0.025,NRAS_13R,13R,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,NRAS_13V,13V,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,colorectal cancer,<40,0,565,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,colorectal cancer,40-50,0,1280,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,colorectal cancer,50-65,0,2814,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,colorectal cancer,>65,0,2052,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,cancer of unknown primary,<40,0,167,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,cancer of unknown primary,40-50,0,211,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,cancer of unknown primary,50-65,0,810,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,cancer of unknown primary,>65,0,796,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,non-small cell lung cancer,>65,1,5698,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0.001,0,0,0.002,NRAS_13V,13V,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,breast cancer,50-65,0,3989,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,soft tissue sarcoma,<40,0,672,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,soft tissue sarcoma,50-65,0,951,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,soft tissue sarcoma,>65,0,777,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0.001,0,0,0.003,NRAS_13V,13V,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0.001,0,0,0.003,NRAS_13V,13V,NA
single,Age,NRAS,pancreatic cancer,50-65,1,999,0.001,0,0,0.002,NRAS_13V,13V,NA
single,Age,NRAS,pancreatic cancer,>65,0,1205,0,0,0,0.002,NRAS_13V,13V,NA
single,Age,NRAS,leukemia,<40,0,204,0.002,0.002,0,0.008,NRAS_13V,13V,NA
single,Age,NRAS,leukemia,40-50,0,128,0.003,0.002,0,0.009,NRAS_13V,13V,NA
single,Age,NRAS,leukemia,50-65,4,515,0.005,0.005,0.001,0.014,NRAS_13V,13V,NA
single,Age,NRAS,leukemia,>65,1,720,0.002,0.002,0,0.006,NRAS_13V,13V,NA
single,Age,NRAS,melanoma,<40,0,289,0.001,0.001,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,melanoma,40-50,0,282,0.001,0.001,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,melanoma,50-65,1,1016,0.001,0.001,0,0.003,NRAS_13V,13V,NA
single,Age,NRAS,melanoma,>65,3,1259,0.002,0.002,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,head and neck cancer,50-65,0,799,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,head and neck cancer,>65,0,582,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,uterine cancer,<40,0,57,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,uterine cancer,40-50,0,162,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,uterine cancer,50-65,0,1046,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,uterine cancer,>65,0,987,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.004,0.004,0,0.011,NRAS_13V,13V,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,1,83,0.006,0.004,0.001,0.019,NRAS_13V,13V,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,2,373,0.005,0.004,0.001,0.011,NRAS_13V,13V,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,2,664,0.004,0.004,0.001,0.009,NRAS_13V,13V,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,ovarian cancer,40-50,0,253,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,ovarian cancer,50-65,0,1092,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,ovarian cancer,>65,0,849,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,esophagogastric cancer,>65,0,725,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,thyroid cancer,<40,0,150,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,thyroid cancer,40-50,0,122,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,thyroid cancer,50-65,0,374,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,thyroid cancer,>65,0,370,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,cervical cancer,<40,0,85,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,cervical cancer,>65,0,36,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,NRAS_13V,13V,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.002,NRAS_13V,13V,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,NRAS_13V,13V,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,NRAS_13V,13V,NA
single,Age,NRAS,cns cancer,<40,0,1602,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,cns cancer,40-50,0,687,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,cns cancer,50-65,0,1439,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,cns cancer,>65,0,836,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,prostate cancer,>65,0,1402,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,anal cancer,40-50,0,12,0.001,0,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.003,NRAS_13V,13V,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.003,NRAS_13V,13V,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.002,NRAS_13V,13V,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.002,NRAS_13V,13V,NA
single,Age,NRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,bladder cancer,<40,0,25,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,bladder cancer,50-65,0,511,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,bladder cancer,>65,0,961,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0.002,0.001,0,0.013,NRAS_13V,13V,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,1,16,0.036,0.015,0,0.176,NRAS_13V,13V,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0.003,0.001,0,0.019,NRAS_13V,13V,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.003,0.001,0,0.021,NRAS_13V,13V,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.002,NRAS_13V,13V,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.007,NRAS_13V,13V,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.008,NRAS_13V,13V,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0.001,0,0,0.007,NRAS_13V,13V,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.007,NRAS_13V,13V,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.007,NRAS_13V,13V,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.007,NRAS_13V,13V,NA
single,Age,NRAS,thymic tumor,<40,0,14,0,0,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0,0,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.01,NRAS_13V,13V,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.008,NRAS_13V,13V,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0.001,0,0,0.008,NRAS_13V,13V,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0,0,0,0.002,NRAS_13V,13V,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0,0,0,0.002,NRAS_13V,13V,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0.001,NRAS_13V,13V,NA
single,Age,NRAS,germ cell tumor,<40,0,650,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,germ cell tumor,40-50,0,131,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,germ cell tumor,50-65,0,92,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,NRAS_13V,13V,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,NRAS_13V,13V,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,NRAS_13V,13V,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.003,0,0,0.034,NRAS_13V,13V,NA
single,Age,NRAS,penile cancer,>65,0,11,0.003,0,0,0.034,NRAS_13V,13V,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.004,0,0,0.045,NRAS_13V,13V,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,b cell lymphoma,50-65,0,357,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,b cell lymphoma,>65,0,413,0,0,0,0,NRAS_13V,13V,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,0,14,0.005,0,0,0.055,NRAS_13V,13V,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.021,NRAS_13V,13V,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,NRAS_13V,13V,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.029,NRAS_13V,13V,NA
single,Age,NRAS,lung cancer,>65,0,18,0.003,0,0,0.032,NRAS_13V,13V,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,NRAS_13V,13V,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,colorectal cancer,<40,0,565,0.002,0.002,0,0.004,NRAS_61H,61H,NA
single,Age,NRAS,colorectal cancer,40-50,3,1280,0.002,0.002,0.001,0.004,NRAS_61H,61H,NA
single,Age,NRAS,colorectal cancer,50-65,6,2814,0.002,0.002,0.001,0.004,NRAS_61H,61H,NA
single,Age,NRAS,colorectal cancer,>65,8,2052,0.003,0.003,0.002,0.005,NRAS_61H,61H,NA
single,Age,NRAS,cancer of unknown primary,<40,0,167,0.002,0.001,0,0.005,NRAS_61H,61H,NA
single,Age,NRAS,cancer of unknown primary,40-50,0,211,0.002,0.001,0,0.005,NRAS_61H,61H,NA
single,Age,NRAS,cancer of unknown primary,50-65,2,810,0.002,0.002,0,0.005,NRAS_61H,61H,NA
single,Age,NRAS,cancer of unknown primary,>65,1,796,0.002,0.001,0,0.004,NRAS_61H,61H,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0,0,0,0.002,NRAS_61H,61H,NA
single,Age,NRAS,non-small cell lung cancer,40-50,0,585,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,non-small cell lung cancer,50-65,0,3677,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,non-small cell lung cancer,>65,4,5698,0.001,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0.001,0,0,0.009,NRAS_61H,61H,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,breast cancer,50-65,0,3989,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,soft tissue sarcoma,<40,1,672,0.001,0.001,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0.001,0.001,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,soft tissue sarcoma,50-65,1,951,0.001,0.001,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,soft tissue sarcoma,>65,1,777,0.001,0.001,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,pancreatic cancer,50-65,0,999,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,pancreatic cancer,>65,0,1205,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,leukemia,<40,2,204,0.006,0.005,0.002,0.015,NRAS_61H,61H,NA
single,Age,NRAS,leukemia,40-50,1,128,0.005,0.005,0.001,0.014,NRAS_61H,61H,NA
single,Age,NRAS,leukemia,50-65,2,515,0.005,0.004,0.002,0.009,NRAS_61H,61H,NA
single,Age,NRAS,leukemia,>65,2,720,0.004,0.004,0.001,0.009,NRAS_61H,61H,NA
single,Age,NRAS,melanoma,<40,0,289,0.005,0.005,0,0.013,NRAS_61H,61H,NA
single,Age,NRAS,melanoma,40-50,1,282,0.007,0.007,0.001,0.014,NRAS_61H,61H,NA
single,Age,NRAS,melanoma,50-65,15,1016,0.012,0.012,0.007,0.021,NRAS_61H,61H,NA
single,Age,NRAS,melanoma,>65,11,1259,0.009,0.009,0.005,0.014,NRAS_61H,61H,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0.001,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0.001,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,head and neck cancer,50-65,1,799,0.001,0.001,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,head and neck cancer,>65,0,582,0.001,0,0,0.002,NRAS_61H,61H,NA
single,Age,NRAS,uterine cancer,<40,0,57,0.002,0.002,0,0.006,NRAS_61H,61H,NA
single,Age,NRAS,uterine cancer,40-50,0,162,0.002,0.002,0,0.005,NRAS_61H,61H,NA
single,Age,NRAS,uterine cancer,50-65,2,1046,0.002,0.002,0,0.004,NRAS_61H,61H,NA
single,Age,NRAS,uterine cancer,>65,2,987,0.002,0.002,0,0.004,NRAS_61H,61H,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.001,0.001,0,0.006,NRAS_61H,61H,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.001,0.001,0,0.006,NRAS_61H,61H,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,1,373,0.002,0.001,0,0.007,NRAS_61H,61H,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0.001,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.004,NRAS_61H,61H,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,NRAS_61H,61H,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,NRAS_61H,61H,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,NRAS_61H,61H,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,ovarian cancer,40-50,0,253,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,ovarian cancer,50-65,0,1092,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,ovarian cancer,>65,0,849,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,esophagogastric cancer,40-50,0,200,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,esophagogastric cancer,50-65,0,752,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,esophagogastric cancer,>65,0,725,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,thyroid cancer,<40,0,150,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,thyroid cancer,40-50,0,122,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,thyroid cancer,50-65,0,374,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,thyroid cancer,>65,0,370,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,cervical cancer,<40,0,85,0.003,0.002,0,0.012,NRAS_61H,61H,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0.003,0.002,0,0.012,NRAS_61H,61H,NA
single,Age,NRAS,cervical cancer,50-65,1,144,0.004,0.003,0,0.017,NRAS_61H,61H,NA
single,Age,NRAS,cervical cancer,>65,0,36,0.003,0.002,0,0.014,NRAS_61H,61H,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0.004,0.002,0,0.021,NRAS_61H,61H,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0.005,0.002,0,0.023,NRAS_61H,61H,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,1,76,0.008,0.005,0,0.035,NRAS_61H,61H,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0.003,0.002,0,0.016,NRAS_61H,61H,NA
single,Age,NRAS,cns cancer,<40,0,1602,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,cns cancer,40-50,0,687,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,cns cancer,50-65,0,1439,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,cns cancer,>65,0,836,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0.001,0.001,0,0.006,NRAS_61H,61H,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0.001,0,0,0.002,NRAS_61H,61H,NA
single,Age,NRAS,prostate cancer,>65,2,1402,0.001,0.001,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,anal cancer,40-50,0,12,0.001,0,0,0.006,NRAS_61H,61H,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.004,NRAS_61H,61H,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.005,NRAS_61H,61H,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,bladder cancer,<40,0,25,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,bladder cancer,50-65,0,511,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,bladder cancer,>65,0,961,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,2,142,0.01,0.008,0.001,0.029,NRAS_61H,61H,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.008,0.006,0,0.032,NRAS_61H,61H,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0.007,0.005,0,0.025,NRAS_61H,61H,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.007,0.005,0,0.025,NRAS_61H,61H,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.002,NRAS_61H,61H,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.002,NRAS_61H,61H,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.002,NRAS_61H,61H,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.011,NRAS_61H,61H,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.011,NRAS_61H,61H,NA
single,Age,NRAS,thymic tumor,<40,0,14,0,0,0,0.004,NRAS_61H,61H,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.01,NRAS_61H,61H,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.007,NRAS_61H,61H,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0.001,0,0,0.007,NRAS_61H,61H,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0.001,NRAS_61H,61H,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0,NRAS_61H,61H,NA
single,Age,NRAS,germ cell tumor,<40,2,650,0.004,0.003,0.001,0.009,NRAS_61H,61H,NA
single,Age,NRAS,germ cell tumor,40-50,1,131,0.005,0.004,0.001,0.015,NRAS_61H,61H,NA
single,Age,NRAS,germ cell tumor,50-65,0,92,0.004,0.003,0,0.011,NRAS_61H,61H,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0.005,0.003,0,0.017,NRAS_61H,61H,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0,0,0,0.003,NRAS_61H,61H,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.003,0,0,0.033,NRAS_61H,61H,NA
single,Age,NRAS,penile cancer,>65,0,11,0.003,0,0,0.036,NRAS_61H,61H,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.004,0,0,0.051,NRAS_61H,61H,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0.002,0.002,0,0.008,NRAS_61H,61H,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0.002,0.002,0,0.007,NRAS_61H,61H,NA
single,Age,NRAS,b cell lymphoma,50-65,1,357,0.002,0.002,0,0.007,NRAS_61H,61H,NA
single,Age,NRAS,b cell lymphoma,>65,1,413,0.002,0.002,0,0.007,NRAS_61H,61H,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.046,NRAS_61H,61H,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.001,0,0,0.013,NRAS_61H,61H,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0,0,0,0.005,NRAS_61H,61H,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.028,NRAS_61H,61H,NA
single,Age,NRAS,lung cancer,>65,1,18,0.061,0.046,0.003,0.203,NRAS_61H,61H,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.006,0,0,0.073,NRAS_61H,61H,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,NRAS_61K,61K,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,colorectal cancer,<40,5,565,0.01,0.01,0.006,0.014,NRAS_61K,61K,NA
single,Age,NRAS,colorectal cancer,40-50,12,1280,0.01,0.01,0.007,0.013,NRAS_61K,61K,NA
single,Age,NRAS,colorectal cancer,50-65,30,2814,0.01,0.01,0.007,0.013,NRAS_61K,61K,NA
single,Age,NRAS,colorectal cancer,>65,18,2052,0.009,0.009,0.007,0.012,NRAS_61K,61K,NA
single,Age,NRAS,cancer of unknown primary,<40,1,167,0.004,0.004,0.001,0.011,NRAS_61K,61K,NA
single,Age,NRAS,cancer of unknown primary,40-50,2,211,0.005,0.004,0.001,0.013,NRAS_61K,61K,NA
single,Age,NRAS,cancer of unknown primary,50-65,2,810,0.003,0.003,0.001,0.007,NRAS_61K,61K,NA
single,Age,NRAS,cancer of unknown primary,>65,2,796,0.003,0.003,0.001,0.007,NRAS_61K,61K,NA
single,Age,NRAS,non-small cell lung cancer,<40,1,161,0.001,0.001,0,0.006,NRAS_61K,61K,NA
single,Age,NRAS,non-small cell lung cancer,40-50,1,585,0.001,0.001,0,0.003,NRAS_61K,61K,NA
single,Age,NRAS,non-small cell lung cancer,50-65,2,3677,0.001,0.001,0,0.002,NRAS_61K,61K,NA
single,Age,NRAS,non-small cell lung cancer,>65,4,5698,0.001,0.001,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0.001,0.001,0,0.005,NRAS_61K,61K,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,breast cancer,50-65,0,3989,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,soft tissue sarcoma,<40,9,672,0.011,0.01,0.004,0.02,NRAS_61K,61K,NA
single,Age,NRAS,soft tissue sarcoma,40-50,2,367,0.006,0.005,0.001,0.013,NRAS_61K,61K,NA
single,Age,NRAS,soft tissue sarcoma,50-65,1,951,0.003,0.002,0,0.007,NRAS_61K,61K,NA
single,Age,NRAS,soft tissue sarcoma,>65,3,777,0.004,0.004,0.001,0.009,NRAS_61K,61K,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0.001,0.001,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0.001,0.001,0,0.003,NRAS_61K,61K,NA
single,Age,NRAS,pancreatic cancer,50-65,0,999,0.001,0,0,0.002,NRAS_61K,61K,NA
single,Age,NRAS,pancreatic cancer,>65,2,1205,0.001,0.001,0,0.003,NRAS_61K,61K,NA
single,Age,NRAS,leukemia,<40,0,204,0.007,0.007,0,0.015,NRAS_61K,61K,NA
single,Age,NRAS,leukemia,40-50,3,128,0.013,0.01,0.005,0.036,NRAS_61K,61K,NA
single,Age,NRAS,leukemia,50-65,3,515,0.008,0.008,0.003,0.014,NRAS_61K,61K,NA
single,Age,NRAS,leukemia,>65,8,720,0.01,0.009,0.005,0.017,NRAS_61K,61K,NA
single,Age,NRAS,melanoma,<40,14,289,0.063,0.064,0.04,0.081,NRAS_61K,61K,NA
single,Age,NRAS,melanoma,40-50,17,282,0.066,0.066,0.046,0.085,NRAS_61K,61K,NA
single,Age,NRAS,melanoma,50-65,83,1016,0.076,0.075,0.062,0.093,NRAS_61K,61K,NA
single,Age,NRAS,melanoma,>65,85,1259,0.068,0.068,0.056,0.08,NRAS_61K,61K,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0.002,0.001,0,0.006,NRAS_61K,61K,NA
single,Age,NRAS,head and neck cancer,40-50,1,216,0.003,0.002,0,0.009,NRAS_61K,61K,NA
single,Age,NRAS,head and neck cancer,50-65,2,799,0.002,0.002,0,0.005,NRAS_61K,61K,NA
single,Age,NRAS,head and neck cancer,>65,0,582,0.001,0.001,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,uterine cancer,<40,0,57,0.003,0.002,0,0.008,NRAS_61K,61K,NA
single,Age,NRAS,uterine cancer,40-50,0,162,0.003,0.002,0,0.006,NRAS_61K,61K,NA
single,Age,NRAS,uterine cancer,50-65,3,1046,0.003,0.003,0.001,0.006,NRAS_61K,61K,NA
single,Age,NRAS,uterine cancer,>65,3,987,0.003,0.003,0.001,0.006,NRAS_61K,61K,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0.002,0.002,0,0.007,NRAS_61K,61K,NA
single,Age,NRAS,ovarian cancer,40-50,2,253,0.003,0.003,0.001,0.012,NRAS_61K,61K,NA
single,Age,NRAS,ovarian cancer,50-65,2,1092,0.002,0.002,0.001,0.005,NRAS_61K,61K,NA
single,Age,NRAS,ovarian cancer,>65,1,849,0.002,0.002,0,0.005,NRAS_61K,61K,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0.001,0.001,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,esophagogastric cancer,40-50,0,200,0.001,0.001,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,esophagogastric cancer,50-65,1,752,0.001,0.001,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,esophagogastric cancer,>65,1,725,0.001,0.001,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,thyroid cancer,<40,3,150,0.027,0.026,0.012,0.043,NRAS_61K,61K,NA
single,Age,NRAS,thyroid cancer,40-50,2,122,0.026,0.026,0.01,0.042,NRAS_61K,61K,NA
single,Age,NRAS,thyroid cancer,50-65,15,374,0.032,0.031,0.02,0.05,NRAS_61K,61K,NA
single,Age,NRAS,thyroid cancer,>65,9,370,0.027,0.027,0.015,0.04,NRAS_61K,61K,NA
single,Age,NRAS,cervical cancer,<40,0,85,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,cervical cancer,>65,0,36,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0.004,0.004,0,0.01,NRAS_61K,61K,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0.005,0.004,0,0.011,NRAS_61K,61K,NA
single,Age,NRAS,hepatobiliary cancer,50-65,3,525,0.005,0.005,0.002,0.011,NRAS_61K,61K,NA
single,Age,NRAS,hepatobiliary cancer,>65,4,601,0.006,0.005,0.002,0.011,NRAS_61K,61K,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,NRAS_61K,61K,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.002,NRAS_61K,61K,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,NRAS_61K,61K,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,NRAS_61K,61K,NA
single,Age,NRAS,cns cancer,<40,6,1602,0.003,0.002,0.001,0.006,NRAS_61K,61K,NA
single,Age,NRAS,cns cancer,40-50,1,687,0.002,0.001,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,cns cancer,50-65,1,1439,0.001,0.001,0,0.003,NRAS_61K,61K,NA
single,Age,NRAS,cns cancer,>65,0,836,0.001,0.001,0,0.003,NRAS_61K,61K,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0.001,0,0,0.005,NRAS_61K,61K,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0.002,NRAS_61K,61K,NA
single,Age,NRAS,prostate cancer,>65,1,1402,0.001,0,0,0.002,NRAS_61K,61K,NA
single,Age,NRAS,anal cancer,40-50,0,12,0.001,0,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.003,NRAS_61K,61K,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.003,NRAS_61K,61K,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.002,NRAS_61K,61K,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.002,NRAS_61K,61K,NA
single,Age,NRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,bladder cancer,<40,0,25,0.003,0.002,0,0.01,NRAS_61K,61K,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0.002,0.002,0,0.008,NRAS_61K,61K,NA
single,Age,NRAS,bladder cancer,50-65,2,511,0.003,0.002,0,0.007,NRAS_61K,61K,NA
single,Age,NRAS,bladder cancer,>65,1,961,0.002,0.002,0,0.005,NRAS_61K,61K,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,3,142,0.017,0.015,0.003,0.045,NRAS_61K,61K,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.008,0.004,0,0.037,NRAS_61K,61K,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0.006,0.003,0,0.028,NRAS_61K,61K,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.006,0.003,0,0.029,NRAS_61K,61K,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.002,NRAS_61K,61K,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.007,NRAS_61K,61K,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.008,NRAS_61K,61K,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0.001,0,0,0.007,NRAS_61K,61K,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.007,NRAS_61K,61K,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0,NRAS_61K,61K,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.007,NRAS_61K,61K,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.007,NRAS_61K,61K,NA
single,Age,NRAS,thymic tumor,<40,0,14,0.008,0.004,0,0.038,NRAS_61K,61K,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0.007,0.003,0,0.032,NRAS_61K,61K,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0.005,0.003,0,0.025,NRAS_61K,61K,NA
single,Age,NRAS,thymic tumor,>65,1,40,0.014,0.008,0,0.061,NRAS_61K,61K,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.01,NRAS_61K,61K,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.008,NRAS_61K,61K,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0.001,0,0,0.008,NRAS_61K,61K,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0.004,0.002,0,0.021,NRAS_61K,61K,NA
single,Age,NRAS,small cell lung cancer,50-65,1,144,0.005,0.003,0,0.018,NRAS_61K,61K,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0.002,0.001,0,0.009,NRAS_61K,61K,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0.001,NRAS_61K,61K,NA
single,Age,NRAS,germ cell tumor,<40,1,650,0.003,0.003,0,0.008,NRAS_61K,61K,NA
single,Age,NRAS,germ cell tumor,40-50,1,131,0.005,0.004,0.001,0.016,NRAS_61K,61K,NA
single,Age,NRAS,germ cell tumor,50-65,1,92,0.006,0.004,0.001,0.021,NRAS_61K,61K,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0.005,0.003,0,0.024,NRAS_61K,61K,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,NRAS_61K,61K,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,NRAS_61K,61K,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,NRAS_61K,61K,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.003,0,0,0.034,NRAS_61K,61K,NA
single,Age,NRAS,penile cancer,>65,0,11,0.003,0,0,0.034,NRAS_61K,61K,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.004,0,0,0.045,NRAS_61K,61K,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0.003,0.003,0,0.01,NRAS_61K,61K,NA
single,Age,NRAS,b cell lymphoma,40-50,1,105,0.004,0.003,0.001,0.015,NRAS_61K,61K,NA
single,Age,NRAS,b cell lymphoma,50-65,1,357,0.003,0.003,0.001,0.009,NRAS_61K,61K,NA
single,Age,NRAS,b cell lymphoma,>65,1,413,0.003,0.003,0.001,0.008,NRAS_61K,61K,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,0,14,0.005,0,0,0.055,NRAS_61K,61K,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.021,NRAS_61K,61K,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,NRAS_61K,61K,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.029,NRAS_61K,61K,NA
single,Age,NRAS,lung cancer,>65,0,18,0.003,0,0,0.032,NRAS_61K,61K,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,NRAS_61K,61K,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0,0,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,appendiceal cancer,40-50,0,62,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,appendiceal cancer,50-65,0,161,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,appendiceal cancer,>65,0,90,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,colorectal cancer,<40,2,565,0.003,0.003,0.002,0.006,NRAS_61L,61L,NA
single,Age,NRAS,colorectal cancer,40-50,4,1280,0.003,0.003,0.002,0.005,NRAS_61L,61L,NA
single,Age,NRAS,colorectal cancer,50-65,11,2814,0.003,0.003,0.002,0.005,NRAS_61L,61L,NA
single,Age,NRAS,colorectal cancer,>65,5,2052,0.003,0.003,0.002,0.005,NRAS_61L,61L,NA
single,Age,NRAS,cancer of unknown primary,<40,0,167,0.001,0,0,0.003,NRAS_61L,61L,NA
single,Age,NRAS,cancer of unknown primary,40-50,0,211,0.001,0,0,0.003,NRAS_61L,61L,NA
single,Age,NRAS,cancer of unknown primary,50-65,0,810,0.001,0,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,cancer of unknown primary,>65,1,796,0.001,0.001,0,0.003,NRAS_61L,61L,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0.003,0.003,0.001,0.006,NRAS_61L,61L,NA
single,Age,NRAS,non-small cell lung cancer,40-50,2,585,0.003,0.003,0.002,0.006,NRAS_61L,61L,NA
single,Age,NRAS,non-small cell lung cancer,50-65,15,3677,0.003,0.003,0.002,0.005,NRAS_61L,61L,NA
single,Age,NRAS,non-small cell lung cancer,>65,15,5698,0.003,0.003,0.002,0.004,NRAS_61L,61L,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0.003,0.003,0.001,0.008,NRAS_61L,61L,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,breast cancer,50-65,0,3989,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,soft tissue sarcoma,<40,2,672,0.002,0.002,0,0.006,NRAS_61L,61L,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0.001,0.001,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,soft tissue sarcoma,50-65,0,951,0.001,0.001,0,0.003,NRAS_61L,61L,NA
single,Age,NRAS,soft tissue sarcoma,>65,2,777,0.002,0.002,0,0.005,NRAS_61L,61L,NA
single,Age,NRAS,pancreatic cancer,<40,0,87,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,pancreatic cancer,40-50,0,200,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,pancreatic cancer,50-65,0,999,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,pancreatic cancer,>65,0,1205,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,leukemia,<40,0,204,0.003,0.003,0,0.008,NRAS_61L,61L,NA
single,Age,NRAS,leukemia,40-50,0,128,0.004,0.003,0,0.009,NRAS_61L,61L,NA
single,Age,NRAS,leukemia,50-65,3,515,0.004,0.004,0.001,0.01,NRAS_61L,61L,NA
single,Age,NRAS,leukemia,>65,3,720,0.004,0.004,0.001,0.008,NRAS_61L,61L,NA
single,Age,NRAS,melanoma,<40,5,289,0.021,0.021,0.009,0.037,NRAS_61L,61L,NA
single,Age,NRAS,melanoma,40-50,7,282,0.026,0.025,0.012,0.043,NRAS_61L,61L,NA
single,Age,NRAS,melanoma,50-65,18,1016,0.02,0.019,0.012,0.029,NRAS_61L,61L,NA
single,Age,NRAS,melanoma,>65,58,1259,0.044,0.043,0.033,0.056,NRAS_61L,61L,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,head and neck cancer,50-65,0,799,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,head and neck cancer,>65,0,582,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,uterine cancer,<40,0,57,0.003,0.002,0,0.008,NRAS_61L,61L,NA
single,Age,NRAS,uterine cancer,40-50,0,162,0.003,0.002,0,0.006,NRAS_61L,61L,NA
single,Age,NRAS,uterine cancer,50-65,4,1046,0.003,0.003,0.001,0.007,NRAS_61L,61L,NA
single,Age,NRAS,uterine cancer,>65,2,987,0.003,0.002,0.001,0.006,NRAS_61L,61L,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,0,373,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,0,664,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,ovarian cancer,<40,0,141,0.001,0,0,0.003,NRAS_61L,61L,NA
single,Age,NRAS,ovarian cancer,40-50,0,253,0.001,0,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,ovarian cancer,50-65,1,1092,0.001,0,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,ovarian cancer,>65,0,849,0,0,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0.001,0,0,0.003,NRAS_61L,61L,NA
single,Age,NRAS,esophagogastric cancer,40-50,0,200,0.001,0,0,0.003,NRAS_61L,61L,NA
single,Age,NRAS,esophagogastric cancer,50-65,0,752,0.001,0,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,esophagogastric cancer,>65,1,725,0.001,0.001,0,0.003,NRAS_61L,61L,NA
single,Age,NRAS,thyroid cancer,<40,0,150,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,thyroid cancer,40-50,0,122,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,thyroid cancer,50-65,0,374,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,thyroid cancer,>65,0,370,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,cervical cancer,<40,0,85,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,cervical cancer,>65,0,36,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,hepatobiliary cancer,40-50,0,110,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,hepatobiliary cancer,50-65,0,525,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,hepatobiliary cancer,>65,0,601,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0,0,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0,0,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,0,76,0,0,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0,0,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,cns cancer,<40,1,1602,0.001,0.001,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,cns cancer,40-50,1,687,0.001,0.001,0,0.003,NRAS_61L,61L,NA
single,Age,NRAS,cns cancer,50-65,1,1439,0.001,0.001,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,cns cancer,>65,2,836,0.001,0.001,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,prostate cancer,>65,0,1402,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,anal cancer,40-50,0,12,0.001,0,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.003,NRAS_61L,61L,NA
single,Age,NRAS,anal cancer,>65,0,45,0,0,0,0.003,NRAS_61L,61L,NA
single,Age,NRAS,neuroendocrine tumors,<40,0,22,0,0,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0,0,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,neuroendocrine tumors,50-65,0,161,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,bladder cancer,<40,0,25,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,bladder cancer,40-50,0,78,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,bladder cancer,50-65,0,511,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,bladder cancer,>65,0,961,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,0,142,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0,0,0,0.002,NRAS_61L,61L,NA
single,Age,NRAS,small bowel cancer,50-65,0,96,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,small bowel cancer,>65,0,78,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0.001,0,0,0.007,NRAS_61L,61L,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.008,NRAS_61L,61L,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0.001,0,0,0.007,NRAS_61L,61L,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0.001,0,0,0.007,NRAS_61L,61L,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0,NRAS_61L,61L,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.007,NRAS_61L,61L,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.007,NRAS_61L,61L,NA
single,Age,NRAS,thymic tumor,<40,0,14,0,0,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0,0,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.01,NRAS_61L,61L,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0.001,0,0,0.008,NRAS_61L,61L,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0.001,0,0,0.008,NRAS_61L,61L,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0.004,0.002,0,0.018,NRAS_61L,61L,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0.002,0.001,0,0.011,NRAS_61L,61L,NA
single,Age,NRAS,small cell lung cancer,>65,1,224,0.004,0.003,0,0.013,NRAS_61L,61L,NA
single,Age,NRAS,mesothelioma,<40,0,30,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,mesothelioma,>65,0,316,0,0,0,0.001,NRAS_61L,61L,NA
single,Age,NRAS,germ cell tumor,<40,1,650,0.001,0.001,0,0.005,NRAS_61L,61L,NA
single,Age,NRAS,germ cell tumor,40-50,0,131,0.001,0.001,0,0.006,NRAS_61L,61L,NA
single,Age,NRAS,germ cell tumor,50-65,0,92,0.001,0.001,0,0.006,NRAS_61L,61L,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0.002,0.001,0,0.01,NRAS_61L,61L,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0,0,0,0.003,NRAS_61L,61L,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0,0,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,nerve sheath tumor,50-65,0,37,0,0,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,nerve sheath tumor,>65,0,13,0.001,0,0,0.005,NRAS_61L,61L,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.003,0,0,0.034,NRAS_61L,61L,NA
single,Age,NRAS,penile cancer,>65,0,11,0.003,0,0,0.034,NRAS_61L,61L,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.004,0,0,0.045,NRAS_61L,61L,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0.001,0.001,0,0.006,NRAS_61L,61L,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0.001,0.001,0,0.006,NRAS_61L,61L,NA
single,Age,NRAS,b cell lymphoma,50-65,0,357,0.001,0.001,0,0.004,NRAS_61L,61L,NA
single,Age,NRAS,b cell lymphoma,>65,1,413,0.002,0.001,0,0.006,NRAS_61L,61L,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,0,14,0.005,0,0,0.055,NRAS_61L,61L,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.021,NRAS_61L,61L,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.012,NRAS_61L,61L,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.029,NRAS_61L,61L,NA
single,Age,NRAS,lung cancer,>65,0,18,0.003,0,0,0.032,NRAS_61L,61L,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.004,0,0,0.046,NRAS_61L,61L,NA
single,Age,NRAS,appendiceal cancer,<40,0,28,0.015,0.013,0.001,0.037,NRAS_61R,61R,NA
single,Age,NRAS,appendiceal cancer,40-50,2,62,0.018,0.016,0.005,0.048,NRAS_61R,61R,NA
single,Age,NRAS,appendiceal cancer,50-65,2,161,0.015,0.014,0.004,0.031,NRAS_61R,61R,NA
single,Age,NRAS,appendiceal cancer,>65,1,90,0.015,0.014,0.003,0.034,NRAS_61R,61R,NA
single,Age,NRAS,colorectal cancer,<40,3,565,0.007,0.007,0.003,0.01,NRAS_61R,61R,NA
single,Age,NRAS,colorectal cancer,40-50,13,1280,0.008,0.007,0.005,0.013,NRAS_61R,61R,NA
single,Age,NRAS,colorectal cancer,50-65,19,2814,0.007,0.007,0.005,0.009,NRAS_61R,61R,NA
single,Age,NRAS,colorectal cancer,>65,11,2052,0.006,0.006,0.004,0.009,NRAS_61R,61R,NA
single,Age,NRAS,cancer of unknown primary,<40,2,167,0.006,0.005,0.002,0.018,NRAS_61R,61R,NA
single,Age,NRAS,cancer of unknown primary,40-50,1,211,0.005,0.004,0.001,0.011,NRAS_61R,61R,NA
single,Age,NRAS,cancer of unknown primary,50-65,4,810,0.004,0.004,0.002,0.009,NRAS_61R,61R,NA
single,Age,NRAS,cancer of unknown primary,>65,1,796,0.003,0.003,0.001,0.007,NRAS_61R,61R,NA
single,Age,NRAS,non-small cell lung cancer,<40,0,161,0.002,0.001,0,0.004,NRAS_61R,61R,NA
single,Age,NRAS,non-small cell lung cancer,40-50,2,585,0.002,0.002,0.001,0.005,NRAS_61R,61R,NA
single,Age,NRAS,non-small cell lung cancer,50-65,6,3677,0.002,0.002,0.001,0.003,NRAS_61R,61R,NA
single,Age,NRAS,non-small cell lung cancer,>65,7,5698,0.001,0.001,0.001,0.002,NRAS_61R,61R,NA
single,Age,NRAS,non-small cell lung cancer,NA,0,10,0.002,0.001,0,0.005,NRAS_61R,61R,NA
single,Age,NRAS,breast cancer,<40,0,840,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,breast cancer,40-50,0,1910,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,breast cancer,50-65,0,3989,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,breast cancer,>65,0,2583,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,breast cancer,NA,0,10,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,soft tissue sarcoma,<40,3,672,0.003,0.003,0.001,0.009,NRAS_61R,61R,NA
single,Age,NRAS,soft tissue sarcoma,40-50,0,367,0.002,0.001,0,0.005,NRAS_61R,61R,NA
single,Age,NRAS,soft tissue sarcoma,50-65,3,951,0.003,0.002,0.001,0.006,NRAS_61R,61R,NA
single,Age,NRAS,soft tissue sarcoma,>65,0,777,0.001,0.001,0,0.004,NRAS_61R,61R,NA
single,Age,NRAS,pancreatic cancer,<40,1,87,0.005,0.003,0.001,0.022,NRAS_61R,61R,NA
single,Age,NRAS,pancreatic cancer,40-50,2,200,0.005,0.004,0.001,0.017,NRAS_61R,61R,NA
single,Age,NRAS,pancreatic cancer,50-65,3,999,0.003,0.003,0.001,0.007,NRAS_61R,61R,NA
single,Age,NRAS,pancreatic cancer,>65,1,1205,0.002,0.002,0,0.005,NRAS_61R,61R,NA
single,Age,NRAS,leukemia,<40,5,204,0.014,0.012,0.007,0.032,NRAS_61R,61R,NA
single,Age,NRAS,leukemia,40-50,1,128,0.011,0.011,0.003,0.021,NRAS_61R,61R,NA
single,Age,NRAS,leukemia,50-65,5,515,0.011,0.011,0.005,0.018,NRAS_61R,61R,NA
single,Age,NRAS,leukemia,>65,6,720,0.01,0.01,0.005,0.017,NRAS_61R,61R,NA
single,Age,NRAS,melanoma,<40,18,289,0.08,0.082,0.055,0.099,NRAS_61R,61R,NA
single,Age,NRAS,melanoma,40-50,28,282,0.09,0.088,0.071,0.115,NRAS_61R,61R,NA
single,Age,NRAS,melanoma,50-65,92,1016,0.088,0.088,0.075,0.103,NRAS_61R,61R,NA
single,Age,NRAS,melanoma,>65,108,1259,0.086,0.086,0.074,0.099,NRAS_61R,61R,NA
single,Age,NRAS,head and neck cancer,<40,0,140,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,head and neck cancer,40-50,0,216,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,head and neck cancer,50-65,0,799,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,head and neck cancer,>65,0,582,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,uterine cancer,<40,0,57,0.004,0.003,0,0.017,NRAS_61R,61R,NA
single,Age,NRAS,uterine cancer,40-50,3,162,0.011,0.008,0.002,0.033,NRAS_61R,61R,NA
single,Age,NRAS,uterine cancer,50-65,5,1046,0.005,0.004,0.002,0.009,NRAS_61R,61R,NA
single,Age,NRAS,uterine cancer,>65,1,987,0.003,0.002,0,0.006,NRAS_61R,61R,NA
single,Age,NRAS,non-melanoma skin cancers,<40,0,27,0,0,0,0.001,NRAS_61R,61R,NA
single,Age,NRAS,non-melanoma skin cancers,40-50,0,20,0,0,0,0.001,NRAS_61R,61R,NA
single,Age,NRAS,non-melanoma skin cancers,50-65,0,149,0,0,0,0.001,NRAS_61R,61R,NA
single,Age,NRAS,non-melanoma skin cancers,>65,0,317,0,0,0,0.001,NRAS_61R,61R,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,<40,0,87,0.002,0.001,0,0.007,NRAS_61R,61R,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,40-50,0,83,0.002,0.001,0,0.007,NRAS_61R,61R,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,50-65,1,373,0.002,0.002,0,0.006,NRAS_61R,61R,NA
single,Age,NRAS,myelodysplastic/myeloproliferative syndromes,>65,1,664,0.002,0.001,0,0.005,NRAS_61R,61R,NA
single,Age,NRAS,adrenocortical carcinoma,<40,0,27,0,0,0,0.003,NRAS_61R,61R,NA
single,Age,NRAS,adrenocortical carcinoma,40-50,0,30,0,0,0,0.004,NRAS_61R,61R,NA
single,Age,NRAS,adrenocortical carcinoma,50-65,0,51,0,0,0,0.004,NRAS_61R,61R,NA
single,Age,NRAS,adrenocortical carcinoma,>65,0,26,0,0,0,0.004,NRAS_61R,61R,NA
single,Age,NRAS,ovarian cancer,<40,2,141,0.011,0.011,0.005,0.021,NRAS_61R,61R,NA
single,Age,NRAS,ovarian cancer,40-50,1,253,0.01,0.01,0.003,0.016,NRAS_61R,61R,NA
single,Age,NRAS,ovarian cancer,50-65,14,1092,0.011,0.011,0.007,0.017,NRAS_61R,61R,NA
single,Age,NRAS,ovarian cancer,>65,8,849,0.01,0.01,0.006,0.016,NRAS_61R,61R,NA
single,Age,NRAS,esophagogastric cancer,<40,0,122,0.002,0.002,0,0.006,NRAS_61R,61R,NA
single,Age,NRAS,esophagogastric cancer,40-50,1,200,0.002,0.002,0,0.008,NRAS_61R,61R,NA
single,Age,NRAS,esophagogastric cancer,50-65,1,752,0.002,0.002,0,0.004,NRAS_61R,61R,NA
single,Age,NRAS,esophagogastric cancer,>65,1,725,0.002,0.002,0,0.004,NRAS_61R,61R,NA
single,Age,NRAS,thyroid cancer,<40,8,150,0.079,0.081,0.041,0.111,NRAS_61R,61R,NA
single,Age,NRAS,thyroid cancer,40-50,15,122,0.103,0.1,0.072,0.153,NRAS_61R,61R,NA
single,Age,NRAS,thyroid cancer,50-65,31,374,0.088,0.088,0.064,0.113,NRAS_61R,61R,NA
single,Age,NRAS,thyroid cancer,>65,41,370,0.102,0.101,0.078,0.133,NRAS_61R,61R,NA
single,Age,NRAS,cervical cancer,<40,1,85,0.006,0.004,0,0.03,NRAS_61R,61R,NA
single,Age,NRAS,cervical cancer,40-50,0,99,0.002,0.001,0,0.012,NRAS_61R,61R,NA
single,Age,NRAS,cervical cancer,50-65,0,144,0.002,0.001,0,0.011,NRAS_61R,61R,NA
single,Age,NRAS,cervical cancer,>65,0,36,0.003,0.001,0,0.016,NRAS_61R,61R,NA
single,Age,NRAS,hepatobiliary cancer,<40,0,137,0.006,0.006,0.001,0.013,NRAS_61R,61R,NA
single,Age,NRAS,hepatobiliary cancer,40-50,1,110,0.007,0.007,0.002,0.016,NRAS_61R,61R,NA
single,Age,NRAS,hepatobiliary cancer,50-65,4,525,0.007,0.007,0.003,0.013,NRAS_61R,61R,NA
single,Age,NRAS,hepatobiliary cancer,>65,4,601,0.007,0.006,0.003,0.012,NRAS_61R,61R,NA
single,Age,NRAS,kidney cancer,<40,0,191,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,kidney cancer,40-50,0,159,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,kidney cancer,50-65,0,628,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,kidney cancer,>65,0,440,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,mature t and nk neoplasms,<40,0,28,0.005,0.003,0,0.024,NRAS_61R,61R,NA
single,Age,NRAS,mature t and nk neoplasms,40-50,0,21,0.005,0.003,0,0.026,NRAS_61R,61R,NA
single,Age,NRAS,mature t and nk neoplasms,50-65,1,76,0.008,0.005,0,0.033,NRAS_61R,61R,NA
single,Age,NRAS,mature t and nk neoplasms,>65,0,106,0.004,0.002,0,0.016,NRAS_61R,61R,NA
single,Age,NRAS,cns cancer,<40,4,1602,0.002,0.002,0.001,0.004,NRAS_61R,61R,NA
single,Age,NRAS,cns cancer,40-50,1,687,0.002,0.001,0,0.003,NRAS_61R,61R,NA
single,Age,NRAS,cns cancer,50-65,1,1439,0.001,0.001,0,0.003,NRAS_61R,61R,NA
single,Age,NRAS,cns cancer,>65,1,836,0.002,0.001,0,0.003,NRAS_61R,61R,NA
single,Age,NRAS,prostate cancer,40-50,0,70,0.001,0,0,0.005,NRAS_61R,61R,NA
single,Age,NRAS,prostate cancer,50-65,0,960,0,0,0,0.002,NRAS_61R,61R,NA
single,Age,NRAS,prostate cancer,>65,1,1402,0.001,0,0,0.002,NRAS_61R,61R,NA
single,Age,NRAS,anal cancer,40-50,0,12,0.001,0,0,0.008,NRAS_61R,61R,NA
single,Age,NRAS,anal cancer,50-65,0,88,0,0,0,0.005,NRAS_61R,61R,NA
single,Age,NRAS,anal cancer,>65,0,45,0.001,0,0,0.006,NRAS_61R,61R,NA
single,Age,NRAS,neuroendocrine tumors,<40,1,22,0.024,0.009,0,0.124,NRAS_61R,61R,NA
single,Age,NRAS,neuroendocrine tumors,40-50,0,55,0.003,0.001,0,0.015,NRAS_61R,61R,NA
single,Age,NRAS,neuroendocrine tumors,50-65,0,161,0.002,0.001,0,0.01,NRAS_61R,61R,NA
single,Age,NRAS,neuroendocrine tumors,>65,0,121,0.002,0.001,0,0.011,NRAS_61R,61R,NA
single,Age,NRAS,bladder cancer,<40,0,25,0.003,0.002,0,0.013,NRAS_61R,61R,NA
single,Age,NRAS,bladder cancer,40-50,1,78,0.004,0.002,0,0.02,NRAS_61R,61R,NA
single,Age,NRAS,bladder cancer,50-65,1,511,0.002,0.002,0,0.006,NRAS_61R,61R,NA
single,Age,NRAS,bladder cancer,>65,1,961,0.002,0.002,0,0.005,NRAS_61R,61R,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,<40,2,142,0.01,0.008,0.001,0.03,NRAS_61R,61R,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,40-50,0,16,0.008,0.006,0,0.032,NRAS_61R,61R,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,50-65,0,48,0.007,0.005,0,0.025,NRAS_61R,61R,NA
single,Age,NRAS,b-lymphoblastic leukemia/lymphoma,>65,0,42,0.007,0.005,0,0.025,NRAS_61R,61R,NA
single,Age,NRAS,small bowel cancer,40-50,0,29,0.01,0.008,0,0.035,NRAS_61R,61R,NA
single,Age,NRAS,small bowel cancer,50-65,1,96,0.011,0.009,0.001,0.031,NRAS_61R,61R,NA
single,Age,NRAS,small bowel cancer,>65,1,78,0.011,0.009,0.001,0.034,NRAS_61R,61R,NA
single,Age,NRAS,sex cord stromal tumor,<40,0,29,0,0,0,0.006,NRAS_61R,61R,NA
single,Age,NRAS,sex cord stromal tumor,40-50,0,15,0.001,0,0,0.006,NRAS_61R,61R,NA
single,Age,NRAS,sex cord stromal tumor,50-65,0,36,0,0,0,0.006,NRAS_61R,61R,NA
single,Age,NRAS,sex cord stromal tumor,>65,0,27,0,0,0,0.006,NRAS_61R,61R,NA
single,Age,NRAS,bone cancer,<40,0,342,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,bone cancer,40-50,0,61,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,bone cancer,50-65,0,96,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,bone cancer,>65,0,67,0,0,0,0,NRAS_61R,61R,NA
single,Age,NRAS,vaginal cancer,50-65,0,34,0.001,0,0,0.012,NRAS_61R,61R,NA
single,Age,NRAS,vaginal cancer,>65,0,30,0.001,0,0,0.012,NRAS_61R,61R,NA
single,Age,NRAS,thymic tumor,<40,0,14,0.001,0,0,0.005,NRAS_61R,61R,NA
single,Age,NRAS,thymic tumor,40-50,0,28,0.001,0,0,0.005,NRAS_61R,61R,NA
single,Age,NRAS,thymic tumor,50-65,0,72,0,0,0,0.004,NRAS_61R,61R,NA
single,Age,NRAS,thymic tumor,>65,0,40,0,0,0,0.005,NRAS_61R,61R,NA
single,Age,NRAS,ampullary cancer,40-50,0,12,0.001,0,0,0.006,NRAS_61R,61R,NA
single,Age,NRAS,ampullary cancer,50-65,0,40,0,0,0,0.005,NRAS_61R,61R,NA
single,Age,NRAS,ampullary cancer,>65,0,50,0,0,0,0.005,NRAS_61R,61R,NA
single,Age,NRAS,small cell lung cancer,40-50,0,22,0,0,0,0.001,NRAS_61R,61R,NA
single,Age,NRAS,small cell lung cancer,50-65,0,144,0,0,0,0.001,NRAS_61R,61R,NA
single,Age,NRAS,small cell lung cancer,>65,0,224,0,0,0,0.001,NRAS_61R,61R,NA
single,Age,NRAS,mesothelioma,<40,0,30,0.003,0.002,0,0.013,NRAS_61R,61R,NA
single,Age,NRAS,mesothelioma,40-50,0,29,0.003,0.002,0,0.012,NRAS_61R,61R,NA
single,Age,NRAS,mesothelioma,50-65,0,122,0.002,0.001,0,0.009,NRAS_61R,61R,NA
single,Age,NRAS,mesothelioma,>65,1,316,0.003,0.002,0,0.009,NRAS_61R,61R,NA
single,Age,NRAS,germ cell tumor,<40,0,650,0.001,0.001,0,0.006,NRAS_61R,61R,NA
single,Age,NRAS,germ cell tumor,40-50,2,131,0.011,0.009,0.001,0.036,NRAS_61R,61R,NA
single,Age,NRAS,germ cell tumor,50-65,1,92,0.008,0.005,0,0.032,NRAS_61R,61R,NA
single,Age,NRAS,germ cell tumor,>65,0,12,0.007,0.002,0,0.049,NRAS_61R,61R,NA
single,Age,NRAS,nerve sheath tumor,<40,0,77,0.01,0.008,0,0.034,NRAS_61R,61R,NA
single,Age,NRAS,nerve sheath tumor,40-50,0,27,0.012,0.009,0,0.045,NRAS_61R,61R,NA
single,Age,NRAS,nerve sheath tumor,50-65,1,37,0.019,0.014,0.002,0.067,NRAS_61R,61R,NA
single,Age,NRAS,nerve sheath tumor,>65,1,13,0.033,0.018,0.002,0.161,NRAS_61R,61R,NA
single,Age,NRAS,penile cancer,50-65,0,11,0.002,0,0,0.019,NRAS_61R,61R,NA
single,Age,NRAS,penile cancer,>65,0,11,0.002,0,0,0.02,NRAS_61R,61R,NA
single,Age,NRAS,pineal tumor,<40,0,14,0.003,0,0,0.036,NRAS_61R,61R,NA
single,Age,NRAS,b cell lymphoma,<40,0,87,0.006,0.005,0,0.014,NRAS_61R,61R,NA
single,Age,NRAS,b cell lymphoma,40-50,0,105,0.005,0.005,0,0.014,NRAS_61R,61R,NA
single,Age,NRAS,b cell lymphoma,50-65,4,357,0.008,0.007,0.003,0.018,NRAS_61R,61R,NA
single,Age,NRAS,b cell lymphoma,>65,2,413,0.006,0.005,0.001,0.013,NRAS_61R,61R,NA
single,Age,NRAS,non-hodgkin lymphoma,>65,0,14,0.004,0,0,0.053,NRAS_61R,61R,NA
single,Age,NRAS,t-lymphoblastic leukemia/lymphoma,<40,0,27,0.002,0,0,0.024,NRAS_61R,61R,NA
single,Age,NRAS,retinoblastoma,<40,0,51,0.001,0,0,0.008,NRAS_61R,61R,NA
single,Age,NRAS,hodgkin lymphoma,<40,0,23,0.002,0,0,0.023,NRAS_61R,61R,NA
single,Age,NRAS,lung cancer,>65,0,18,0.002,0,0,0.02,NRAS_61R,61R,NA
single,Age,NRAS,peritoneal cancer,>65,0,11,0.005,0,0,0.062,NRAS_61R,61R,NA
